Variant_ID;Variant;Entity1_type;Disease_ID;Disease;Entity2_type;LADME
PA166218661;rs351776;VARIANT;PA165108809;NEONATAL ABSTINENCE SYNDROME;DISEASE;PD
PA166156025;rs4818;VARIANT;PA445208;PAIN;DISEASE;
PA166156025;rs4818;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166154626;rs11045585;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166161516;rs2228014;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166176039;rs367398;VARIANT;PA166120929;SEVERE CUTANEOUS ADVERSE REACTIONS;DISEASE;PD
PA166157485;rs28401781;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166153617;rs1061170;VARIANT;PA134850558;MACULAR DEGENERATION;DISEASE;PD
PA166179108;rs780668;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166156912;rs200148;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166259922;rs11782370;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166156406;rs6438552;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166163749;rs12119882;VARIANT;PA444511;HYPERBILIRUBINEMIA;DISEASE;PD
PA166163749;rs12119882;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166157216;rs72552763;VARIANT;PA443890;DIABETES MELLITUS, TYPE 2;DISEASE;
PA166157216;rs72552763;VARIANT;PA444614;INFECTION;DISEASE;
PA166157216;rs72552763;VARIANT;PA446155;PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;DISEASE;
PA166155344;rs14158;VARIANT;PA446863;CHRONIC HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166155344;rs14158;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166157560;rs1495741;VARIANT;PA445941;TUBERCULOSIS;DISEASE;PD
PA166156827;rs4431329;VARIANT;PA447288;ESSENTIAL HYPERTENSION;DISEASE;PD
PA166157809;rs10739150;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166155256;rs16960228;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166283281;rs444904;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166156906;rs25648;VARIANT;PA445742;STOMACH NEOPLASMS;DISEASE;PD
PA166155597;rs676210;VARIANT;PA446120;HYPERTRIGLYCERIDEMIA;DISEASE;PD
PA166154854;rs1008805;VARIANT;PA166048848;MENOPAUSE;DISEASE;
PA166154854;rs1008805;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166155632;rs1367117;VARIANT;PA166123431;HEART VALVE REPLACEMENT;DISEASE;PD
PA166155632;rs1367117;VARIANT;PA444417;HEMORRHAGE;DISEASE;PD
PA166155632;rs1367117;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166155039;rs2307240;VARIANT;PA165108401;ACUTE CORONARY SYNDROME;DISEASE;PD
PA166155630;rs1143634;VARIANT;PA443815;CROHN DISEASE;DISEASE;PD
PA166155630;rs1143634;VARIANT;PA445210;PAIN, POSTOPERATIVE;DISEASE;PD
PA166155630;rs1143634;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166155674;rs2241883;VARIANT;PA446120;HYPERTRIGLYCERIDEMIA;DISEASE;PD
PA166184212;rs508448;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;
PA166164951;rs150212784;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166154091;rs7917983;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166157349;rs2270007;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166155046;rs3024530;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166157424;rs6966038;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166157538;rs320;VARIANT;PA446120;HYPERTRIGLYCERIDEMIA;DISEASE;PD
PA166153827;rs11265572;VARIANT;PA447247;LIVER TRANSPLANTATION;DISEASE;
PA166154844;rs660652;VARIANT;PA445208;PAIN;DISEASE;PD
PA166154844;rs660652;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166156093;rs2284017;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166154090;rs7917432;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166203408;rs2233407;VARIANT;PA164925725;TOXIC LIVER DISEASE;DISEASE;PD
PA166203408;rs2233407;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166155619;rs1051685;VARIANT;PA444985;MULTIPLE MYELOMA;DISEASE;PD
PA166177127;rs10123866;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166153776;rs4844880;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;
PA166199041;rs757081;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166157541;rs3594;VARIANT;PA445204;OVARIAN NEOPLASMS;DISEASE;PD
PA166179948;rs3852209;VARIANT;PA166123046;SMOKING CESSATION;DISEASE;
PA166179948;rs3852209;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166154602;rs7311358;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;
PA166154602;rs7311358;VARIANT;PA166114454;TRANSPLANT REJECTION;DISEASE;PD
PA166154602;rs7311358;VARIANT;PA166114457;LUNG TRANSPLANTATION;DISEASE;PD
PA166154602;rs7311358;VARIANT;PA166123207;OVERALL SURVIVAL;DISEASE;PD
PA166154602;rs7311358;VARIANT;PA166195784;CHRONIC LUNG ALLOGRAFT DYSFUNCTION;DISEASE;PD
PA166154602;rs7311358;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166180172;rs9397685;VARIANT;PA445048;NAUSEA;DISEASE;PD
PA166180172;rs9397685;VARIANT;PA445210;PAIN, POSTOPERATIVE;DISEASE;PD
PA166180172;rs9397685;VARIANT;PA446051;VOMITING;DISEASE;PD
PA166177119;rs9873889;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166155798;rs11123469;VARIANT;PA162370415;METABOLIC SYNDROME;DISEASE;
PA166155798;rs11123469;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;
PA166156787;rs2216711;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166156091;rs2267076;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166153719;rs2819742;VARIANT;PA443635;CARDIOVASCULAR DISEASE;DISEASE;PD
PA166153719;rs2819742;VARIANT;PA445549;RHABDOMYOLYSIS;DISEASE;PD
PA166154633;rs11045879;VARIANT;PA166124386;GASTROINTESTINAL TOXICITY;DISEASE;PD
PA166154633;rs11045879;VARIANT;PA444840;LYMPHOMA;DISEASE;PD
PA166154633;rs11045879;VARIANT;PA445062;NEOPLASMS;DISEASE;
PA166154633;rs11045879;VARIANT;PA445601;OSTEOSARCOMA;DISEASE;PD
PA166154633;rs11045879;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166157391;rs4646437;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;PD
PA166157391;rs4646437;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166157391;rs4646437;VARIANT;PA445009;MYCOSES;DISEASE;
PA166157391;rs4646437;VARIANT;PA445431;PROTEINURIA;DISEASE;
PA166157391;rs4646437;VARIANT;PA447247;LIVER TRANSPLANTATION;DISEASE;
PA166154375;rs2514218;VARIANT;PA166123368;SCHIZOAFFECTIVE DISORDER;DISEASE;PD
PA166154375;rs2514218;VARIANT;PA445452;PSYCHOMOTOR AGITATION;DISEASE;PD
PA166154375;rs2514218;VARIANT;PA447215;PSYCHOTIC DISORDER;DISEASE;PD
PA166154375;rs2514218;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166161174;rs5993883;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166182407;rs795484;VARIANT;PA445208;PAIN;DISEASE;PD
PA166182407;rs795484;VARIANT;PA445210;PAIN, POSTOPERATIVE;DISEASE;PD
PA166157795;rs7867504;VARIANT;PA445062;NEOPLASMS;DISEASE;
PA166153865;rs16851030;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166156707;rs5326;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166153547;rs5051;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166154139;rs11572076;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;PD
PA166178411;rs79430272;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166178411;rs79430272;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166153829;rs11580409;VARIANT;PA447207;DEPRESSIVE DISORDER;DISEASE;PD
PA166201505;rs3115672;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166201505;rs3115672;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166157862;rs1414334;VARIANT;PA162370415;METABOLIC SYNDROME;DISEASE;PD
PA166157862;rs1414334;VARIANT;PA447208;MENTAL DISORDERS;DISEASE;PD
PA166157862;rs1414334;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166155297;rs4799915;VARIANT;PA447300;ACQUIRED LONG QT SYNDROME (ALQTS);DISEASE;PD
PA166177204;rs61908410;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166156596;rs4696480;VARIANT;PA443750;ULCERATIVE COLITIS;DISEASE;PD
PA166156596;rs4696480;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166156893;rs70991108;VARIANT;PA166119041;DRUG-INDUCED LIVER INJURY;DISEASE;PD
PA166156893;rs70991108;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;
PA166156893;rs70991108;VARIANT;PA444773;LEUKOPENIA;DISEASE;PD
PA166156893;rs70991108;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166156893;rs70991108;VARIANT;PA446155;PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;DISEASE;PD
PA166154701;rs1678387;VARIANT;PA445187;OSTEONECROSIS;DISEASE;PD
PA166206202;rs3802279;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166156012;rs9977268;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166178067;rs397508435;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166157290;rs1149222;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166156543;rs2231137;VARIANT;PA151958383;GASTROINTESTINAL STROMAL TUMORS;DISEASE;PD
PA166156543;rs2231137;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166156543;rs2231137;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166177115;rs9310657;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166154579;rs4149056;VARIANT;PA162263533;NEPHROTOXICITY;DISEASE;PD
PA166154579;rs4149056;VARIANT;PA165108110;DYSLIPIDAEMIA;DISEASE;PD
PA166154579;rs4149056;VARIANT;PA165108401;ACUTE CORONARY SYNDROME;DISEASE;
PA166154579;rs4149056;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;PD
PA166154579;rs4149056;VARIANT;PA166114942;FAMILIAL HYPERCHOLESTEROLEMIA;DISEASE;PD
PA166154579;rs4149056;VARIANT;PA166163391;STATIN-RELATED MYOPATHY;DISEASE;PD
PA166154579;rs4149056;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166154579;rs4149056;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166154579;rs4149056;VARIANT;PA443635;CARDIOVASCULAR DISEASE;DISEASE;PD
PA166154579;rs4149056;VARIANT;PA443890;DIABETES MELLITUS, TYPE 2;DISEASE;PD
PA166154579;rs4149056;VARIANT;PA444516;HYPERCHOLESTEROLEMIA;DISEASE;PD
PA166154579;rs4149056;VARIANT;PA444528;HYPERLIPIDEMIAS;DISEASE;PD
PA166154579;rs4149056;VARIANT;PA444760;LEUKEMIA, MYELOID, ACUTE;DISEASE;PD
PA166154579;rs4149056;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166154579;rs4149056;VARIANT;PA445549;RHABDOMYOLYSIS;DISEASE;PD
PA166154579;rs4149056;VARIANT;PA445601;OSTEOSARCOMA;DISEASE;
PA166154579;rs4149056;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166154579;rs4149056;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166154579;rs4149056;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;
PA166154579;rs4149056;VARIANT;PA447288;ESSENTIAL HYPERTENSION;DISEASE;PD
PA166155582;rs6166;VARIANT;PA165108853;OVARIAN HYPERSTIMULATION SYNDROME;DISEASE;PD
PA166155582;rs6166;VARIANT;PA444617;INFERTILITY DISORDER;DISEASE;PD
PA166155582;rs6166;VARIANT;PA444618;INFERTILITY, FEMALE;DISEASE;PD
PA166161188;rs121909011;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166155809;rs11692021;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166205744;rs3749034;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166235847;rs718656;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166157891;rs113165732;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;
PA166206581;rs36024412;VARIANT;PA445048;NAUSEA;DISEASE;PD
PA166206581;rs36024412;VARIANT;PA446051;VOMITING;DISEASE;PD
PA166154718;rs7317112;VARIANT;PA162263533;NEPHROTOXICITY;DISEASE;PD
PA166154718;rs7317112;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166154467;rs12800734;VARIANT;PA447207;DEPRESSIVE DISORDER;DISEASE;PD
PA166180286;rs1801516;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166155718;rs3832043;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;
PA166155718;rs3832043;VARIANT;PA166114377;HAND-FOOT SYNDROME;DISEASE;
PA166155718;rs3832043;VARIANT;PA166122058;MUCOSITIS;DISEASE;
PA166155718;rs3832043;VARIANT;PA443314;ALOPECIA;DISEASE;
PA166155718;rs3832043;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166155718;rs3832043;VARIANT;PA443937;DRUG TOXICITY;DISEASE;
PA166155718;rs3832043;VARIANT;PA445857;THYROID NEOPLASMS;DISEASE;
PA166185920;rs28935490;VARIANT;PA443367;FABRY DISEASE;DISEASE;PD
PA166154532;rs2229774;VARIANT;PA166128121;CARDIOTOXICITY;DISEASE;PD
PA166154532;rs2229774;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166178596;rs540825;VARIANT;PA446051;VOMITING;DISEASE;PD
PA166177208;rs78482393;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166153738;rs3215400;VARIANT;PA166114377;HAND-FOOT SYNDROME;DISEASE;PD
PA166153738;rs3215400;VARIANT;PA443937;DRUG TOXICITY;DISEASE;
PA166153738;rs3215400;VARIANT;PA444750;LEUKEMIA;DISEASE;
PA166153738;rs3215400;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166153738;rs3215400;VARIANT;PA446309;LYMPHOMA, T-CELL;DISEASE;
PA166179651;rs3828743;VARIANT;PA445425;PROSTATIC NEOPLASMS;DISEASE;PD
PA166156603;rs6600879;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166177126;rs62319299;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166178541;rs141084494;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166178541;rs141084494;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166177138;rs3889402;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166153711;rs2501873;VARIANT;PA443340;ANEMIA;DISEASE;PD
PA166153711;rs2501873;VARIANT;PA445046;NASOPHARYNGEAL NEOPLASMS;DISEASE;PD
PA166153999;rs2227310;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166177139;rs56355515;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166154688;rs899494;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166154688;rs899494;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166156533;rs2066702;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166159965;rs3025040;VARIANT;PA166114377;HAND-FOOT SYNDROME;DISEASE;PD
PA166159965;rs3025040;VARIANT;PA444447;HEPATOCELLULAR CARCINOMA;DISEASE;PD
PA166156728;rs307821;VARIANT;PA443624;RENAL CELL CARCINOMA;DISEASE;PD
PA166155546;rs121918595;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166154975;rs5882;VARIANT;PA444516;HYPERCHOLESTEROLEMIA;DISEASE;PD
PA166154519;rs1806201;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166156938;rs699947;VARIANT;PA134850558;MACULAR DEGENERATION;DISEASE;PD
PA166156938;rs699947;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166156938;rs699947;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166156938;rs699947;VARIANT;PA444606;ERECTILE DYSFUNCTION;DISEASE;PD
PA166156938;rs699947;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166156947;rs760370;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166156947;rs760370;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166156947;rs760370;VARIANT;PA446863;CHRONIC HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166319644;rs568367673;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166185304;rs362267;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166178088;rs121909047;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166178397;rs8110364;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166178397;rs8110364;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166157468;rs17135437;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166199021;rs10224002;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166157100;rs4305746;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166153615;rs1056515;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166185792;rs28656907;VARIANT;PA151958383;GASTROINTESTINAL STROMAL TUMORS;DISEASE;PD
PA166185792;rs28656907;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166156447;rs12487736;VARIANT;PA444516;HYPERCHOLESTEROLEMIA;DISEASE;PD
PA166154138;rs11568732;VARIANT;PA444417;HEMORRHAGE;DISEASE;PD
PA166154138;rs11568732;VARIANT;PA445019;MYOCARDIAL INFARCTION;DISEASE;PD
PA166153700;rs2307424;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;
PA166260501;rs12678747;VARIANT;PA447240;PEPTIC ULCER DISEASE;DISEASE;PD
PA166154747;rs11568658;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;PD
PA166154747;rs11568658;VARIANT;PA444282;OPEN-ANGLE GLAUCOMA;DISEASE;PD
PA166155918;rs1884613;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;
PA166156774;rs1800925;VARIANT;PA443624;RENAL CELL CARCINOMA;DISEASE;PD
PA166153773;rs4654327;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166153773;rs4654327;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166154270;rs187238;VARIANT;PA446863;CHRONIC HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166154758;rs77876672;VARIANT;PA447288;ESSENTIAL HYPERTENSION;DISEASE;PD
PA166156762;rs1423515;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166157902;CYB5R3 deficiency;VARIANT;PA444684;KIDNEY FAILURE, CHRONIC;DISEASE;
PA166157902;CYB5R3 deficiency;VARIANT;PA444942;METHEMOGLOBINEMIA;DISEASE;
PA166183705;rs3778156;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166183705;rs3778156;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166183705;rs3778156;VARIANT;PA446878;COCAINE DEPENDENCE;DISEASE;PD
PA166157296;rs1448673;VARIANT;PA444987;MULTIPLE SCLEROSIS;DISEASE;PD
PA166156792;rs2243250;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166155228;rs4796793;VARIANT;PA443624;RENAL CELL CARCINOMA;DISEASE;PD
PA166159971;rs17180299;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;
PA166157720;rs1126442;VARIANT;PA447215;PSYCHOTIC DISORDER;DISEASE;PD
PA166162981;rs7512462;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166155593;rs264663;VARIANT;PA445425;PROSTATIC NEOPLASMS;DISEASE;PD
PA166155022;rs1805010;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166163174;rs2942857;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;
PA166153990;rs2031920;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166153990;rs2031920;VARIANT;PA445941;TUBERCULOSIS;DISEASE;PD
PA166155954;rs6071980;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166154789;rs2236225;VARIANT;PA164925725;TOXIC LIVER DISEASE;DISEASE;PD
PA166154789;rs2236225;VARIANT;PA166122058;MUCOSITIS;DISEASE;PD
PA166154789;rs2236225;VARIANT;PA443340;ANEMIA;DISEASE;PD
PA166154789;rs2236225;VARIANT;PA444773;LEUKOPENIA;DISEASE;PD
PA166154789;rs2236225;VARIANT;PA444845;NON-HODGKIN LYMPHOMA;DISEASE;PD
PA166154789;rs2236225;VARIANT;PA444937;MESOTHELIOMA;DISEASE;PD
PA166154789;rs2236225;VARIANT;PA445601;OSTEOSARCOMA;DISEASE;PD
PA166154789;rs2236225;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166154789;rs2236225;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166153545;rs4762;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166153545;rs4762;VARIANT;PA446479;HYPERTROPHY, LEFT VENTRICULAR;DISEASE;PD
PA166201543;rs11572078;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166201543;rs11572078;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166282801;rs1799762;VARIANT;PA444997;MUSCULAR DISEASES;DISEASE;
PA166282801;rs1799762;VARIANT;PA445187;OSTEONECROSIS;DISEASE;
PA166282801;rs1799762;VARIANT;PA445273;PEMPHIGUS;DISEASE;
PA166180325;rs144336148;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166164927;rs2254638;VARIANT;PA166129560;MAJOR ADVERSE CARDIAC EVENTS (MACE);DISEASE;PD
PA166179355;rs1029359343;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166156442;rs11313667;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166163239;rs3217164;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166157269;rs854547;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166155163;rs242941;VARIANT;PA447196;ANXIETY DISORDERS;DISEASE;PD
PA166155163;rs242941;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166156933;rs628031;VARIANT;PA166124386;GASTROINTESTINAL TOXICITY;DISEASE;PD
PA166156933;rs628031;VARIANT;PA443890;DIABETES MELLITUS, TYPE 2;DISEASE;PD
PA166156933;rs628031;VARIANT;PA444065;EPILEPSY;DISEASE;
PA166156933;rs628031;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166154478;rs61888800;VARIANT;PA447278;DEPRESSION;DISEASE;PD
PA166154478;rs61888800;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166154400;rs3758785;VARIANT;PA447288;ESSENTIAL HYPERTENSION;DISEASE;PD
PA166156725;rs274717;VARIANT;PA445218;PANCREATIC NEOPLASMS;DISEASE;PD
PA166154301;rs757110;VARIANT;PA443886;DIABETES MELLITUS;DISEASE;PD
PA166160694;rs7958375;VARIANT;PA445941;TUBERCULOSIS;DISEASE;PD
PA166154056;rs4506565;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166154726;rs7997012;VARIANT;PA447196;ANXIETY DISORDERS;DISEASE;PD
PA166154726;rs7997012;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166154726;rs7997012;VARIANT;PA447207;DEPRESSIVE DISORDER;DISEASE;PD
PA166154726;rs7997012;VARIANT;PA447278;DEPRESSION;DISEASE;PD
PA166154726;rs7997012;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166157911;NAT2 deficiency;VARIANT;PA444626;INSULIN RESISTANCE;DISEASE;
PA166155435;rs8099917;VARIANT;PA444445;HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166155435;rs8099917;VARIANT;PA446863;CHRONIC HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166154888;rs2305364;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166178193;rs397508602;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166283681;rs7557402;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166177205;rs61908411;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166157160;rs9461684;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166156031;rs16947;VARIANT;PA443548;BRADYCARDIA;DISEASE;PD
PA166155098;rs9939609;VARIANT;PA446863;CHRONIC HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166155098;rs9939609;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166153620;rs1061631;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166155465;rs12721646;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;
PA166154052;rs4148950;VARIANT;PA445425;PROSTATIC NEOPLASMS;DISEASE;PD
PA166157579;rs2669429;VARIANT;PA444522;HYPERGLYCEMIA;DISEASE;PD
PA166157579;rs2669429;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166155709;rs3770102;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166155709;rs3770102;VARIANT;PA446975;NEUROTOXICITY SYNDROMES;DISEASE;PD
PA166232202;rs16974799;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166179805;rs2205986;VARIANT;PA166119041;DRUG-INDUCED LIVER INJURY;DISEASE;PD
PA166179805;rs2205986;VARIANT;PA444987;MULTIPLE SCLEROSIS;DISEASE;PD
PA166157380;rs3789243;VARIANT;PA444065;EPILEPSY;DISEASE;PD
PA166154155;rs12768009;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;
PA166154374;rs2513265;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166266481;rs13210472;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166157458;rs12720067;VARIANT;PA447278;DEPRESSION;DISEASE;PD
PA166155842;rs17183814;VARIANT;PA444065;EPILEPSY;DISEASE;PD
PA166155711;rs3792269;VARIANT;PA443886;DIABETES MELLITUS;DISEASE;PD
PA166156423;rs7643645;VARIANT;PA444065;EPILEPSY;DISEASE;
PA166156423;rs7643645;VARIANT;PA447215;PSYCHOTIC DISORDER;DISEASE;
PA166179453;rs11065987;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166153556;rs7079;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166177792;rs495491;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166177792;rs495491;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166177792;rs495491;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166177792;rs495491;VARIANT;PA446878;COCAINE DEPENDENCE;DISEASE;PD
PA166178424;rs9402944;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166178424;rs9402944;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166157068;rs3130100;VARIANT;PA131285571;ASPIRIN-INDUCED ASTHMA;DISEASE;PD
PA166157068;rs3130100;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166157527;rs121434568;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166155575;rs193922876;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166157566;rs1799998;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166157566;rs1799998;VARIANT;PA447288;ESSENTIAL HYPERTENSION;DISEASE;PD
PA166155903;rs113095083;VARIANT;PA447288;ESSENTIAL HYPERTENSION;DISEASE;PD
PA166154455;rs11231825;VARIANT;PA444760;LEUKEMIA, MYELOID, ACUTE;DISEASE;PD
PA166285621;rs12283870;VARIANT;PA166279881;ELEVATED LIVER ENZYMES;DISEASE;
PA166285621;rs12283870;VARIANT;PA446155;PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;DISEASE;
PA166156579;rs3775291;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166154329;rs1491850;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166154329;rs1491850;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166156394;rs4135385;VARIANT;PA444985;MULTIPLE MYELOMA;DISEASE;PD
PA166153621;rs1065634;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166159310;rs2523864;VARIANT;PA445532;RETINAL DISEASES;DISEASE;PD
PA166154877;rs2069526;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166157095;rs4149178;VARIANT;PA443899;DIARRHEA;DISEASE;PD
PA166157095;rs4149178;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166155544;rs121918593;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166157067;rs3129294;VARIANT;PA131285571;ASPIRIN-INDUCED ASTHMA;DISEASE;PD
PA166157067;rs3129294;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166156605;rs6600893;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166156659;rs12505410;VARIANT;PA445601;OSTEOSARCOMA;DISEASE;
PA166156659;rs12505410;VARIANT;PA446171;CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE;DISEASE;PD
PA166154893;rs2470890;VARIANT;PA446432;BETA-THALASSEMIA AND RELATED DISEASES;DISEASE;
PA166154893;rs2470890;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166155655;rs1983023;VARIANT;PA446432;BETA-THALASSEMIA AND RELATED DISEASES;DISEASE;PD
PA166177136;rs12595802;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166164946;rs121908752;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166157339;rs2235047;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166155454;rs10426377;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166157128;rs7769719;VARIANT;PA445425;PROSTATIC NEOPLASMS;DISEASE;PD
PA166157272;rs854555;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166156166;rs35320474;VARIANT;PA165109162;BRONCHOPULMONARY DYSPLASIA OF NEWBORN;DISEASE;
PA166156166;rs35320474;VARIANT;PA166248161;APNEA OF PREMATURITY;DISEASE;
PA166156166;rs35320474;VARIANT;PA444704;PREMATURE BIRTH;DISEASE;
PA166157093;rs3957356;VARIANT;PA444823;LUPUS NEPHRITIS;DISEASE;PD
PA166153895;rs67376798;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166201541;rs10491684;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166201541;rs10491684;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166154644;rs12819210;VARIANT;PA444445;HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166154336;rs1799963;VARIANT;PA446969;VENOUS THROMBOSIS;DISEASE;PD
PA166154336;rs1799963;VARIANT;PA447054;STROKE;DISEASE;PD
PA166157440;rs10248420;VARIANT;PA166185626;SOMNOLENCE;DISEASE;PD
PA166157440;rs10248420;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166157440;rs10248420;VARIANT;PA447278;DEPRESSION;DISEASE;PD
PA166159127;rs9725457;VARIANT;PA443340;ANEMIA;DISEASE;PD
PA166159127;rs9725457;VARIANT;PA445046;NASOPHARYNGEAL NEOPLASMS;DISEASE;PD
PA166159807;rs2257212;VARIANT;PA444447;HEPATOCELLULAR CARCINOMA;DISEASE;PD
PA166319224;rs371258350;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166153570;rs340874;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166155456;rs10853728;VARIANT;PA446863;CHRONIC HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166235850;rs4530637;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166156013;rs9981861;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166156013;rs9981861;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166153802;rs10494366;VARIANT;PA165818136;SHORTENED QT INTERVAL;DISEASE;PD
PA166153802;rs10494366;VARIANT;PA443890;DIABETES MELLITUS, TYPE 2;DISEASE;PD
PA166153802;rs10494366;VARIANT;PA444570;HYPOGLYCEMIA;DISEASE;PD
PA166153802;rs10494366;VARIANT;PA447300;ACQUIRED LONG QT SYNDROME (ALQTS);DISEASE;PD
PA166159499;rs10964552;VARIANT;PA443512;URINARY BLADDER NEOPLASMS;DISEASE;PD
PA166157734;rs1611115;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166157734;rs1611115;VARIANT;PA445768;SUBSTANCE WITHDRAWAL SYNDROME;DISEASE;
PA166157734;rs1611115;VARIANT;PA446878;COCAINE DEPENDENCE;DISEASE;PD
PA166177193;rs17786394;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166197642;rs58801820;VARIANT;PA446876;SUBSTANCE-RELATED DISORDERS;DISEASE;
PA166176933;rs17685420;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166154784;rs1663332;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166155962;rs6130615;VARIANT;PA443340;ANEMIA;DISEASE;PD
PA166155962;rs6130615;VARIANT;PA445046;NASOPHARYNGEAL NEOPLASMS;DISEASE;PD
PA166177045;rs186983396;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;
PA166154111;rs10510050;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166154313;rs1076560;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;
PA166154313;rs1076560;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;
PA166154313;rs1076560;VARIANT;PA445254;PARKINSON DISEASE;DISEASE;PD
PA166154313;rs1076560;VARIANT;PA446878;COCAINE DEPENDENCE;DISEASE;PD
PA166154313;rs1076560;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166181044;rs2233678;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166155567;rs193922770;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166155247;rs11868035;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166224541;rs1059513;VARIANT;PA166224501;EOSINOPHILIC ESOPHAGITIS;DISEASE;PD
PA166154262;rs6279;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;
PA166154262;rs6279;VARIANT;PA447278;DEPRESSION;DISEASE;
PA166157511;rs74503330;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166185755;rs1456862;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166157359;rs2299267;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166156616;rs7349683;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166156616;rs7349683;VARIANT;PA445204;OVARIAN NEOPLASMS;DISEASE;PD
PA166156616;rs7349683;VARIANT;PA445301;PERIPHERAL NERVOUS SYSTEM DISEASES;DISEASE;PD
PA166274202;rs3740563;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166184307;rs2980976;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166153977;rs1801253;VARIANT;PA443459;ATRIAL FIBRILLATION;DISEASE;PD
PA166153977;rs1801253;VARIANT;PA443632;CARDIOMYOPATHY, DILATED;DISEASE;PD
PA166153977;rs1801253;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166153977;rs1801253;VARIANT;PA443886;DIABETES MELLITUS;DISEASE;PD
PA166153977;rs1801253;VARIANT;PA443994;EDEMA;DISEASE;PD
PA166153977;rs1801253;VARIANT;PA444370;HEART FAILURE;DISEASE;PD
PA166153977;rs1801253;VARIANT;PA444528;HYPERLIPIDEMIAS;DISEASE;PD
PA166153977;rs1801253;VARIANT;PA445802;TACHYCARDIA;DISEASE;PD
PA166153977;rs1801253;VARIANT;PA447288;ESSENTIAL HYPERTENSION;DISEASE;PD
PA166153891;rs59086055;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166156094;rs2284018;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166154610;rs8192440;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166157066;rs3099844;VARIANT;PA166120927;DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;DISEASE;PD
PA166157066;rs3099844;VARIANT;PA166120929;SEVERE CUTANEOUS ADVERSE REACTIONS;DISEASE;PD
PA166157066;rs3099844;VARIANT;PA443250;ACQUIRED IMMUNODEFICIENCY SYNDROME;DISEASE;PD
PA166157066;rs3099844;VARIANT;PA445738;STEVENS-JOHNSON SYNDROME;DISEASE;PD
PA166197643;rs75168521;VARIANT;PA446876;SUBSTANCE-RELATED DISORDERS;DISEASE;
PA166170701;rs10841753;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;
PA166157703;rs301434;VARIANT;PA447211;OBSESSIVE-COMPULSIVE DISORDER;DISEASE;PD
PA166268981;rs17064642;VARIANT;PA165108401;ACUTE CORONARY SYNDROME;DISEASE;PD
PA166268981;rs17064642;VARIANT;PA166129560;MAJOR ADVERSE CARDIAC EVENTS (MACE);DISEASE;PD
PA166156500;rs1047626;VARIANT;PA131285571;ASPIRIN-INDUCED ASTHMA;DISEASE;PD
PA166199007;rs932764;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166161456;rs34650714;VARIANT;PA444318;GOUT;DISEASE;PD
PA166160419;rs836554;VARIANT;PA443937;DRUG TOXICITY;DISEASE;
PA166160419;rs836554;VARIANT;PA444818;LUNG NEOPLASMS;DISEASE;
PA166153652;rs1801274;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166153652;rs1801274;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166153652;rs1801274;VARIANT;PA444352;HEAD AND NECK NEOPLASMS;DISEASE;PD
PA166153652;rs1801274;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166153652;rs1801274;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166156360;rs2654754;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166155986;rs1051266;VARIANT;PA151958383;GASTROINTESTINAL STROMAL TUMORS;DISEASE;PD
PA166155986;rs1051266;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166155986;rs1051266;VARIANT;PA443580;BURKITT LYMPHOMA;DISEASE;
PA166155986;rs1051266;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166155986;rs1051266;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166155986;rs1051266;VARIANT;PA444750;LEUKEMIA;DISEASE;
PA166155986;rs1051266;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166155986;rs1051266;VARIANT;PA445601;OSTEOSARCOMA;DISEASE;
PA166155986;rs1051266;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166155986;rs1051266;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166155986;rs1051266;VARIANT;PA446309;LYMPHOMA, T-CELL;DISEASE;
PA166155017;rs1800566;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166155017;rs1800566;VARIANT;PA444417;HEMORRHAGE;DISEASE;PD
PA166155017;rs1800566;VARIANT;PA445058;METASTATIC NEOPLASM;DISEASE;PD
PA166155017;rs1800566;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166155017;rs1800566;VARIANT;PA445742;STOMACH NEOPLASMS;DISEASE;PD
PA166155017;rs1800566;VARIANT;PA445850;THROMBOTIC DISEASE;DISEASE;PD
PA166157597;rs4271002;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166156019;rs75222709;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166155204;rs2252281;VARIANT;PA443890;DIABETES MELLITUS, TYPE 2;DISEASE;PD
PA166155204;rs2252281;VARIANT;PA445376;POLYCYSTIC OVARY SYNDROME;DISEASE;PD
PA166154108;rs10509373;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166155995;rs2070401;VARIANT;PA164925725;TOXIC LIVER DISEASE;DISEASE;PD
PA166155995;rs2070401;VARIANT;PA166119041;DRUG-INDUCED LIVER INJURY;DISEASE;PD
PA166157874;rs3813928;VARIANT;PA447198;AUTISM;DISEASE;PD
PA166154408;rs4460839;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166176947;rs4902333;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166202221;rs616147;VARIANT;PA443332;AMYOTROPHIC LATERAL SCLEROSIS;DISEASE;PD
PA166206602;rs41269255;VARIANT;PA445048;NAUSEA;DISEASE;PD
PA166206602;rs41269255;VARIANT;PA446051;VOMITING;DISEASE;PD
PA166155099;rs9940629;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166184699;rs10485057;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166184699;rs10485057;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166154093;rs8187707;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166153893;rs60369023;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166153893;rs60369023;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166155648;rs1804645;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166156003;rs2835859;VARIANT;PA445210;PAIN, POSTOPERATIVE;DISEASE;PD
PA166157448;rs10499563;VARIANT;PA443750;ULCERATIVE COLITIS;DISEASE;PD
PA166157448;rs10499563;VARIANT;PA446116;INFLAMMATORY BOWEL DISEASES;DISEASE;PD
PA166177053;rs6090043;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166157745;rs2230808;VARIANT;PA446120;HYPERTRIGLYCERIDEMIA;DISEASE;PD
PA166258761;rs12749274;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166155855;rs17868320;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;PD
PA166155855;rs17868320;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166156593;rs4693075;VARIANT;PA444997;MUSCULAR DISEASES;DISEASE;PD
PA166203342;rs2272733;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166203342;rs2272733;VARIANT;PA444109;EXANTHEMA;DISEASE;PD
PA166155496;rs35303484;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;
PA166182096;rs7905446;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166182096;rs7905446;VARIANT;PA447278;DEPRESSION;DISEASE;PD
PA166156118;rs5751876;VARIANT;PA447196;ANXIETY DISORDERS;DISEASE;PD
PA166241901;rs1603218569;VARIANT;PA162263534;OTOTOXICITY;DISEASE;PD
PA166154927;rs9806699;VARIANT;PA445019;MYOCARDIAL INFARCTION;DISEASE;PD
PA166182408;rs1277441;VARIANT;PA445208;PAIN;DISEASE;PD
PA166182408;rs1277441;VARIANT;PA445210;PAIN, POSTOPERATIVE;DISEASE;PD
PA166160685;rs10946739;VARIANT;PA445941;TUBERCULOSIS;DISEASE;PD
PA166154312;rs1062613;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166154260;rs6275;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166154260;rs6275;VARIANT;PA444949;MIGRAINE WITHOUT AURA;DISEASE;PD
PA166154260;rs6275;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;
PA166154260;rs6275;VARIANT;PA447278;DEPRESSION;DISEASE;
PA166259901;rs62368105;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166157849;rs6318;VARIANT;PA128406954;WEIGHT GAIN;DISEASE;PD
PA166157849;rs6318;VARIANT;PA162263525;NEUROPATHIC PAIN;DISEASE;PD
PA166157849;rs6318;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166157007;rs2016520;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166157007;rs2016520;VARIANT;PA445425;PROSTATIC NEOPLASMS;DISEASE;PD
PA166155343;rs13181;VARIANT;PA162263533;NEPHROTOXICITY;DISEASE;PD
PA166155343;rs13181;VARIANT;PA166123026;PROGRESSION-FREE SURVIVAL;DISEASE;
PA166155343;rs13181;VARIANT;PA443314;ALOPECIA;DISEASE;PD
PA166155343;rs13181;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166155343;rs13181;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166155343;rs13181;VARIANT;PA444101;NEOPLASM OF ESOPHAGUS;DISEASE;PD
PA166155343;rs13181;VARIANT;PA444937;MESOTHELIOMA;DISEASE;PD
PA166155343;rs13181;VARIANT;PA445204;OVARIAN NEOPLASMS;DISEASE;PD
PA166155343;rs13181;VARIANT;PA445218;PANCREATIC NEOPLASMS;DISEASE;PD
PA166155343;rs13181;VARIANT;PA445601;OSTEOSARCOMA;DISEASE;PD
PA166155343;rs13181;VARIANT;PA445828;TESTICULAR NEOPLASMS;DISEASE;PD
PA166155343;rs13181;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166153971;rs1786929;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166210024;rs7900002;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166157646;rs13273672;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166157751;rs2302821;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166157378;rs3750117;VARIANT;PA444760;LEUKEMIA, MYELOID, ACUTE;DISEASE;PD
PA166157378;rs3750117;VARIANT;PA445062;NEOPLASMS;DISEASE;
PA166153816;rs10918594;VARIANT;PA447300;ACQUIRED LONG QT SYNDROME (ALQTS);DISEASE;PD
PA166181287;rs4148324;VARIANT;PA445601;OSTEOSARCOMA;DISEASE;
PA166184846;rs17552189;VARIANT;PA446876;SUBSTANCE-RELATED DISORDERS;DISEASE;
PA166155004;rs1029489;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166177124;rs56229625;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166176955;rs9032;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166154436;rs10792367;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166236402;rs568724445;VARIANT;PA443407;APNEA;DISEASE;PD
PA166156029;rs11479;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166157880;rs5030868;VARIANT;PA443890;DIABETES MELLITUS, TYPE 2;DISEASE;PD
PA166157106;rs4870061;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166154128;rs11189015;VARIANT;PA447288;ESSENTIAL HYPERTENSION;DISEASE;PD
PA166155266;rs80338792;VARIANT;PA445030;MYOTONIA;DISEASE;PD
PA166155900;rs72551330;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;PD
PA166161405;rs2734583;VARIANT;PA166120927;DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;DISEASE;PD
PA166161405;rs2734583;VARIANT;PA445738;STEVENS-JOHNSON SYNDROME;DISEASE;PD
PA166184253;rs17614642;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166182211;rs471760;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166182211;rs471760;VARIANT;PA445218;PANCREATIC NEOPLASMS;DISEASE;PD
PA166161150;rs10782001;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166179966;rs562859;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166155800;rs11125883;VARIANT;PA164925725;TOXIC LIVER DISEASE;DISEASE;PD
PA166155800;rs11125883;VARIANT;PA166119041;DRUG-INDUCED LIVER INJURY;DISEASE;PD
PA166169844;rs9200;VARIANT;PA447247;LIVER TRANSPLANTATION;DISEASE;
PA166196166;rs145837941;VARIANT;PA445210;PAIN, POSTOPERATIVE;DISEASE;PD
PA166157737;rs1800975;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166156103;rs3761422;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166156103;rs3761422;VARIANT;PA447196;ANXIETY DISORDERS;DISEASE;PD
PA166155149;rs4359;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166155533;rs118192162;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166179207;rs1976391;VARIANT;PA444545;HYPERPROLACTINEMIA;DISEASE;PD
PA166153715;rs2661319;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166176954;rs929740;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166153595;rs846908;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;
PA166154113;rs10752271;VARIANT;PA447288;ESSENTIAL HYPERTENSION;DISEASE;PD
PA166153631;rs1476413;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166155202;rs2240017;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166163663;rs193922843;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166155182;rs1135989;VARIANT;PA446975;NEUROTOXICITY SYNDROMES;DISEASE;PD
PA166154547;rs2306283;VARIANT;PA165108110;DYSLIPIDAEMIA;DISEASE;PD
PA166154547;rs2306283;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;
PA166154547;rs2306283;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166154547;rs2306283;VARIANT;PA443797;CORONARY DISEASE;DISEASE;PD
PA166154547;rs2306283;VARIANT;PA443886;DIABETES MELLITUS;DISEASE;PD
PA166154547;rs2306283;VARIANT;PA443899;DIARRHEA;DISEASE;PD
PA166154547;rs2306283;VARIANT;PA444516;HYPERCHOLESTEROLEMIA;DISEASE;PD
PA166154547;rs2306283;VARIANT;PA444528;HYPERLIPIDEMIAS;DISEASE;PD
PA166154547;rs2306283;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166154547;rs2306283;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166154547;rs2306283;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;
PA166154516;rs1544410;VARIANT;PA444445;HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166154516;rs1544410;VARIANT;PA445190;OSTEOPOROSIS;DISEASE;PD
PA166154516;rs1544410;VARIANT;PA446432;BETA-THALASSEMIA AND RELATED DISEASES;DISEASE;PD
PA166157193;rs17574269;VARIANT;PA446661;SMALL CELL CARCINOMA;DISEASE;PD
PA166154390;rs2854116;VARIANT;PA444528;HYPERLIPIDEMIAS;DISEASE;PD
PA166154390;rs2854116;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166157747;rs2250242;VARIANT;PA445425;PROSTATIC NEOPLASMS;DISEASE;
PA166159656;rs1330344;VARIANT;PA166129560;MAJOR ADVERSE CARDIAC EVENTS (MACE);DISEASE;PD
PA166156703;rs201279313;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166176938;rs10420097;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166156482;rs9852;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166153569;rs324420;VARIANT;PA166185626;SOMNOLENCE;DISEASE;PD
PA166153569;rs324420;VARIANT;PA443782;CONSTIPATION;DISEASE;PD
PA166153569;rs324420;VARIANT;PA443851;DELIRIUM;DISEASE;PD
PA166153569;rs324420;VARIANT;PA444818;LUNG NEOPLASMS;DISEASE;PD
PA166153569;rs324420;VARIANT;PA445048;NAUSEA;DISEASE;PD
PA166153569;rs324420;VARIANT;PA445208;PAIN;DISEASE;PD
PA166153569;rs324420;VARIANT;PA445437;PRURITUS;DISEASE;PD
PA166153569;rs324420;VARIANT;PA445522;RESPIRATORY INSUFFICIENCY;DISEASE;PD
PA166153569;rs324420;VARIANT;PA446264;URINARY RETENTION;DISEASE;PD
PA166153569;rs324420;VARIANT;PA446876;SUBSTANCE-RELATED DISORDERS;DISEASE;PD
PA166153569;rs324420;VARIANT;PA446970;POSTOPERATIVE NAUSEA AND VOMITING;DISEASE;PD
PA166153569;rs324420;VARIANT;PA447215;PSYCHOTIC DISORDER;DISEASE;PD
PA166155278;rs1123617;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166201526;rs3130985;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166201526;rs3130985;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166171034;rs324899;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166236481;rs1560022535;VARIANT;PA443407;APNEA;DISEASE;PD
PA166157481;rs28371759;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;
PA166176608;rs4646450;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;
PA166176608;rs4646450;VARIANT;PA447247;LIVER TRANSPLANTATION;DISEASE;
PA166156376;rs3749438;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166274204;rs4752292;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166156654;rs11938228;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166156654;rs11938228;VARIANT;PA446116;INFLAMMATORY BOWEL DISEASES;DISEASE;PD
PA166155729;rs4550690;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166156331;rs1801282;VARIANT;PA443890;DIABETES MELLITUS, TYPE 2;DISEASE;PD
PA166156331;rs1801282;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166154847;rs700518;VARIANT;PA166048848;MENOPAUSE;DISEASE;
PA166154847;rs700518;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;
PA166154069;rs4948496;VARIANT;PA444773;LEUKOPENIA;DISEASE;PD
PA166154069;rs4948496;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166155592;rs264651;VARIANT;PA445425;PROSTATIC NEOPLASMS;DISEASE;PD
PA166155912;rs1044396;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166156358;rs2472677;VARIANT;PA162355520;NEPHROLITHIASIS;DISEASE;
PA166156358;rs2472677;VARIANT;PA166123507;DISCONTINUATION;DISEASE;PD
PA166156358;rs2472677;VARIANT;PA166151827;ADVERSE EVENTS;DISEASE;PD
PA166156358;rs2472677;VARIANT;PA443250;ACQUIRED IMMUNODEFICIENCY SYNDROME;DISEASE;
PA166156358;rs2472677;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;
PA166157727;rs1387923;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166164948;rs397508288;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166184665;rs9478495;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166186146;rs1042028;VARIANT;PA445208;PAIN;DISEASE;PD
PA166186146;rs1042028;VARIANT;PA446411;ENDOMETRIAL NEOPLASMS;DISEASE;PD
PA166154982;rs35592;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166154982;rs35592;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166153974;rs1800544;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166153974;rs1800544;VARIANT;PA447207;DEPRESSIVE DISORDER;DISEASE;PD
PA166153974;rs1800544;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166283762;rs9973653;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166155534;rs118192163;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166157811;rs10760397;VARIANT;PA444987;MULTIPLE SCLEROSIS;DISEASE;PD
PA166159977;rs50872;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA133888799;ORGAN TRANSPLANTATION;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA134850491;TRANSPLANTATION;DISEASE;
PA166157284;rs1045642;VARIANT;PA157379134;MYALGIA;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA164925725;TOXIC LIVER DISEASE;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA165108401;ACUTE CORONARY SYNDROME;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA166048740;HELICOBACTER INFECTIONS;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA166122058;MUCOSITIS;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA166124406;PLATELET REACTIVITY;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA443433;JUVENILE RHEUMATOID ARTHRITIS;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA443580;BURKITT LYMPHOMA;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA443624;RENAL CELL CARCINOMA;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA443750;ULCERATIVE COLITIS;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA443797;CORONARY DISEASE;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA443842;DEATH;DISEASE;
PA166157284;rs1045642;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA444065;EPILEPSY;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA444066;EPILEPSIES, PARTIAL;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA444067;EPILEPSY, IDIOPATHIC GENERALIZED;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA444101;NEOPLASM OF ESOPHAGUS;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA444222;FRACTURES, BONE;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA444255;GASTROESOPHAGEAL REFLUX;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA444417;HEMORRHAGE;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA444516;HYPERCHOLESTEROLEMIA;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA444584;HYPOTENSIVE DISORDER;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA444591;HYPOVENTILATION;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA444760;LEUKEMIA, MYELOID, ACUTE;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA444949;MIGRAINE WITHOUT AURA;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA444985;MULTIPLE MYELOMA;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA445019;MYOCARDIAL INFARCTION;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA445042;NARCOLEPSY;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA445208;PAIN;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA445210;PAIN, POSTOPERATIVE;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA445301;PERIPHERAL NERVOUS SYSTEM DISEASES;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA445828;TESTICULAR NEOPLASMS;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA445941;TUBERCULOSIS;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA446051;VOMITING;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA446171;CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA446309;LYMPHOMA, T-CELL;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA446444;LOW BACK PAIN;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA446761;ARTHRALGIA;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA446876;SUBSTANCE-RELATED DISORDERS;DISEASE;
PA166157284;rs1045642;VARIANT;PA446970;POSTOPERATIVE NAUSEA AND VOMITING;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA447004;MIGRAINE WITH AURA;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;
PA166157284;rs1045642;VARIANT;PA447207;DEPRESSIVE DISORDER;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA447215;PSYCHOTIC DISORDER;DISEASE;
PA166157284;rs1045642;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA447278;DEPRESSION;DISEASE;PD
PA166157284;rs1045642;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166155135;rs71647871;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166154147;rs12248560;VARIANT;PA166123007;HEMATOPOIETIC STEM CELL TRANSPLANTATION;DISEASE;
PA166154147;rs12248560;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166154147;rs12248560;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166157364;rs2571598;VARIANT;PA443319;ALZHEIMER DISEASE;DISEASE;PD
PA166208983;rs10770140;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166156961;rs879825;VARIANT;PA445204;OVARIAN NEOPLASMS;DISEASE;PD
PA166175925;rs1611131;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166155748;rs6714486;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;PD
PA166156462;rs17024608;VARIANT;PA445187;OSTEONECROSIS;DISEASE;PD
PA166153581;rs602950;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166155222;rs4541111;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166154623;rs10877012;VARIANT;PA446432;BETA-THALASSEMIA AND RELATED DISEASES;DISEASE;PD
PA166154623;rs10877012;VARIANT;PA446863;CHRONIC HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166156511;rs1364805;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166155038;rs2292954;VARIANT;PA445425;PROSTATIC NEOPLASMS;DISEASE;PD
PA166156379;rs3772810;VARIANT;PA445058;METASTATIC NEOPLASM;DISEASE;PD
PA166154469;rs16909440;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166154993;rs708272;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166154993;rs708272;VARIANT;PA444516;HYPERCHOLESTEROLEMIA;DISEASE;PD
PA166154993;rs708272;VARIANT;PA444517;HYPERLIPOPROTEINEMIA TYPE II;DISEASE;PD
PA166268445;rs3749187;VARIANT;PA165108401;ACUTE CORONARY SYNDROME;DISEASE;PD
PA166268445;rs3749187;VARIANT;PA166129560;MAJOR ADVERSE CARDIAC EVENTS (MACE);DISEASE;PD
PA166184544;rs6090378;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166169897;rs73594404;VARIANT;PA165817398;MYELOSUPPRESSION;DISEASE;PD
PA166169897;rs73594404;VARIANT;PA166122058;MUCOSITIS;DISEASE;PD
PA166169897;rs73594404;VARIANT;PA443340;ANEMIA;DISEASE;PD
PA166169897;rs73594404;VARIANT;PA443875;DERMATITIS;DISEASE;PD
PA166169897;rs73594404;VARIANT;PA444773;LEUKOPENIA;DISEASE;PD
PA166169897;rs73594404;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166169897;rs73594404;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166153839;rs12041331;VARIANT;PA445019;MYOCARDIAL INFARCTION;DISEASE;PD
PA166157650;rs17060812;VARIANT;PA447278;DEPRESSION;DISEASE;PD
PA166153559;rs20417;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166154583;rs4149117;VARIANT;PA151958383;GASTROINTESTINAL STROMAL TUMORS;DISEASE;PD
PA166154583;rs4149117;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;PD
PA166154583;rs4149117;VARIANT;PA166114454;TRANSPLANT REJECTION;DISEASE;PD
PA166154583;rs4149117;VARIANT;PA166114457;LUNG TRANSPLANTATION;DISEASE;PD
PA166154583;rs4149117;VARIANT;PA166123207;OVERALL SURVIVAL;DISEASE;PD
PA166154583;rs4149117;VARIANT;PA166195784;CHRONIC LUNG ALLOGRAFT DYSFUNCTION;DISEASE;PD
PA166154583;rs4149117;VARIANT;PA444818;LUNG NEOPLASMS;DISEASE;PD
PA166154360;rs2276307;VARIANT;PA157379134;MYALGIA;DISEASE;PD
PA166153809;rs10800397;VARIANT;PA444807;LONG QT SYNDROME;DISEASE;PD
PA166155087;rs8060157;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166157423;rs6962291;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166157573;rs2073618;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166161855;rs96844;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166178060;rs397508510;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166185420;rs8109485;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166180324;rs193922768;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166157828;rs11141915;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166176948;rs4627790;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166156738;rs702553;VARIANT;PA445086;NEPHROSCLEROSIS;DISEASE;PD
PA166155237;rs9895420;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166161452;rs75995567;VARIANT;PA444318;GOUT;DISEASE;PD
PA166155590;rs264588;VARIANT;PA445425;PROSTATIC NEOPLASMS;DISEASE;PD
PA166163241;rs2244614;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166153573;rs521093;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166177206;rs7306991;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166159020;rs8175347;VARIANT;PA447230;HIV INFECTIONS;DISEASE;
PA166161543;rs35621;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;
PA166157731;rs1544105;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166157731;rs1544105;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166153682;rs2236861;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166153682;rs2236861;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;
PA166154362;rs2279238;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166154362;rs2279238;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166179571;rs1337512;VARIANT;PA445549;RHABDOMYOLYSIS;DISEASE;PD
PA166154769;rs944050;VARIANT;PA445218;PANCREATIC NEOPLASMS;DISEASE;PD
PA166155169;rs879207;VARIANT;PA445204;OVARIAN NEOPLASMS;DISEASE;PD
PA166155829;rs13393173;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166201545;rs6118;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166201545;rs6118;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166203235;rs4774388;VARIANT;PA444987;MULTIPLE SCLEROSIS;DISEASE;PD
PA166157471;rs17160359;VARIANT;PA445058;METASTATIC NEOPLASM;DISEASE;PD
PA166154431;rs10501087;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166178398;rs56022120;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166178398;rs56022120;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166184563;rs3890011;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166154774;rs1160351;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166157593;rs3758149;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166157593;rs3758149;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166157075;rs3218592;VARIANT;PA445058;METASTATIC NEOPLASM;DISEASE;PD
PA166155219;rs4148416;VARIANT;PA445601;OSTEOSARCOMA;DISEASE;PD
PA166158909;rs267606619;VARIANT;PA162263534;OTOTOXICITY;DISEASE;PD
PA166155629;rs1143627;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166154972;rs5569;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166185910;rs727504348;VARIANT;PA443367;FABRY DISEASE;DISEASE;PD
PA166171043;rs6728642;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166156905;rs20455;VARIANT;PA443797;CORONARY DISEASE;DISEASE;PD
PA166156905;rs20455;VARIANT;PA444516;HYPERCHOLESTEROLEMIA;DISEASE;PD
PA166156905;rs20455;VARIANT;PA445019;MYOCARDIAL INFARCTION;DISEASE;PD
PA166196821;rs9828223;VARIANT;PA443815;CROHN DISEASE;DISEASE;PD
PA166155342;rs11615;VARIANT;PA166122058;MUCOSITIS;DISEASE;PD
PA166155342;rs11615;VARIANT;PA166170245;FEBRILE NEUTROPENIA;DISEASE;PD
PA166155342;rs11615;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166155342;rs11615;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166155342;rs11615;VARIANT;PA443756;COLONIC NEOPLASMS;DISEASE;PD
PA166155342;rs11615;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166155342;rs11615;VARIANT;PA444101;NEOPLASM OF ESOPHAGUS;DISEASE;PD
PA166155342;rs11615;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166155342;rs11615;VARIANT;PA445204;OVARIAN NEOPLASMS;DISEASE;PD
PA166155342;rs11615;VARIANT;PA445218;PANCREATIC NEOPLASMS;DISEASE;PD
PA166155342;rs11615;VARIANT;PA445503;RECTAL NEOPLASMS;DISEASE;PD
PA166155342;rs11615;VARIANT;PA445601;OSTEOSARCOMA;DISEASE;PD
PA166155342;rs11615;VARIANT;PA445742;STOMACH NEOPLASMS;DISEASE;PD
PA166155342;rs11615;VARIANT;PA445828;TESTICULAR NEOPLASMS;DISEASE;PD
PA166155342;rs11615;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166154702;rs1751034;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;
PA166160641;rs11125;VARIANT;PA444546;HYPERSENSITIVITY;DISEASE;PD
PA166154798;rs2776546;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166210002;rs61767420;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166154646;rs17109924;VARIANT;PA443756;COLONIC NEOPLASMS;DISEASE;PD
PA166154703;rs1801249;VARIANT;PA445204;OVARIAN NEOPLASMS;DISEASE;PD
PA166171051;rs79403677;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166154793;rs2494732;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166201546;rs6119;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166201546;rs6119;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166233341;rs6981827;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166154857;rs1060896;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166178065;rs121908751;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166157014;rs2073724;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166156853;rs10036156;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166177052;rs6090041;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166177182;rs4639250;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166155289;rs2849380;VARIANT;PA445204;OVARIAN NEOPLASMS;DISEASE;PD
PA166176322;rs3804100;VARIANT;PA445210;PAIN, POSTOPERATIVE;DISEASE;PD
PA166154163;rs17222723;VARIANT;PA443421;CARDIAC RHYTHM DISEASE;DISEASE;PD
PA166154163;rs17222723;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166154163;rs17222723;VARIANT;PA444773;LEUKOPENIA;DISEASE;PD
PA166154163;rs17222723;VARIANT;PA444845;NON-HODGKIN LYMPHOMA;DISEASE;PD
PA166154163;rs17222723;VARIANT;PA445601;OSTEOSARCOMA;DISEASE;PD
PA166154163;rs17222723;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166157873;rs3810651;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166157104;rs4713916;VARIANT;PA443815;CROHN DISEASE;DISEASE;PD
PA166157104;rs4713916;VARIANT;PA447207;DEPRESSIVE DISORDER;DISEASE;PD
PA166157104;rs4713916;VARIANT;PA447209;MOOD DISORDER;DISEASE;PD
PA166154311;rs1042927;VARIANT;PA444937;MESOTHELIOMA;DISEASE;PD
PA166156005;rs3788189;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166156005;rs3788189;VARIANT;PA444937;MESOTHELIOMA;DISEASE;PD
PA166154824;rs11628713;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166177122;rs11933890;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166155948;rs4815273;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166154740;rs9561765;VARIANT;PA151958383;GASTROINTESTINAL STROMAL TUMORS;DISEASE;PD
PA166157351;rs2278294;VARIANT;PA133888799;ORGAN TRANSPLANTATION;DISEASE;PD
PA166157351;rs2278294;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;PD
PA166157351;rs2278294;VARIANT;PA444773;LEUKOPENIA;DISEASE;PD
PA166154502;rs767455;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166154502;rs767455;VARIANT;PA446198;ARTHRITIS, PSORIATIC;DISEASE;PD
PA166153976;rs1801252;VARIANT;PA166129560;MAJOR ADVERSE CARDIAC EVENTS (MACE);DISEASE;PD
PA166153976;rs1801252;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166153996;rs2115819;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166230141;rs74497159;VARIANT;PA445301;PERIPHERAL NERVOUS SYSTEM DISEASES;DISEASE;PD
PA166155280;rs1800477;VARIANT;PA444445;HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166154392;rs2898950;VARIANT;PA444760;LEUKEMIA, MYELOID, ACUTE;DISEASE;PD
PA166157744;rs2230806;VARIANT;PA443797;CORONARY DISEASE;DISEASE;PD
PA166157744;rs2230806;VARIANT;PA446120;HYPERTRIGLYCERIDEMIA;DISEASE;PD
PA166153674;rs2144300;VARIANT;PA444552;HYPERTENSION;DISEASE;
PA166156833;rs4704559;VARIANT;PA445254;PARKINSON DISEASE;DISEASE;PD
PA166176956;rs11552708;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166157824;rs10975641;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166185422;rs1476592;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166155467;rs12721655;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166153822;rs11211524;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166163757;rs2853741;VARIANT;PA443899;DIARRHEA;DISEASE;PD
PA166163757;rs2853741;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166154135;rs11200638;VARIANT;PA134850558;MACULAR DEGENERATION;DISEASE;PD
PA166156924;rs510769;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166156924;rs510769;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166184306;rs8050896;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166155734;rs4675690;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166199601;rs114077267;VARIANT;PA446199;OVERDOSE;DISEASE;PD
PA166183681;rs1044394;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166185425;rs4432372;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166156798;rs2301149;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166156798;rs2301149;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166160497;rs3045983;VARIANT;PA443434;ARTHRITIS, RHEUMATOID;DISEASE;
PA166160497;rs3045983;VARIANT;PA443937;DRUG TOXICITY;DISEASE;
PA166184318;rs813676;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166159089;rs11185648;VARIANT;PA445046;NASOPHARYNGEAL NEOPLASMS;DISEASE;PD
PA166157472;rs17161788;VARIANT;PA444516;HYPERCHOLESTEROLEMIA;DISEASE;PD
PA166155337;rs688;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166155527;rs113288603;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;
PA166154302;rs948854;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;
PA166154302;rs948854;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166157554;rs1265138;VARIANT;PA444760;LEUKEMIA, MYELOID, ACUTE;DISEASE;PD
PA166185918;rs398123223;VARIANT;PA443367;FABRY DISEASE;DISEASE;PD
PA166154466;rs12795437;VARIANT;PA443886;DIABETES MELLITUS;DISEASE;PD
PA166154466;rs12795437;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166184026;rs2066713;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166157606;rs4737771;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166319205;rs374825099;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166154354;rs2237892;VARIANT;PA443890;DIABETES MELLITUS, TYPE 2;DISEASE;PD
PA166164950;rs141033578;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166156944;rs746647;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166160587;rs10846744;VARIANT;PA446863;CHRONIC HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166155651;rs1872328;VARIANT;PA145069467;HEARING LOSS;DISEASE;PD
PA166155651;rs1872328;VARIANT;PA162263534;OTOTOXICITY;DISEASE;PD
PA166155651;rs1872328;VARIANT;PA443557;BRAIN NEOPLASMS;DISEASE;PD
PA166155469;rs12980275;VARIANT;PA446863;CHRONIC HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166155291;rs3745009;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166155767;rs7582141;VARIANT;PA445425;PROSTATIC NEOPLASMS;DISEASE;PD
PA166155950;rs6021191;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166155742;rs6431558;VARIANT;PA445062;NEOPLASMS;DISEASE;
PA166157959;G6PD deficiency;VARIANT;PA166048714;PREGNANCY;DISEASE;
PA166157959;G6PD deficiency;VARIANT;PA166048814;HYPERURICEMIA;DISEASE;
PA166157959;G6PD deficiency;VARIANT;PA443343;ANEMIA, HEMOLYTIC;DISEASE;
PA166157959;G6PD deficiency;VARIANT;PA443580;BURKITT LYMPHOMA;DISEASE;
PA166157959;G6PD deficiency;VARIANT;PA443750;COLITIS, ULCERATIVE;DISEASE;
PA166157959;G6PD deficiency;VARIANT;PA444318;GOUT;DISEASE;
PA166157959;G6PD deficiency;VARIANT;PA444400;HEMATURIA;DISEASE;
PA166157959;G6PD deficiency;VARIANT;PA444411;HEMOLYSIS;DISEASE;
PA166157959;G6PD deficiency;VARIANT;PA444511;HYPERBILIRUBINEMIA;DISEASE;
PA166157959;G6PD deficiency;VARIANT;PA444648;JAUNDICE;DISEASE;
PA166157959;G6PD deficiency;VARIANT;PA444683;KIDNEY FAILURE, ACUTE;DISEASE;
PA166157959;G6PD deficiency;VARIANT;PA444756;LEUKEMIA, LYMPHOID;DISEASE;
PA166157959;G6PD deficiency;VARIANT;PA444859;MALARIA;DISEASE;
PA166157959;G6PD deficiency;VARIANT;PA444942;METHEMOGLOBINEMIA;DISEASE;
PA166157959;G6PD deficiency;VARIANT;PA445062;NEOPLASMS;DISEASE;
PA166157959;G6PD deficiency;VARIANT;PA445970;TYPHOID FEVER;DISEASE;
PA166157959;G6PD deficiency;VARIANT;PA446126;TUMOR LYSIS SYNDROME;DISEASE;
PA166157959;G6PD deficiency;VARIANT;PA446155;PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;DISEASE;
PA166157959;G6PD deficiency;VARIANT;PA446166;PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;DISEASE;
PA166157959;G6PD deficiency;VARIANT;PA446392;MALARIA, VIVAX;DISEASE;
PA166157959;G6PD deficiency;VARIANT;PA447230;HIV INFECTIONS;DISEASE;
PA166157829;rs11144870;VARIANT;PA447207;DEPRESSIVE DISORDER;DISEASE;PD
PA166153646;rs1801159;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166154040;rs3810950;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166177198;rs61908404;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166157954;CYP1A2 high activity;VARIANT;PA166048714;PREGNANCY;DISEASE;
PA166157954;CYP1A2 high activity;VARIANT;PA443227;ABORTION, SPONTANEOUS;DISEASE;
PA166157704;rs301435;VARIANT;PA447211;OBSESSIVE-COMPULSIVE DISORDER;DISEASE;PD
PA166263562;rs73568641;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166157221;rs76228616;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166155922;rs2229959;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;
PA166156332;rs1803274;VARIANT;PA166122649;BUTYRYLCHOLINESTERASE DEFICIENCY;DISEASE;PD
PA166156332;rs1803274;VARIANT;PA166176306;COGNITIVE DISORDER;DISEASE;PD
PA166156332;rs1803274;VARIANT;PA443319;ALZHEIMER DISEASE;DISEASE;PD
PA166156332;rs1803274;VARIANT;PA443407;APNEA;DISEASE;
PA166156332;rs1803274;VARIANT;PA446878;COCAINE DEPENDENCE;DISEASE;
PA166156332;rs1803274;VARIANT;PA447127;LEWY BODY DISEASE;DISEASE;PD
PA166155628;rs1143623;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166155628;rs1143623;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166154837;rs10046;VARIANT;PA166048848;MENOPAUSE;DISEASE;
PA166154837;rs10046;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;
PA166156901;rs5370;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166156901;rs5370;VARIANT;PA443886;DIABETES MELLITUS;DISEASE;PD
PA166156901;rs5370;VARIANT;PA443994;EDEMA;DISEASE;PD
PA166156901;rs5370;VARIANT;PA444528;HYPERLIPIDEMIAS;DISEASE;PD
PA166156901;rs5370;VARIANT;PA447288;ESSENTIAL HYPERTENSION;DISEASE;PD
PA166153695;rs2297480;VARIANT;PA443797;CORONARY DISEASE;DISEASE;
PA166153695;rs2297480;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166153695;rs2297480;VARIANT;PA445187;OSTEONECROSIS;DISEASE;PD
PA166153695;rs2297480;VARIANT;PA445190;OSTEOPOROSIS;DISEASE;PD
PA166153695;rs2297480;VARIANT;PA446214;OSTEOPOROSIS, POSTMENOPAUSAL;DISEASE;PD
PA166155468;rs12979860;VARIANT;PA444445;HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166155468;rs12979860;VARIANT;PA445016;MYELOPROLIFERATIVE DISORDER;DISEASE;PD
PA166155468;rs12979860;VARIANT;PA445506;RECURRENCE;DISEASE;PD
PA166155468;rs12979860;VARIANT;PA446862;HEPATITIS B, CHRONIC;DISEASE;PD
PA166155468;rs12979860;VARIANT;PA446863;CHRONIC HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166155468;rs12979860;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;
PA166155653;rs1901440;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166155606;rs885036;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166163134;rs3732759;VARIANT;PA443797;CORONARY DISEASE;DISEASE;PD
PA166171038;rs59724122;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166175796;rs11465996;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166156042;rs138335;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166157831;rs11185647;VARIANT;PA443340;ANEMIA;DISEASE;PD
PA166157831;rs11185647;VARIANT;PA445046;NASOPHARYNGEAL NEOPLASMS;DISEASE;PD
PA166157831;rs11185647;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166157603;rs4646244;VARIANT;PA445941;TUBERCULOSIS;DISEASE;PD
PA166153985;rs1934951;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166153985;rs1934951;VARIANT;PA444985;MULTIPLE MYELOMA;DISEASE;PD
PA166153985;rs1934951;VARIANT;PA445187;OSTEONECROSIS;DISEASE;PD
PA166154053;rs4244285;VARIANT;PA165108401;ACUTE CORONARY SYNDROME;DISEASE;PD
PA166154053;rs4244285;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166154053;rs4244285;VARIANT;PA444822;SYSTEMIC LUPUS ERYTHEMATOSUS;DISEASE;PD
PA166154053;rs4244285;VARIANT;PA445218;PANCREATIC NEOPLASMS;DISEASE;
PA166154053;rs4244285;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;
PA166154053;rs4244285;VARIANT;PA447278;DEPRESSION;DISEASE;PD
PA166154441;rs10898815;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166156364;rs2742390;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166200061;rs1525085;VARIANT;PA128406954;WEIGHT GAIN;DISEASE;PD
PA166154564;rs3764043;VARIANT;PA446171;CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE;DISEASE;
PA166154684;rs778293;VARIANT;PA447215;PSYCHOTIC DISORDER;DISEASE;PD
PA166185779;rs2159140;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166185779;rs2159140;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166155746;rs6545803;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166157537;rs267606723;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166157888;rs72554665;VARIANT;PA166048754;G6PD DEFICIENCY;DISEASE;
PA166157888;rs72554665;VARIANT;PA443343;HEMOLYTIC ANEMIA;DISEASE;
PA166157050;rs2813543;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166157033;rs2305089;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166155100;rs10514475;VARIANT;PA447278;DEPRESSION;DISEASE;PD
PA166161873;rs11124945;VARIANT;PA443886;DIABETES MELLITUS;DISEASE;PD
PA166161873;rs11124945;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166185412;rs10405681;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166155779;rs10192566;VARIANT;PA443890;DIABETES MELLITUS, TYPE 2;DISEASE;PD
PA166184313;rs17742120;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166176939;rs3810818;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166178063;rs397508328;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166154663;rs112445441;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166156349;rs2245705;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166157622;rs6988229;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166161880;rs1021737;VARIANT;PA166123007;HEMATOPOIETIC STEM CELL TRANSPLANTATION;DISEASE;PD
PA166156661;rs12507552;VARIANT;PA445218;PANCREATIC NEOPLASMS;DISEASE;PD
PA166186121;rs4430924;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166186121;rs4430924;VARIANT;PA445941;TUBERCULOSIS;DISEASE;PD
PA166162698;rs80224560;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166199008;rs740406;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166177202;rs61908408;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166156882;rs16886403;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166154884;rs2289105;VARIANT;PA166048848;MENOPAUSE;DISEASE;
PA166154884;rs2289105;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;
PA166155031;rs2228479;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166159110;rs4148738;VARIANT;PA443459;ATRIAL FIBRILLATION;DISEASE;
PA166180183;rs13093031;VARIANT;PA445210;PAIN, POSTOPERATIVE;DISEASE;PD
PA166156812;rs2975226;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166157253;rs324650;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;
PA166156443;rs11706052;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;PD
PA166156951;rs766127;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166154049;rs4148943;VARIANT;PA445425;PROSTATIC NEOPLASMS;DISEASE;PD
PA166154264;rs9344;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;
PA166154264;rs9344;VARIANT;PA443756;COLONIC NEOPLASMS;DISEASE;PD
PA166154264;rs9344;VARIANT;PA444840;LYMPHOMA;DISEASE;PD
PA166154264;rs9344;VARIANT;PA445601;OSTEOSARCOMA;DISEASE;PD
PA166154264;rs9344;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166154264;rs9344;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166153975;rs1800545;VARIANT;PA446479;HYPERTROPHY, LEFT VENTRICULAR;DISEASE;PD
PA166155285;rs2612091;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166154723;rs7992226;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;
PA166157931;DPYD deficiency;VARIANT;PA166122058;MUCOSITIS;DISEASE;
PA166157931;DPYD deficiency;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;
PA166157931;DPYD deficiency;VARIANT;PA443756;COLONIC NEOPLASMS;DISEASE;
PA166157931;DPYD deficiency;VARIANT;PA443842;DEATH;DISEASE;
PA166157931;DPYD deficiency;VARIANT;PA443937;DRUG TOXICITY;DISEASE;
PA166157931;DPYD deficiency;VARIANT;PA444352;HEAD AND NECK NEOPLASMS;DISEASE;
PA166157931;DPYD deficiency;VARIANT;PA445062;NEOPLASMS;DISEASE;
PA166157931;DPYD deficiency;VARIANT;PA445113;NEUTROPENIA;DISEASE;
PA166157931;DPYD deficiency;VARIANT;PA445503;RECTAL NEOPLASMS;DISEASE;
PA166157931;DPYD deficiency;VARIANT;PA446975;NEUROTOXICITY SYNDROMES;DISEASE;
PA166162295;rs8192950;VARIANT;PA443672;TRANSIENT ISCHEMIC ATTACK;DISEASE;PD
PA166162295;rs8192950;VARIANT;PA443678;CEREBROVASCULAR DISORDERS;DISEASE;PD
PA166162295;rs8192950;VARIANT;PA447054;STROKE;DISEASE;PD
PA166156978;rs1142345;VARIANT;PA162263534;OTOTOXICITY;DISEASE;PD
PA166156978;rs1142345;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166156978;rs1142345;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166156978;rs1142345;VARIANT;PA445204;OVARIAN NEOPLASMS;DISEASE;PD
PA166156978;rs1142345;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166157453;rs11983225;VARIANT;PA447278;DEPRESSION;DISEASE;PD
PA166156807;rs2631367;VARIANT;PA151958383;GASTROINTESTINAL STROMAL TUMORS;DISEASE;PD
PA166153655;rs1805094;VARIANT;PA165108401;ACUTE CORONARY SYNDROME;DISEASE;PD
PA166157530;rs121908757;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166155720;rs4124874;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166155720;rs4124874;VARIANT;PA444840;LYMPHOMA;DISEASE;PD
PA166155720;rs4124874;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166155720;rs4124874;VARIANT;PA446432;BETA-THALASSEMIA AND RELATED DISEASES;DISEASE;PD
PA166176035;rs3131003;VARIANT;PA166120929;SEVERE CUTANEOUS ADVERSE REACTIONS;DISEASE;PD
PA166155721;rs4148323;VARIANT;PA443362;ANGINA PECTORIS;DISEASE;
PA166155721;rs4148323;VARIANT;PA444370;HEART FAILURE;DISEASE;
PA166155721;rs4148323;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166176945;rs2799018;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166178432;rs78428806;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166178432;rs78428806;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166184140;rs7164594;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166156134;rs9606186;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166161288;rs363341;VARIANT;PA447215;PSYCHOTIC DISORDER;DISEASE;PD
PA166153875;rs17421511;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166155055;rs3785143;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166156352;rs2276707;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;
PA166156352;rs2276707;VARIANT;PA446876;SUBSTANCE-RELATED DISORDERS;DISEASE;
PA166156352;rs2276707;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;
PA166156352;rs2276707;VARIANT;PA447278;DEPRESSION;DISEASE;
PA166157112;rs6907567;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166154120;rs10994982;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;
PA166155375;rs1801086;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166177190;rs17724452;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166156044;rs139887;VARIANT;PA445204;OVARIAN NEOPLASMS;DISEASE;PD
PA166171035;rs6942227;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166153752;rs3768142;VARIANT;PA443297;AGRANULOCYTOSIS;DISEASE;PD
PA166155183;rs1136201;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166155183;rs1136201;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166153542;rs3397;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166157426;rs6977820;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166157426;rs6977820;VARIANT;PA447268;TARDIVE DYSKINESIA;DISEASE;PD
PA166155097;rs9936750;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166178415;rs148013902;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166178415;rs148013902;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166157750;rs2291858;VARIANT;PA444987;MULTIPLE SCLEROSIS;DISEASE;PD
PA166163521;rs7968606;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166157432;rs7799039;VARIANT;PA153906318;AUTISM SPECTRUM DISORDER;DISEASE;PD
PA166157432;rs7799039;VARIANT;PA447209;MOOD DISORDER;DISEASE;PD
PA166154345;rs1954787;VARIANT;PA447207;DEPRESSIVE DISORDER;DISEASE;PD
PA166162248;rs3761548;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;PD
PA166162248;rs3761548;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166154030;rs3740556;VARIANT;PA444818;LUNG NEOPLASMS;DISEASE;PD
PA166156212;rs149711321;VARIANT;PA443886;DIABETES MELLITUS;DISEASE;PD
PA166177112;rs7616119;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166155373;rs1800470;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166156523;rs1800591;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166156523;rs1800591;VARIANT;PA444517;HYPERLIPOPROTEINEMIA TYPE II;DISEASE;PD
PA166155984;rs914232;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166155984;rs914232;VARIANT;PA444937;MESOTHELIOMA;DISEASE;PD
PA166171037;rs1611259;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166155951;rs6028945;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166157411;rs6465084;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166176941;rs9901675;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166154465;rs12422149;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166157551;rs1051660;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166157551;rs1051660;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166157551;rs1051660;VARIANT;PA445208;PAIN;DISEASE;PD
PA166154783;rs1663330;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166155024;rs1967309;VARIANT;PA165108401;ACUTE CORONARY SYNDROME;DISEASE;PD
PA166155989;rs1056892;VARIANT;PA444370;HEART FAILURE;DISEASE;PD
PA166155989;rs1056892;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166154991;rs246240;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166154991;rs246240;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166154991;rs246240;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166155953;rs6064463;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166161055;rs137852330;VARIANT;PA166048754;G6PD DEFICIENCY;DISEASE;
PA166161286;rs1334802;VARIANT;PA447215;PSYCHOTIC DISORDER;DISEASE;PD
PA166157428;rs7787082;VARIANT;PA447207;DEPRESSIVE DISORDER;DISEASE;PD
PA166157428;rs7787082;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166160807;rs7301582;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166157810;rs10757274;VARIANT;PA165108401;ACUTE CORONARY SYNDROME;DISEASE;PD
PA166154132;rs11191561;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166201542;rs1058932;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166201542;rs1058932;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166157006;rs2010963;VARIANT;PA166114377;HAND-FOOT SYNDROME;DISEASE;PD
PA166157006;rs2010963;VARIANT;PA443624;RENAL CELL CARCINOMA;DISEASE;PD
PA166157006;rs2010963;VARIANT;PA444447;HEPATOCELLULAR CARCINOMA;DISEASE;PD
PA166157006;rs2010963;VARIANT;PA445425;PROSTATIC NEOPLASMS;DISEASE;PD
PA166157006;rs2010963;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166157006;rs2010963;VARIANT;PA446974;CHOROIDAL NEOVASCULARIZATION;DISEASE;PD
PA166159126;rs10538494;VARIANT;PA443340;ANEMIA;DISEASE;PD
PA166159126;rs10538494;VARIANT;PA445046;NASOPHARYNGEAL NEOPLASMS;DISEASE;PD
PA166157314;rs1990040;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;
PA166156638;rs10030044;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166157845;rs62576288;VARIANT;PA445046;NASOPHARYNGEAL NEOPLASMS;DISEASE;PD
PA166235849;rs1384401;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166156027;rs6269;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166156027;rs6269;VARIANT;PA445208;PAIN;DISEASE;PD
PA166156027;rs6269;VARIANT;PA445210;PAIN, POSTOPERATIVE;DISEASE;PD
PA166156027;rs6269;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166156777;rs1992647;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166156046;rs165599;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166156046;rs165599;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166253284;rs2336219;VARIANT;PA445204;OVARIAN NEOPLASMS;DISEASE;PD
PA166259921;rs13169373;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166156689;rs61361928;VARIANT;PA165108401;ACUTE CORONARY SYNDROME;DISEASE;
PA166157316;rs2032582;VARIANT;PA157379134;MYALGIA;DISEASE;PD
PA166157316;rs2032582;VARIANT;PA165108401;ACUTE CORONARY SYNDROME;DISEASE;PD
PA166157316;rs2032582;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;PD
PA166157316;rs2032582;VARIANT;PA166114377;HAND-FOOT SYNDROME;DISEASE;PD
PA166157316;rs2032582;VARIANT;PA166123007;HEMATOPOIETIC STEM CELL TRANSPLANTATION;DISEASE;
PA166157316;rs2032582;VARIANT;PA443512;URINARY BLADDER NEOPLASMS;DISEASE;
PA166157316;rs2032582;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166157316;rs2032582;VARIANT;PA443624;RENAL CELL CARCINOMA;DISEASE;PD
PA166157316;rs2032582;VARIANT;PA443750;ULCERATIVE COLITIS;DISEASE;PD
PA166157316;rs2032582;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166157316;rs2032582;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;
PA166157316;rs2032582;VARIANT;PA444065;EPILEPSY;DISEASE;PD
PA166157316;rs2032582;VARIANT;PA444222;FRACTURES, BONE;DISEASE;PD
PA166157316;rs2032582;VARIANT;PA444516;HYPERCHOLESTEROLEMIA;DISEASE;PD
PA166157316;rs2032582;VARIANT;PA444517;HYPERLIPOPROTEINEMIA TYPE II;DISEASE;PD
PA166157316;rs2032582;VARIANT;PA444591;HYPOVENTILATION;DISEASE;PD
PA166157316;rs2032582;VARIANT;PA444760;LEUKEMIA, MYELOID, ACUTE;DISEASE;PD
PA166157316;rs2032582;VARIANT;PA444848;LYMPHOPENIA;DISEASE;PD
PA166157316;rs2032582;VARIANT;PA444985;MULTIPLE MYELOMA;DISEASE;PD
PA166157316;rs2032582;VARIANT;PA445042;NARCOLEPSY;DISEASE;PD
PA166157316;rs2032582;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;
PA166157316;rs2032582;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166157316;rs2032582;VARIANT;PA445089;NEPHROTIC SYNDROME;DISEASE;PD
PA166157316;rs2032582;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166157316;rs2032582;VARIANT;PA445204;OVARIAN NEOPLASMS;DISEASE;PD
PA166157316;rs2032582;VARIANT;PA445208;PAIN;DISEASE;PD
PA166157316;rs2032582;VARIANT;PA445210;PAIN, POSTOPERATIVE;DISEASE;PD
PA166157316;rs2032582;VARIANT;PA446051;VOMITING;DISEASE;PD
PA166157316;rs2032582;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166157316;rs2032582;VARIANT;PA446970;POSTOPERATIVE NAUSEA AND VOMITING;DISEASE;PD
PA166157316;rs2032582;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166157316;rs2032582;VARIANT;PA447207;DEPRESSIVE DISORDER;DISEASE;PD
PA166157316;rs2032582;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166157316;rs2032582;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166157316;rs2032582;VARIANT;PA447247;LIVER TRANSPLANTATION;DISEASE;PD
PA166157316;rs2032582;VARIANT;PA447278;DEPRESSION;DISEASE;PD
PA166157130;rs7772821;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166156480;rs4961;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166156480;rs4961;VARIANT;PA444797;LIVER CIRRHOSIS;DISEASE;PD
PA166156480;rs4961;VARIANT;PA445019;MYOCARDIAL INFARCTION;DISEASE;PD
PA166156480;rs4961;VARIANT;PA447288;ESSENTIAL HYPERTENSION;DISEASE;PD
PA166184035;rs6928499;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166155539;rs118192176;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166319422;rs187713395;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166154459;rs11600347;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166178429;rs117458836;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166178429;rs117458836;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166412241;rs10916819;VARIANT;PA444760;LEUKEMIA, MYELOID, ACUTE;DISEASE;
PA166157634;rs11545078;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166157634;rs11545078;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166155764;rs7572857;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166155346;rs25487;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166155346;rs25487;VARIANT;PA443685;UTERINE CERVICAL NEOPLASM;DISEASE;PD
PA166155346;rs25487;VARIANT;PA443756;COLONIC NEOPLASMS;DISEASE;PD
PA166155346;rs25487;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166155346;rs25487;VARIANT;PA445204;OVARIAN NEOPLASMS;DISEASE;PD
PA166155346;rs25487;VARIANT;PA445503;RECTAL NEOPLASMS;DISEASE;PD
PA166155346;rs25487;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166155177;rs1052536;VARIANT;PA445204;OVARIAN NEOPLASMS;DISEASE;PD
PA166155462;rs11881222;VARIANT;PA444445;HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166155462;rs11881222;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166154447;rs11030918;VARIANT;PA444760;LEUKEMIA, MYELOID, ACUTE;DISEASE;
PA166154447;rs11030918;VARIANT;PA444937;MESOTHELIOMA;DISEASE;PD
PA166283381;rs1346563;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166159488;rs244898;VARIANT;PA443512;URINARY BLADDER NEOPLASMS;DISEASE;PD
PA166156607;rs6813183;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166154980;rs10517;VARIANT;PA151958383;GASTROINTESTINAL STROMAL TUMORS;DISEASE;PD
PA166155196;rs1979277;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166155196;rs1979277;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166205843;rs769404;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166236822;rs201820739;VARIANT;PA443407;APNEA;DISEASE;PD
PA166153978;rs1871450;VARIANT;PA445425;PROSTATIC NEOPLASMS;DISEASE;PD
PA166185306;rs362306;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166157063;rs3093726;VARIANT;PA443936;DRUG HYPERSENSITIVITY;DISEASE;PD
PA166175853;rs55781567;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166154444;rs11030104;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166155254;rs12948783;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166157779;rs4877900;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166157779;rs4877900;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166156024;rs4680;VARIANT;PA165108308;TEMPOROMANDIBULAR JOINT DYSFUNCTION SYNDROME;DISEASE;PD
PA166156024;rs4680;VARIANT;PA165108809;NEONATAL ABSTINENCE SYNDROME;DISEASE;PD
PA166156024;rs4680;VARIANT;PA166119022;METHAMPHETAMINE DEPENDENCE;DISEASE;PD
PA166156024;rs4680;VARIANT;PA166123046;SMOKING CESSATION;DISEASE;
PA166156024;rs4680;VARIANT;PA166151827;ADVERSE EVENTS;DISEASE;PD
PA166156024;rs4680;VARIANT;PA166185626;SOMNOLENCE;DISEASE;PD
PA166156024;rs4680;VARIANT;PA443782;CONSTIPATION;DISEASE;PD
PA166156024;rs4680;VARIANT;PA443842;DEATH;DISEASE;PD
PA166156024;rs4680;VARIANT;PA443851;DELIRIUM;DISEASE;PD
PA166156024;rs4680;VARIANT;PA444083;ERYTHEMA;DISEASE;PD
PA166156024;rs4680;VARIANT;PA444109;EXANTHEMA;DISEASE;PD
PA166156024;rs4680;VARIANT;PA444510;HYPERALGESIA;DISEASE;PD
PA166156024;rs4680;VARIANT;PA444949;MIGRAINE WITHOUT AURA;DISEASE;PD
PA166156024;rs4680;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166156024;rs4680;VARIANT;PA445048;NAUSEA;DISEASE;PD
PA166156024;rs4680;VARIANT;PA445208;PAIN;DISEASE;PD
PA166156024;rs4680;VARIANT;PA445210;PAIN, POSTOPERATIVE;DISEASE;PD
PA166156024;rs4680;VARIANT;PA445254;PARKINSON DISEASE;DISEASE;PD
PA166156024;rs4680;VARIANT;PA445437;PRURITUS;DISEASE;PD
PA166156024;rs4680;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166156024;rs4680;VARIANT;PA446051;VOMITING;DISEASE;PD
PA166156024;rs4680;VARIANT;PA446264;URINARY RETENTION;DISEASE;PD
PA166156024;rs4680;VARIANT;PA447004;MIGRAINE WITH AURA;DISEASE;PD
PA166156024;rs4680;VARIANT;PA447196;ANXIETY DISORDERS;DISEASE;PD
PA166156024;rs4680;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166156024;rs4680;VARIANT;PA447207;DEPRESSIVE DISORDER;DISEASE;PD
PA166156024;rs4680;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166156024;rs4680;VARIANT;PA447268;TARDIVE DYSKINESIA;DISEASE;PD
PA166156024;rs4680;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166210005;rs2673136;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166157526;rs114202595;VARIANT;PA443886;DIABETES MELLITUS;DISEASE;PD
PA166154801;rs3803300;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166157465;rs13242038;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;
PA166176934;rs3210967;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166156724;rs274713;VARIANT;PA445218;PANCREATIC NEOPLASMS;DISEASE;PD
PA166154310;rs1042919;VARIANT;PA444760;LEUKEMIA, MYELOID, ACUTE;DISEASE;PD
PA166154713;rs3742106;VARIANT;PA162263533;NEPHROTOXICITY;DISEASE;PD
PA166154713;rs3742106;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166201561;rs73450548;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166201561;rs73450548;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166157353;rs2284220;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166178090;rs75549581;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166154545;rs2301339;VARIANT;PA447288;ESSENTIAL HYPERTENSION;DISEASE;PD
PA166154851;rs809736;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166319421;rs140039091;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166155682;rs2304016;VARIANT;PA444065;EPILEPSY;DISEASE;PD
PA166157030;rs2275913;VARIANT;PA443750;ULCERATIVE COLITIS;DISEASE;PD
PA166157030;rs2275913;VARIANT;PA445210;PAIN, POSTOPERATIVE;DISEASE;PD
PA166157030;rs2275913;VARIANT;PA446116;INFLAMMATORY BOWEL DISEASES;DISEASE;PD
PA166156547;rs2239702;VARIANT;PA443624;RENAL CELL CARCINOMA;DISEASE;PD
PA166157137;rs9322335;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166154664;rs113681054;VARIANT;PA165108401;ACUTE CORONARY SYNDROME;DISEASE;
PA166154751;rs16950650;VARIANT;PA446661;SMALL CELL CARCINOMA;DISEASE;PD
PA166155259;rs28364032;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166203403;rs3748022;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166203403;rs3748022;VARIANT;PA444109;EXANTHEMA;DISEASE;PD
PA166177889;rs9943291;VARIANT;PA444522;HYPERGLYCEMIA;DISEASE;PD
PA166177889;rs9943291;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166163170;rs2295490;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166155763;rs7569963;VARIANT;PA447278;DEPRESSION;DISEASE;PD
PA166154795;rs2494752;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166155429;rs7248668;VARIANT;PA446863;CHRONIC HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166184548;rs3787140;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166156824;rs4133101;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166157157;rs9394992;VARIANT;PA445218;PANCREATIC NEOPLASMS;DISEASE;PD
PA166157157;rs9394992;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166153644;rs1801133;VARIANT;PA162263533;NEPHROTOXICITY;DISEASE;PD
PA166153644;rs1801133;VARIANT;PA164925725;TOXIC LIVER DISEASE;DISEASE;PD
PA166153644;rs1801133;VARIANT;PA165817398;MYELOSUPPRESSION;DISEASE;PD
PA166153644;rs1801133;VARIANT;PA166122058;MUCOSITIS;DISEASE;PD
PA166153644;rs1801133;VARIANT;PA166252441;PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA;DISEASE;PD
PA166153644;rs1801133;VARIANT;PA443433;JUVENILE RHEUMATOID ARTHRITIS;DISEASE;PD
PA166153644;rs1801133;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166153644;rs1801133;VARIANT;PA443580;BURKITT LYMPHOMA;DISEASE;
PA166153644;rs1801133;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166153644;rs1801133;VARIANT;PA443756;COLONIC NEOPLASMS;DISEASE;PD
PA166153644;rs1801133;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166153644;rs1801133;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166153644;rs1801133;VARIANT;PA444065;EPILEPSY;DISEASE;PD
PA166153644;rs1801133;VARIANT;PA444320;GRAFT VS HOST DISEASE;DISEASE;PD
PA166153644;rs1801133;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166153644;rs1801133;VARIANT;PA444750;LEUKEMIA;DISEASE;PD
PA166153644;rs1801133;VARIANT;PA444773;LEUKOPENIA;DISEASE;PD
PA166153644;rs1801133;VARIANT;PA444840;LYMPHOMA;DISEASE;PD
PA166153644;rs1801133;VARIANT;PA444937;MESOTHELIOMA;DISEASE;PD
PA166153644;rs1801133;VARIANT;PA445019;MYOCARDIAL INFARCTION;DISEASE;PD
PA166153644;rs1801133;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166153644;rs1801133;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166153644;rs1801133;VARIANT;PA445601;OSTEOSARCOMA;DISEASE;PD
PA166153644;rs1801133;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166153644;rs1801133;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166153644;rs1801133;VARIANT;PA446171;CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE;DISEASE;PD
PA166153644;rs1801133;VARIANT;PA446198;ARTHRITIS, PSORIATIC;DISEASE;PD
PA166153644;rs1801133;VARIANT;PA446309;LYMPHOMA, T-CELL;DISEASE;
PA166153644;rs1801133;VARIANT;PA446878;COCAINE DEPENDENCE;DISEASE;PD
PA166153644;rs1801133;VARIANT;PA447215;PSYCHOTIC DISORDER;DISEASE;PD
PA166153644;rs1801133;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166153644;rs1801133;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166177933;rs1022563;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166178021;rs34911792;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166155444;rs8192719;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;
PA166238104;rs2024627;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166238104;rs2024627;VARIANT;PA444685;KIDNEY NEOPLASMS;DISEASE;PD
PA166238104;rs2024627;VARIANT;PA446713;NEUROENDOCRINE TUMORS;DISEASE;PD
PA166155621;rs1056836;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166157172;rs10945919;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166156080;rs1883112;VARIANT;PA444760;LEUKEMIA, MYELOID, ACUTE;DISEASE;PD
PA166156080;rs1883112;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166210016;rs61974485;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166155924;rs2273359;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166156487;rs352046;VARIANT;PA165108401;ACUTE CORONARY SYNDROME;DISEASE;PD
PA166160976;rs79206939;VARIANT;PA166048887;IRRITABLE BOWEL SYNDROME;DISEASE;PD
PA166160976;rs79206939;VARIANT;PA444773;LEUKOPENIA;DISEASE;PD
PA166156368;rs2742435;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166155504;rs36118214;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;
PA166177130;rs10989064;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166157875;rs3813929;VARIANT;PA447208;MENTAL DISORDERS;DISEASE;PD
PA166157875;rs3813929;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166155251;rs12943590;VARIANT;PA443886;DIABETES MELLITUS;DISEASE;PD
PA166209222;rs201376588;VARIANT;PA445210;PAIN, POSTOPERATIVE;DISEASE;PD
PA166156086;rs2076369;VARIANT;PA446876;SUBSTANCE-RELATED DISORDERS;DISEASE;PD
PA166156086;rs2076369;VARIANT;PA447215;PSYCHOTIC DISORDER;DISEASE;PD
PA166156899;rs3077;VARIANT;PA446862;HEPATITIS B, CHRONIC;DISEASE;PD
PA166156768;rs1643650;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166283722;rs12948059;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166177184;rs9369266;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166268442;rs74569896;VARIANT;PA165108401;ACUTE CORONARY SYNDROME;DISEASE;PD
PA166268442;rs74569896;VARIANT;PA166129560;MAJOR ADVERSE CARDIAC EVENTS (MACE);DISEASE;PD
PA166155015;rs1532624;VARIANT;PA444528;HYPERLIPIDEMIAS;DISEASE;PD
PA166185907;rs869312399;VARIANT;PA443367;FABRY DISEASE;DISEASE;PD
PA166157177;rs12201199;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166157079;rs3778151;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166153941;rs10711;VARIANT;PA166124223;PNEUMONITIS;DISEASE;PD
PA166154620;rs10848635;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166157152;rs9376230;VARIANT;PA446432;BETA-THALASSEMIA AND RELATED DISEASES;DISEASE;PD
PA166157183;rs13207351;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166179290;rs9381299;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166157061;rs3025039;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166157061;rs3025039;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166156584;rs4292394;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166319501;rs536577604;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166157043;rs2619538;VARIANT;PA447215;PSYCHOTIC DISORDER;DISEASE;PD
PA166164877;rs11636687;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166164877;rs11636687;VARIANT;PA444773;LEUKOPENIA;DISEASE;PD
PA166164877;rs11636687;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166159951;rs10948059;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166163754;rs2270860;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166163754;rs2270860;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166155794;rs10929302;VARIANT;PA444545;HYPERPROLACTINEMIA;DISEASE;PD
PA166155794;rs10929302;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166164941;rs115545701;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166165078;rs738409;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166165078;rs738409;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166157535;rs199695765;VARIANT;PA445220;PANCREATITIS;DISEASE;PD
PA166157535;rs199695765;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166181222;rs28386840;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166156468;rs28933390;VARIANT;PA166122649;BUTYRYLCHOLINESTERASE DEFICIENCY;DISEASE;
PA166156468;rs28933390;VARIANT;PA443407;APNEA;DISEASE;
PA166156992;rs1800460;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166156336;rs1969624;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166176964;rs2013169;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166157336;rs2235015;VARIANT;PA447207;DEPRESSIVE DISORDER;DISEASE;PD
PA166157336;rs2235015;VARIANT;PA447278;DEPRESSION;DISEASE;PD
PA166157336;rs2235015;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166171048;rs1611255;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166153667;rs2072671;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166153667;rs2072671;VARIANT;PA444750;LEUKEMIA;DISEASE;PD
PA166153667;rs2072671;VARIANT;PA444840;LYMPHOMA;DISEASE;PD
PA166153667;rs2072671;VARIANT;PA444937;MESOTHELIOMA;DISEASE;PD
PA166153667;rs2072671;VARIANT;PA445048;NAUSEA;DISEASE;PD
PA166153667;rs2072671;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166153667;rs2072671;VARIANT;PA445218;PANCREATIC NEOPLASMS;DISEASE;PD
PA166156054;rs713729;VARIANT;PA446876;SUBSTANCE-RELATED DISORDERS;DISEASE;
PA166154628;rs11045819;VARIANT;PA444516;HYPERCHOLESTEROLEMIA;DISEASE;PD
PA166210017;rs72768626;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166184141;rs8109525;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166157047;rs2760118;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166185914;rs869312138;VARIANT;PA443367;FABRY DISEASE;DISEASE;PD
PA166163667;rs193922832;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166155693;rs3087243;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166183982;rs10055255;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166155529;rs118192122;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166176944;rs17712523;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166257861;rs62436463;VARIANT;PA166151827;ADVERSE EVENTS;DISEASE;PD
PA166177194;rs17786400;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166210042;rs56722963;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166178416;rs55633228;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166178416;rs55633228;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166153750;rs3754446;VARIANT;PA444760;LEUKEMIA, MYELOID, ACUTE;DISEASE;
PA166176943;rs4562;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166157303;rs1799983;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166157303;rs1799983;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166157303;rs1799983;VARIANT;PA443797;CORONARY DISEASE;DISEASE;PD
PA166157303;rs1799983;VARIANT;PA444370;HEART FAILURE;DISEASE;PD
PA166157303;rs1799983;VARIANT;PA444447;HEPATOCELLULAR CARCINOMA;DISEASE;PD
PA166157303;rs1799983;VARIANT;PA444760;LEUKEMIA, MYELOID, ACUTE;DISEASE;PD
PA166157303;rs1799983;VARIANT;PA444949;MIGRAINE WITHOUT AURA;DISEASE;PD
PA166157303;rs1799983;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166157303;rs1799983;VARIANT;PA445204;OVARIAN NEOPLASMS;DISEASE;PD
PA166157303;rs1799983;VARIANT;PA445742;STOMACH NEOPLASMS;DISEASE;PD
PA166157303;rs1799983;VARIANT;PA447004;MIGRAINE WITH AURA;DISEASE;PD
PA166154613;rs10747673;VARIANT;PA443886;DIABETES MELLITUS;DISEASE;PD
PA166348241;rs6770663;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166154921;rs7176005;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166153763;rs4278350;VARIANT;PA444987;MULTIPLE SCLEROSIS;DISEASE;PD
PA166177178;rs2419128;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166154394;rs3133084;VARIANT;PA444987;MULTIPLE SCLEROSIS;DISEASE;PD
PA166154566;rs3794271;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166154566;rs3794271;VARIANT;PA446198;ARTHRITIS, PSORIATIC;DISEASE;PD
PA166155201;rs2228100;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166266702;rs10908521;VARIANT;PA162263533;NEPHROTOXICITY;DISEASE;PD
PA166185915;rs1569304898;VARIANT;PA443367;FABRY DISEASE;DISEASE;PD
PA166157904;TPMT poor metabolizer;VARIANT;PA446116;INFLAMMATORY BOWEL DISEASES;DISEASE;
PA166177185;rs3124955;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166183701;rs511435;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166183701;rs511435;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166183701;rs511435;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166195021;rs6487504;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166283743;rs315498;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166236401;rs764841347;VARIANT;PA443407;APNEA;DISEASE;PD
PA166161950;rs11265618;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166156677;rs28365063;VARIANT;PA444065;EPILEPSY;DISEASE;
PA166154468;rs12806698;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166154468;rs12806698;VARIANT;PA444937;MESOTHELIOMA;DISEASE;PD
PA166153850;rs12118636;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166154407;rs4436578;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166157026;rs2234693;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166157026;rs2234693;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166157026;rs2234693;VARIANT;PA447215;PSYCHOTIC DISORDER;DISEASE;PD
PA166155173;rs1042522;VARIANT;PA166123207;OVERALL SURVIVAL;DISEASE;PD
PA166155173;rs1042522;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166153633;rs1563828;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166155545;rs121918594;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166156869;rs11739136;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166156330;rs1801019;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166157540;rs1208;VARIANT;PA165108622;DRUG INTERACTION WITH DRUG;DISEASE;PD
PA166157540;rs1208;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166185917;rs869312146;VARIANT;PA443367;FABRY DISEASE;DISEASE;PD
PA166156831;rs4702484;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166153673;rs2144297;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166182190;rs11249454;VARIANT;PA151958383;GASTROINTESTINAL STROMAL TUMORS;DISEASE;PD
PA166153759;rs3917643;VARIANT;PA446459;MYOCARDIAL ISCHEMIA;DISEASE;PD
PA166179817;rs2284922;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166155288;rs2847153;VARIANT;PA445218;PANCREATIC NEOPLASMS;DISEASE;PD
PA166182161;rs1202283;VARIANT;PA151958383;GASTROINTESTINAL STROMAL TUMORS;DISEASE;PD
PA166238642;rs17004921;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166153640;rs1800872;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;PD
PA166153640;rs1800872;VARIANT;PA447247;LIVER TRANSPLANTATION;DISEASE;PD
PA166156604;rs6600880;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166154298;rs720106;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166153609;rs1047840;VARIANT;PA445058;METASTATIC NEOPLASM;DISEASE;PD
PA166156632;rs7699188;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166268447;rs201441480;VARIANT;PA165108401;ACUTE CORONARY SYNDROME;DISEASE;PD
PA166268447;rs201441480;VARIANT;PA166129560;MAJOR ADVERSE CARDIAC EVENTS (MACE);DISEASE;PD
PA166157385;rs4148737;VARIANT;PA445601;OSTEOSARCOMA;DISEASE;PD
PA166158908;rs267606618;VARIANT;PA162263534;OTOTOXICITY;DISEASE;PD
PA166153623;rs1126742;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166156092;rs2269577;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166154007;rs2273697;VARIANT;PA151958383;GASTROINTESTINAL STROMAL TUMORS;DISEASE;PD
PA166154007;rs2273697;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166154007;rs2273697;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166154007;rs2273697;VARIANT;PA443658;CENTRAL NERVOUS SYSTEM INFECTIOUS DISORDER;DISEASE;
PA166154007;rs2273697;VARIANT;PA444065;EPILEPSY;DISEASE;PD
PA166154007;rs2273697;VARIANT;PA444682;KIDNEY DISORDER;DISEASE;PD
PA166154007;rs2273697;VARIANT;PA444937;MESOTHELIOMA;DISEASE;PD
PA166154007;rs2273697;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;
PA166154007;rs2273697;VARIANT;PA446432;BETA-THALASSEMIA AND RELATED DISEASES;DISEASE;
PA166154007;rs2273697;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166156956;rs806378;VARIANT;PA153906318;AUTISM SPECTRUM DISORDER;DISEASE;PD
PA166156956;rs806378;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166156976;rs1063320;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166274201;rs10787959;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166176111;rs927650;VARIANT;PA446432;BETA-THALASSEMIA AND RELATED DISEASES;DISEASE;
PA166157854;rs518147;VARIANT;PA128406954;WEIGHT GAIN;DISEASE;PD
PA166157854;rs518147;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166185686;rs10516440;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166156744;rs881152;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166154464;rs12364283;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166153705;rs2445142;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166157168;rs10455872;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166157715;rs868856;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166156378;rs3772809;VARIANT;PA445058;METASTATIC NEOPLASM;DISEASE;PD
PA166154395;rs3135506;VARIANT;PA446120;HYPERTRIGLYCERIDEMIA;DISEASE;PD
PA166181168;rs4251417;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166155818;rs12613732;VARIANT;PA444447;HEPATOCELLULAR CARCINOMA;DISEASE;PD
PA166157759;rs2814707;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166176963;rs1061115;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166154900;rs3087374;VARIANT;PA164925725;TOXIC LIVER DISEASE;DISEASE;PD
PA166153889;rs56038477;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166155679;rs2291767;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166153841;rs12044852;VARIANT;PA444987;MULTIPLE SCLEROSIS;DISEASE;PD
PA166164958;rs75541969;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166163186;rs9361233;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166252981;rs6465938;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;
PA166169893;rs1059698;VARIANT;PA165817398;MYELOSUPPRESSION;DISEASE;PD
PA166169893;rs1059698;VARIANT;PA166122058;MUCOSITIS;DISEASE;PD
PA166169893;rs1059698;VARIANT;PA443340;ANEMIA;DISEASE;PD
PA166169893;rs1059698;VARIANT;PA443875;DERMATITIS;DISEASE;PD
PA166169893;rs1059698;VARIANT;PA445046;NASOPHARYNGEAL NEOPLASMS;DISEASE;PD
PA166169893;rs1059698;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166169893;rs1059698;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166157780;rs4986790;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166157780;rs4986790;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166156771;rs1650723;VARIANT;PA445601;OSTEOSARCOMA;DISEASE;PD
PA166157252;rs274622;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;
PA166156365;rs2742417;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166157058;rs3025000;VARIANT;PA134850558;MACULAR DEGENERATION;DISEASE;PD
PA166155367;rs1433099;VARIANT;PA446021;VASCULAR DISEASES;DISEASE;PD
PA166319664;rs538336580;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166165040;rs4646536;VARIANT;PA162263533;NEPHROTOXICITY;DISEASE;PD
PA166165040;rs4646536;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166155506;rs56113850;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;
PA166157859;rs1050828;VARIANT;PA444859;MALARIA;DISEASE;PD
PA166157859;rs1050828;VARIANT;PA446390;MALARIA, FALCIPARUM;DISEASE;PD
PA166157009;rs2071303;VARIANT;PA443815;CROHN DISEASE;DISEASE;PD
PA166155690;rs2741049;VARIANT;PA444065;EPILEPSY;DISEASE;PD
PA166155690;rs2741049;VARIANT;PA445629;SEIZURES;DISEASE;PD
PA166154744;rs9590353;VARIANT;PA447288;ESSENTIAL HYPERTENSION;DISEASE;PD
PA166155926;rs2273618;VARIANT;PA443340;ANEMIA;DISEASE;PD
PA166155926;rs2273618;VARIANT;PA445046;NASOPHARYNGEAL NEOPLASMS;DISEASE;PD
PA166157521;rs80282562;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166163244;rs11861118;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166153765;rs4329505;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166156280;rs167771;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166156280;rs167771;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166154352;rs2229437;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166157022;rs2207396;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166157555;rs1367094;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166156908;rs130058;VARIANT;PA447278;DEPRESSION;DISEASE;PD
PA166184626;rs1718125;VARIANT;PA445210;PAIN, POSTOPERATIVE;DISEASE;PD
PA166153626;rs1137101;VARIANT;PA443797;CORONARY DISEASE;DISEASE;PD
PA166153626;rs1137101;VARIANT;PA444065;EPILEPSY;DISEASE;PD
PA166153626;rs1137101;VARIANT;PA444528;HYPERLIPIDEMIAS;DISEASE;PD
PA166185729;rs121908547;VARIANT;PA447130;MYOTONIC DISORDERS;DISEASE;PD
PA166156890;rs28363170;VARIANT;PA443309;ALCOHOLISM;DISEASE;PD
PA166156890;rs28363170;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;
PA166156890;rs28363170;VARIANT;PA446878;COCAINE-RELATED DISORDERS;DISEASE;PD
PA166184842;rs9829896;VARIANT;PA446876;SUBSTANCE-RELATED DISORDERS;DISEASE;PD
PA166179815;rs2229046;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166154508;rs1019385;VARIANT;PA444065;EPILEPSY;DISEASE;PD
PA166155768;rs7586110;VARIANT;PA444511;HYPERBILIRUBINEMIA;DISEASE;PD
PA166155768;rs7586110;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166153821;rs11209716;VARIANT;PA443803;COUGH;DISEASE;PD
PA166153821;rs11209716;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166157191;rs17179108;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166199581;rs115208233;VARIANT;PA446199;OVERDOSE;DISEASE;PD
PA166153801;rs10494227;VARIANT;PA444987;MULTIPLE SCLEROSIS;DISEASE;PD
PA166156591;rs4604006;VARIANT;PA444447;HEPATOCELLULAR CARCINOMA;DISEASE;PD
PA166154705;rs1933437;VARIANT;PA165817398;MYELOSUPPRESSION;DISEASE;PD
PA166154705;rs1933437;VARIANT;PA444773;LEUKOPENIA;DISEASE;PD
PA166154705;rs1933437;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166154705;rs1933437;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166160979;rs16952570;VARIANT;PA166048887;IRRITABLE BOWEL SYNDROME;DISEASE;PD
PA166160979;rs16952570;VARIANT;PA443750;ULCERATIVE COLITIS;DISEASE;PD
PA166160979;rs16952570;VARIANT;PA443815;CROHN DISEASE;DISEASE;PD
PA166160979;rs16952570;VARIANT;PA444773;LEUKOPENIA;DISEASE;PD
PA166160979;rs16952570;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166154895;rs2472297;VARIANT;PA447215;PSYCHOTIC DISORDER;DISEASE;
PA166156339;rs2046934;VARIANT;PA165108401;ACUTE CORONARY SYNDROME;DISEASE;PD
PA166156339;rs2046934;VARIANT;PA166129560;MAJOR ADVERSE CARDIAC EVENTS (MACE);DISEASE;PD
PA166156339;rs2046934;VARIANT;PA443362;ANGINA PECTORIS;DISEASE;PD
PA166156913;rs316019;VARIANT;PA162263534;OTOTOXICITY;DISEASE;PD
PA166156913;rs316019;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166156913;rs316019;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166157238;rs662;VARIANT;PA443362;ANGINA PECTORIS;DISEASE;PD
PA166157238;rs662;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166157238;rs662;VARIANT;PA444516;HYPERCHOLESTEROLEMIA;DISEASE;PD
PA166157238;rs662;VARIANT;PA445019;MYOCARDIAL INFARCTION;DISEASE;PD
PA166157238;rs662;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166157238;rs662;VARIANT;PA445742;STOMACH NEOPLASMS;DISEASE;PD
PA166157238;rs662;VARIANT;PA445850;THROMBOTIC DISEASE;DISEASE;PD
PA166157238;rs662;VARIANT;PA446459;MYOCARDIAL ISCHEMIA;DISEASE;PD
PA166157746;rs2234753;VARIANT;PA443340;ANEMIA;DISEASE;PD
PA166157746;rs2234753;VARIANT;PA445046;NASOPHARYNGEAL NEOPLASMS;DISEASE;PD
PA166157524;rs113993959;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;
PA166183998;rs1079596;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166155844;rs17583889;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166157739;rs1948308;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166157739;rs1948308;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166157390;rs4410790;VARIANT;PA447215;PSYCHOTIC DISORDER;DISEASE;
PA166154391;rs2854117;VARIANT;PA444528;HYPERLIPIDEMIAS;DISEASE;PD
PA166154391;rs2854117;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166236761;rs531738678;VARIANT;PA443407;APNEA;DISEASE;PD
PA166157784;rs6413517;VARIANT;PA443340;ANEMIA;DISEASE;PD
PA166157784;rs6413517;VARIANT;PA445046;NASOPHARYNGEAL NEOPLASMS;DISEASE;PD
PA166153965;rs1127687;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166157114;rs6920220;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166157114;rs6920220;VARIANT;PA446198;ARTHRITIS, PSORIATIC;DISEASE;PD
PA166153677;rs2228079;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166169464;rs11503014;VARIANT;PA446878;COCAINE DEPENDENCE;DISEASE;PD
PA166154073;rs6413432;VARIANT;PA445204;OVARIAN NEOPLASMS;DISEASE;PD
PA166176957;rs1061735;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166154418;rs7103411;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166155383;rs2112460;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166201521;rs9262132;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166201521;rs9262132;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166153876;rs17602729;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166157691;rs141059755;VARIANT;PA445187;OSTEONECROSIS;DISEASE;PD
PA166157691;rs141059755;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166205161;rs2366929;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166154781;rs1353411;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166155987;rs1051296;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;
PA166155923;rs2236196;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;
PA166155860;rs28898617;VARIANT;PA444065;EPILEPSY;DISEASE;
PA166252941;rs155333;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;
PA166157653;rs17716295;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166157126;rs7756992;VARIANT;PA443886;DIABETES MELLITUS;DISEASE;PD
PA166157413;rs6467136;VARIANT;PA443890;DIABETES MELLITUS, TYPE 2;DISEASE;PD
PA166155049;rs3743527;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166156717;rs153560;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166155143;rs4291;VARIANT;PA443319;ALZHEIMER DISEASE;DISEASE;PD
PA166155143;rs4291;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166155143;rs4291;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166164943;rs113993958;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166155296;rs4483927;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166156374;rs3732359;VARIANT;PA443340;ANEMIA;DISEASE;PD
PA166156374;rs3732359;VARIANT;PA445046;NASOPHARYNGEAL NEOPLASMS;DISEASE;PD
PA166163715;rs4788863;VARIANT;PA162263534;OTOTOXICITY;DISEASE;PD
PA166163715;rs4788863;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166163715;rs4788863;VARIANT;PA445828;TESTICULAR NEOPLASMS;DISEASE;PD
PA166159897;rs28362491;VARIANT;PA445451;PSORIASIS;DISEASE;
PA166171041;rs66486766;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166154142;rs11598702;VARIANT;PA445062;NEOPLASMS;DISEASE;
PA166154142;rs11598702;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166177195;rs17786412;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166153574;rs529520;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166156004;rs2838956;VARIANT;PA166151827;ADVERSE EVENTS;DISEASE;PD
PA166156004;rs2838956;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166156730;rs307826;VARIANT;PA443624;RENAL CELL CARCINOMA;DISEASE;PD
PA166155543;rs121918592;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166179565;rs3857532;VARIANT;PA445549;RHABDOMYOLYSIS;DISEASE;PD
PA166283401;rs2330951;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166155532;rs118192161;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166157228;rs144854329;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166157228;rs144854329;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;
PA166155075;rs6500843;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166160680;rs10946737;VARIANT;PA445941;TUBERCULOSIS;DISEASE;PD
PA166156918;rs451774;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166153825;rs11264359;VARIANT;PA443797;CORONARY DISEASE;DISEASE;PD
PA166153825;rs11264359;VARIANT;PA445190;OSTEOPOROSIS;DISEASE;PD
PA166155220;rs4267385;VARIANT;PA443803;COUGH;DISEASE;PD
PA166176959;rs362272;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166154531;rs2228570;VARIANT;PA446863;CHRONIC HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166155331;rs45445694;VARIANT;PA165817398;MYELOSUPPRESSION;DISEASE;
PA166155331;rs45445694;VARIANT;PA166114377;HAND-FOOT SYNDROME;DISEASE;
PA166155331;rs45445694;VARIANT;PA166123026;PROGRESSION-FREE SURVIVAL;DISEASE;PD
PA166155331;rs45445694;VARIANT;PA166123207;OVERALL SURVIVAL;DISEASE;PD
PA166155331;rs45445694;VARIANT;PA166123507;DISCONTINUATION;DISEASE;
PA166155331;rs45445694;VARIANT;PA166151827;ADVERSE EVENTS;DISEASE;
PA166155331;rs45445694;VARIANT;PA166153403;GASTROESOPHAGEAL CANCER;DISEASE;
PA166155331;rs45445694;VARIANT;PA443265;ADENOCARCINOMA;DISEASE;
PA166155331;rs45445694;VARIANT;PA443340;ANEMIA;DISEASE;
PA166155331;rs45445694;VARIANT;PA443434;ARTHRITIS, RHEUMATOID;DISEASE;PD
PA166155331;rs45445694;VARIANT;PA443448;ASTHENIA;DISEASE;
PA166155331;rs45445694;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;
PA166155331;rs45445694;VARIANT;PA443899;DIARRHEA;DISEASE;
PA166155331;rs45445694;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166155331;rs45445694;VARIANT;PA444101;ESOPHAGEAL NEOPLASMS;DISEASE;
PA166155331;rs45445694;VARIANT;PA444257;GASTROINTESTINAL NEOPLASMS;DISEASE;
PA166155331;rs45445694;VARIANT;PA444845;LYMPHOMA, NON-HODGKIN;DISEASE;PD
PA166155331;rs45445694;VARIANT;PA445018;CARDIOMYOPATHIES;DISEASE;
PA166155331;rs45445694;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166155331;rs45445694;VARIANT;PA445113;NEUTROPENIA;DISEASE;
PA166155331;rs45445694;VARIANT;PA445218;PANCREATIC NEOPLASMS;DISEASE;
PA166155331;rs45445694;VARIANT;PA445451;PSORIASIS;DISEASE;
PA166155331;rs45445694;VARIANT;PA445503;RECTAL NEOPLASMS;DISEASE;
PA166155331;rs45445694;VARIANT;PA445742;STOMACH NEOPLASMS;DISEASE;
PA166155331;rs45445694;VARIANT;PA445746;STOMATITIS;DISEASE;
PA166155331;rs45445694;VARIANT;PA446051;VOMITING;DISEASE;
PA166155331;rs45445694;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166155331;rs45445694;VARIANT;PA446116;INFLAMMATORY BOWEL DISEASES;DISEASE;
PA166155331;rs45445694;VARIANT;PA446155;PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;DISEASE;PD
PA166155331;rs45445694;VARIANT;PA447146;HYPERAMMONEMIA;DISEASE;
PA166153954;rs730720;VARIANT;PA445425;PROSTATIC NEOPLASMS;DISEASE;PD
PA166155591;rs264631;VARIANT;PA445425;PROSTATIC NEOPLASMS;DISEASE;PD
PA166157039;rs2500535;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166155034;rs2238476;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166154488;rs5888;VARIANT;PA444516;HYPERCHOLESTEROLEMIA;DISEASE;PD
PA166157202;rs35864111;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166164955;rs78769542;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166169977;rs10040363;VARIANT;PA445742;STOMACH NEOPLASMS;DISEASE;PD
PA166201322;rs6025211;VARIANT;PA444804;LIVER CANCER;DISEASE;PD
PA166155408;rs3213239;VARIANT;PA443622;CARCINOMA, NON-SMALL-CELL LUNG;DISEASE;PD
PA166155071;rs4888024;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166155071;rs4888024;VARIANT;PA446714;RESIDUAL NEOPLASM;DISEASE;PD
PA166157121;rs7740004;VARIANT;PA445187;OSTEONECROSIS;DISEASE;PD
PA166157866;rs2227291;VARIANT;PA445425;PROSTATIC NEOPLASMS;DISEASE;PD
PA166184305;rs6688363;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166162695;rs80034486;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166209223;rs775887911;VARIANT;PA445210;PAIN, POSTOPERATIVE;DISEASE;PD
PA166154749;rs11568695;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;
PA166177955;rs62638690;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166177955;rs62638690;VARIANT;PA446878;COCAINE DEPENDENCE;DISEASE;PD
PA166157776;rs4742610;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166154772;rs1130214;VARIANT;PA444818;LUNG NEOPLASMS;DISEASE;PD
PA166184312;rs17382202;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166154369;rs2440390;VARIANT;PA447208;MENTAL DISORDERS;DISEASE;PD
PA166153768;rs4646487;VARIANT;PA445425;PROSTATIC NEOPLASMS;DISEASE;PD
PA166201502;rs3094086;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166201502;rs3094086;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166157151;rs9373839;VARIANT;PA446116;INFLAMMATORY BOWEL DISEASES;DISEASE;PD
PA166156619;rs7439366;VARIANT;PA444065;EPILEPSY;DISEASE;PD
PA166156619;rs7439366;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166156619;rs7439366;VARIANT;PA445208;PAIN;DISEASE;PD
PA166156619;rs7439366;VARIANT;PA445210;PAIN, POSTOPERATIVE;DISEASE;PD
PA166156619;rs7439366;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;
PA166177622;rs5746136;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166156430;rs9825762;VARIANT;PA445204;OVARIAN NEOPLASMS;DISEASE;PD
PA166154969;rs4673;VARIANT;PA166122058;MUCOSITIS;DISEASE;PD
PA166154969;rs4673;VARIANT;PA443340;ANEMIA;DISEASE;PD
PA166154969;rs4673;VARIANT;PA444516;HYPERCHOLESTEROLEMIA;DISEASE;
PA166154969;rs4673;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166154969;rs4673;VARIANT;PA445601;OSTEOSARCOMA;DISEASE;PD
PA166182189;rs305968;VARIANT;PA151958383;GASTROINTESTINAL STROMAL TUMORS;DISEASE;PD
PA166177133;rs7472;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166184206;rs2236855;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166155759;rs6755571;VARIANT;PA445062;NEOPLASMS;DISEASE;
PA166201527;rs3130907;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166201527;rs3130907;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166181364;rs1948;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166153972;rs1799853;VARIANT;PA166123007;HEMATOPOIETIC STEM CELL TRANSPLANTATION;DISEASE;
PA166157270;rs854548;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166154079;rs7091672;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166157111;rs6901146;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;
PA166157153;rs9380142;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166156796;rs2290732;VARIANT;PA444065;EPILEPSY;DISEASE;PD
PA166156100;rs2413739;VARIANT;PA166048887;IRRITABLE BOWEL SYNDROME;DISEASE;PD
PA166156100;rs2413739;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166153751;rs3766355;VARIANT;PA444282;OPEN-ANGLE GLAUCOMA;DISEASE;PD
PA166156398;rs4402960;VARIANT;PA443890;DIABETES MELLITUS, TYPE 2;DISEASE;PD
PA166155542;rs118204423;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166157570;rs1801280;VARIANT;PA165108622;DRUG INTERACTION WITH DRUG;DISEASE;PD
PA166157570;rs1801280;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166157570;rs1801280;VARIANT;PA445204;OVARIAN NEOPLASMS;DISEASE;PD
PA166157307;rs1801368;VARIANT;PA445204;OVARIAN NEOPLASMS;DISEASE;PD
PA166283383;rs11125039;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166155365;rs1131882;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166155365;rs1131882;VARIANT;PA443890;DIABETES MELLITUS, TYPE 2;DISEASE;PD
PA166153689;rs2274567;VARIANT;PA166122772;PAROXYSMAL NOCTURNAL HEMOGLOBINURIA;DISEASE;PD
PA166154094;rs8187710;VARIANT;PA444145;FANCONI RENOTUBULAR SYNDROME;DISEASE;PD
PA166154094;rs8187710;VARIANT;PA444845;NON-HODGKIN LYMPHOMA;DISEASE;PD
PA166154094;rs8187710;VARIANT;PA446432;BETA-THALASSEMIA AND RELATED DISEASES;DISEASE;PD
PA166154094;rs8187710;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166153906;rs75017182;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166178422;rs3805945;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166178422;rs3805945;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166155704;rs3738948;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166218621;rs4732636;VARIANT;PA165108809;NEONATAL ABSTINENCE SYNDROME;DISEASE;PD
PA166154510;rs1072388;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166155351;rs429358;VARIANT;PA443319;ALZHEIMER DISEASE;DISEASE;PD
PA166155351;rs429358;VARIANT;PA444417;HEMORRHAGE;DISEASE;PD
PA166155351;rs429358;VARIANT;PA444528;HYPERLIPIDEMIAS;DISEASE;PD
PA166155351;rs429358;VARIANT;PA445019;MYOCARDIAL INFARCTION;DISEASE;PD
PA166155351;rs429358;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166155351;rs429358;VARIANT;PA447298;VENOUS THROMBOEMBOLISM;DISEASE;PD
PA166154849;rs749292;VARIANT;PA166048848;MENOPAUSE;DISEASE;
PA166154849;rs749292;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;
PA166156277;rs6280;VARIANT;PA153906318;AUTISM SPECTRUM DISORDER;DISEASE;PD
PA166156277;rs6280;VARIANT;PA166124386;GASTROINTESTINAL TOXICITY;DISEASE;PD
PA166156277;rs6280;VARIANT;PA444339;HALLUCINATIONS;DISEASE;PD
PA166156277;rs6280;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166156277;rs6280;VARIANT;PA445254;PARKINSON DISEASE;DISEASE;PD
PA166156277;rs6280;VARIANT;PA447198;AUTISM;DISEASE;PD
PA166156277;rs6280;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166156277;rs6280;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166156277;rs6280;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166154047;rs4148386;VARIANT;PA444065;EPILEPSY;DISEASE;
PA166156696;rs77107237;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;
PA166154028;rs3740066;VARIANT;PA133888799;ORGAN TRANSPLANTATION;DISEASE;
PA166154028;rs3740066;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;
PA166154028;rs3740066;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166154028;rs3740066;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166154028;rs3740066;VARIANT;PA444065;EPILEPSY;DISEASE;PD
PA166155765;rs7574296;VARIANT;PA166114377;HAND-FOOT SYNDROME;DISEASE;PD
PA166155765;rs7574296;VARIANT;PA444447;HEPATOCELLULAR CARCINOMA;DISEASE;PD
PA166155033;rs2238472;VARIANT;PA445425;PROSTATIC NEOPLASMS;DISEASE;PD
PA166155206;rs2289669;VARIANT;PA443890;DIABETES MELLITUS, TYPE 2;DISEASE;PD
PA166155206;rs2289669;VARIANT;PA445376;POLYCYSTIC OVARY SYNDROME;DISEASE;PD
PA166157855;rs518329;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166156554;rs2306744;VARIANT;PA444760;LEUKEMIA, MYELOID, ACUTE;DISEASE;PD
PA166154998;rs889299;VARIANT;PA443890;DIABETES MELLITUS, TYPE 2;DISEASE;PD
PA166157561;rs1517114;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166157736;rs1778929;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166155063;rs4240803;VARIANT;PA162263525;NEUROPATHIC PAIN;DISEASE;PD
PA166155063;rs4240803;VARIANT;PA166151827;ADVERSE EVENTS;DISEASE;PD
PA166155063;rs4240803;VARIANT;PA444985;MULTIPLE MYELOMA;DISEASE;PD
PA166157267;rs776746;VARIANT;PA157379134;MYALGIA;DISEASE;
PA166157267;rs776746;VARIANT;PA164925725;TOXIC LIVER DISEASE;DISEASE;PD
PA166157267;rs776746;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;
PA166157267;rs776746;VARIANT;PA166048714;PREGNANCY;DISEASE;
PA166157267;rs776746;VARIANT;PA166114454;TRANSPLANT REJECTION;DISEASE;PD
PA166157267;rs776746;VARIANT;PA443425;ARTERIOSCLEROSIS;DISEASE;PD
PA166157267;rs776746;VARIANT;PA443459;ATRIAL FIBRILLATION;DISEASE;
PA166157267;rs776746;VARIANT;PA443624;RENAL CELL CARCINOMA;DISEASE;PD
PA166157267;rs776746;VARIANT;PA443750;ULCERATIVE COLITIS;DISEASE;PD
PA166157267;rs776746;VARIANT;PA443937;DRUG TOXICITY;DISEASE;
PA166157267;rs776746;VARIANT;PA444065;EPILEPSY;DISEASE;PD
PA166157267;rs776746;VARIANT;PA444516;HYPERCHOLESTEROLEMIA;DISEASE;
PA166157267;rs776746;VARIANT;PA444528;HYPERLIPIDEMIAS;DISEASE;PD
PA166157267;rs776746;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166157267;rs776746;VARIANT;PA444614;INFECTIOUS DISEASE;DISEASE;PD
PA166157267;rs776746;VARIANT;PA444859;MALARIA;DISEASE;
PA166157267;rs776746;VARIANT;PA445019;MYOCARDIAL INFARCTION;DISEASE;PD
PA166157267;rs776746;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166157267;rs776746;VARIANT;PA446171;CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE;DISEASE;
PA166157267;rs776746;VARIANT;PA446438;KIDNEY FAILURE;DISEASE;PD
PA166157267;rs776746;VARIANT;PA446975;NEUROTOXICITY SYNDROMES;DISEASE;PD
PA166157267;rs776746;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;
PA166157267;rs776746;VARIANT;PA447247;LIVER TRANSPLANTATION;DISEASE;PD
PA166157125;rs7754840;VARIANT;PA443886;DIABETES MELLITUS;DISEASE;PD
PA166155537;rs118192172;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166155537;rs118192172;VARIANT;PA444997;MUSCULAR DISEASES;DISEASE;PD
PA166155395;rs2279345;VARIANT;PA445941;TUBERCULOSIS;DISEASE;
PA166155395;rs2279345;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;
PA166155961;rs6127921;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166156353;rs2291078;VARIANT;PA445058;METASTATIC NEOPLASM;DISEASE;PD
PA166177116;rs9310658;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166153605;rs983332;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166210018;rs492602;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166157375;rs3735451;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166157149;rs9369421;VARIANT;PA445204;OVARIAN NEOPLASMS;DISEASE;PD
PA166157089;rs3828913;VARIANT;PA446863;CHRONIC HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166161450;rs3731722;VARIANT;PA444318;GOUT;DISEASE;PD
PA166153766;rs4492666;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166199022;rs12521868;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166157065;rs3097671;VARIANT;PA131285571;ASPIRIN-INDUCED ASTHMA;DISEASE;PD
PA166156595;rs4694362;VARIANT;PA445218;PANCREATIC NEOPLASMS;DISEASE;PD
PA166164956;rs202179988;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166155607;rs887829;VARIANT;PA166123431;HEART VALVE REPLACEMENT;DISEASE;PD
PA166155607;rs887829;VARIANT;PA444545;HYPERPROLACTINEMIA;DISEASE;PD
PA166155607;rs887829;VARIANT;PA446432;BETA-THALASSEMIA AND RELATED DISEASES;DISEASE;PD
PA166155607;rs887829;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;
PA166157332;rs2228075;VARIANT;PA133888799;ORGAN TRANSPLANTATION;DISEASE;PD
PA166321181;rs143004875;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166154117;rs10821936;VARIANT;PA162263533;NEPHROTOXICITY;DISEASE;PD
PA166154117;rs10821936;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;
PA166155336;rs183205964;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166154364;rs2283265;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166154364;rs2283265;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166154364;rs2283265;VARIANT;PA445254;PARKINSON DISEASE;DISEASE;PD
PA166154364;rs2283265;VARIANT;PA446878;COCAINE DEPENDENCE;DISEASE;PD
PA166154364;rs2283265;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166177207;rs7316769;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166319225;rs368146607;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166154904;rs3813567;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166157545;rs20575;VARIANT;PA443430;ARTHRITIS;DISEASE;PD
PA166177994;rs121918596;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166259904;rs7205113;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166155390;rs2269879;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166154254;rs5128;VARIANT;PA444528;HYPERLIPIDEMIAS;DISEASE;PD
PA166154254;rs5128;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166154399;rs3750920;VARIANT;PA445468;PULMONARY FIBROSIS;DISEASE;PD
PA166157398;rs4728709;VARIANT;PA443448;ASTHENIA;DISEASE;PD
PA166157398;rs4728709;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166274203;rs11198893;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166157143;rs9340799;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166157143;rs9340799;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166155929;rs2650972;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166153549;rs5065;VARIANT;PA166128188;SYSTOLIC BLOOD PRESSURE;DISEASE;
PA166153549;rs5065;VARIANT;PA443635;CARDIOVASCULAR DISEASE;DISEASE;PD
PA166153549;rs5065;VARIANT;PA443797;CORONARY DISEASE;DISEASE;PD
PA166153549;rs5065;VARIANT;PA444552;HYPERTENSION;DISEASE;
PA166153549;rs5065;VARIANT;PA447054;STROKE;DISEASE;PD
PA166153618;rs1061622;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166153618;rs1061622;VARIANT;PA445724;SPONDYLITIS, ANKYLOSING;DISEASE;PD
PA166155915;rs1127354;VARIANT;PA165817398;MYELOSUPPRESSION;DISEASE;PD
PA166155915;rs1127354;VARIANT;PA166114454;TRANSPLANT REJECTION;DISEASE;PD
PA166155915;rs1127354;VARIANT;PA443340;ANEMIA;DISEASE;PD
PA166155915;rs1127354;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166155915;rs1127354;VARIANT;PA444822;SYSTEMIC LUPUS ERYTHEMATOSUS;DISEASE;PD
PA166155915;rs1127354;VARIANT;PA446116;INFLAMMATORY BOWEL DISEASES;DISEASE;PD
PA166155915;rs1127354;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166155915;rs1127354;VARIANT;PA446863;CHRONIC HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166155915;rs1127354;VARIANT;PA447247;LIVER TRANSPLANTATION;DISEASE;PD
PA166160865;rs2304429;VARIANT;PA166123431;HEART VALVE REPLACEMENT;DISEASE;PD
PA166177140;rs58042962;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166223161;rs71103505;VARIANT;PA443371;ANGIOEDEMA;DISEASE;
PA166223161;rs71103505;VARIANT;PA443803;COUGH;DISEASE;
PA166153712;rs2502815;VARIANT;PA443340;ANEMIA;DISEASE;PD
PA166153712;rs2502815;VARIANT;PA445046;NASOPHARYNGEAL NEOPLASMS;DISEASE;PD
PA166157435;rs9282564;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;
PA166157435;rs9282564;VARIANT;PA166114457;LUNG TRANSPLANTATION;DISEASE;
PA166157435;rs9282564;VARIANT;PA443842;DEATH;DISEASE;PD
PA166157435;rs9282564;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166155130;rs45511401;VARIANT;PA443421;CARDIAC RHYTHM DISEASE;DISEASE;PD
PA166155130;rs45511401;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166155130;rs45511401;VARIANT;PA444845;NON-HODGKIN LYMPHOMA;DISEASE;PD
PA166156133;rs9332377;VARIANT;PA162263533;NEPHROTOXICITY;DISEASE;PD
PA166156133;rs9332377;VARIANT;PA162263534;OTOTOXICITY;DISEASE;PD
PA166156133;rs9332377;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166156133;rs9332377;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166155482;rs28933397;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166157768;rs3849942;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166178402;rs138602176;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166178402;rs138602176;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166155976;rs225440;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166156544;rs2231142;VARIANT;PA166163391;STATIN-RELATED MYOPATHY;DISEASE;PD
PA166156544;rs2231142;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166156544;rs2231142;VARIANT;PA443459;ATRIAL FIBRILLATION;DISEASE;
PA166156544;rs2231142;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166156544;rs2231142;VARIANT;PA443580;BURKITT LYMPHOMA;DISEASE;PD
PA166156544;rs2231142;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166156544;rs2231142;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166156544;rs2231142;VARIANT;PA444065;EPILEPSY;DISEASE;
PA166156544;rs2231142;VARIANT;PA444318;GOUT;DISEASE;PD
PA166156544;rs2231142;VARIANT;PA444516;HYPERCHOLESTEROLEMIA;DISEASE;PD
PA166156544;rs2231142;VARIANT;PA444818;LUNG NEOPLASMS;DISEASE;PD
PA166156544;rs2231142;VARIANT;PA445019;MYOCARDIAL INFARCTION;DISEASE;PD
PA166156544;rs2231142;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166156544;rs2231142;VARIANT;PA445601;OSTEOSARCOMA;DISEASE;PD
PA166156544;rs2231142;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166156544;rs2231142;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166156544;rs2231142;VARIANT;PA446309;LYMPHOMA, T-CELL;DISEASE;PD
PA166156544;rs2231142;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166155599;rs724710;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166155599;rs724710;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166235724;rs4906902;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166157714;rs774359;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166394241;rs59569490;VARIANT;PA443936;DRUG HYPERSENSITIVITY;DISEASE;
PA166394241;rs59569490;VARIANT;PA445062;NEOPLASMS;DISEASE;
PA166184308;rs2636697;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166156664;rs13120400;VARIANT;PA443658;CENTRAL NERVOUS SYSTEM INFECTIOUS DISORDER;DISEASE;
PA166156664;rs13120400;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166156664;rs13120400;VARIANT;PA445601;OSTEOSARCOMA;DISEASE;
PA166156664;rs13120400;VARIANT;PA446171;CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE;DISEASE;PD
PA166156664;rs13120400;VARIANT;PA446432;BETA-THALASSEMIA AND RELATED DISEASES;DISEASE;PD
PA166156706;rs4532;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;
PA166156706;rs4532;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166156706;rs4532;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166157341;rs2235067;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166154732;rs9316233;VARIANT;PA447207;DEPRESSIVE DISORDER;DISEASE;PD
PA166210022;rs13382553;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166154841;rs588765;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166154841;rs588765;VARIANT;PA446878;COCAINE DEPENDENCE;DISEASE;PD
PA166154938;rs16969968;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;
PA166154938;rs16969968;VARIANT;PA445208;PAIN;DISEASE;PD
PA166154938;rs16969968;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166154938;rs16969968;VARIANT;PA446878;COCAINE DEPENDENCE;DISEASE;PD
PA166178406;rs299313;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166178406;rs299313;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166157487;rs35599367;VARIANT;PA133888799;ORGAN TRANSPLANTATION;DISEASE;
PA166157487;rs35599367;VARIANT;PA445062;NEOPLASMS;DISEASE;
PA166201523;rs886424;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166201523;rs886424;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166210015;rs12296477;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166164942;rs397508537;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166154875;rs2069521;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166163760;rs2279199;VARIANT;PA445048;NAUSEA;DISEASE;PD
PA166163760;rs2279199;VARIANT;PA446051;VOMITING;DISEASE;PD
PA166156923;rs510432;VARIANT;PA446116;INFLAMMATORY BOWEL DISEASES;DISEASE;PD
PA166153979;rs1880676;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166176775;rs10258429;VARIANT;PA151958383;GASTROINTESTINAL STROMAL TUMORS;DISEASE;PD
PA166175942;rs1129844;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166178421;rs41412545;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166178421;rs41412545;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166155516;rs63749869;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166153687;rs2266780;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;
PA166179288;rs3734704;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166179452;rs4978536;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166201522;rs9262143;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166201522;rs9262143;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166156279;rs167770;VARIANT;PA447196;ANXIETY DISORDERS;DISEASE;PD
PA166155126;rs28364006;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166154736;rs9535826;VARIANT;PA444818;LUNG NEOPLASMS;DISEASE;PD
PA166157255;rs342293;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166156855;rs10042486;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166156855;rs10042486;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166156388;rs3856806;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166156679;rs34231037;VARIANT;PA444685;KIDNEY NEOPLASMS;DISEASE;PD
PA166155479;rs28416813;VARIANT;PA446863;CHRONIC HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166155479;rs28416813;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166163497;rs308395;VARIANT;PA444985;MULTIPLE MYELOMA;DISEASE;PD
PA166163612;rs10774053;VARIANT;PA166151827;ADVERSE EVENTS;DISEASE;PD
PA166163612;rs10774053;VARIANT;PA444704;PREMATURE BIRTH;DISEASE;PD
PA166156327;rs1799807;VARIANT;PA166122649;BUTYRYLCHOLINESTERASE DEFICIENCY;DISEASE;PD
PA166156327;rs1799807;VARIANT;PA443407;APNEA;DISEASE;
PA166154427;rs7934165;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166154427;rs7934165;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166155249;rs11869731;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166156328;rs1799852;VARIANT;PA443815;CROHN DISEASE;DISEASE;PD
PA166183392;rs193922852;VARIANT;PA166314441;SURGERY;DISEASE;
PA166183392;rs193922852;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;
PA166175850;rs503464;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166155964;rs7270101;VARIANT;PA443340;ANEMIA;DISEASE;PD
PA166155964;rs7270101;VARIANT;PA444773;LEUKOPENIA;DISEASE;PD
PA166155964;rs7270101;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166155964;rs7270101;VARIANT;PA446116;INFLAMMATORY BOWEL DISEASES;DISEASE;PD
PA166155964;rs7270101;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166155964;rs7270101;VARIANT;PA446863;CHRONIC HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166155190;rs1800012;VARIANT;PA444065;EPILEPSY;DISEASE;PD
PA166155190;rs1800012;VARIANT;PA445190;OSTEOPOROSIS;DISEASE;
PA166155147;rs4343;VARIANT;PA444606;ERECTILE DYSFUNCTION;DISEASE;PD
PA166154887;rs2290573;VARIANT;PA446171;CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE;DISEASE;PD
PA166157790;rs7853758;VARIANT;PA166128121;CARDIOTOXICITY;DISEASE;PD
PA166154315;rs1079597;VARIANT;PA445048;NAUSEA;DISEASE;PD
PA166154315;rs1079597;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166154443;rs11023197;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166257863;rs11049274;VARIANT;PA166151827;ADVERSE EVENTS;DISEASE;PD
PA166153610;rs1048977;VARIANT;PA444511;HYPERBILIRUBINEMIA;DISEASE;PD
PA166153610;rs1048977;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166162699;rs75961395;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166155378;rs2054675;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166177114;rs7653345;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166201547;rs6504649;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166201547;rs6504649;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166163546;rs181781;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;
PA166155060;rs4148350;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166155244;rs11078659;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166154768;rs861539;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166154768;rs861539;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166153543;rs4606;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166157486;rs34548976;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166153742;rs3219484;VARIANT;PA445204;OVARIAN NEOPLASMS;DISEASE;PD
PA166154598;rs7297610;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166154598;rs7297610;VARIANT;PA447288;ESSENTIAL HYPERTENSION;DISEASE;PD
PA166153634;rs1736557;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166155107;rs11649514;VARIANT;PA444522;HYPERGLYCEMIA;DISEASE;PD
PA166179574;rs261316;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166153541;rs1205;VARIANT;PA443797;CORONARY DISEASE;DISEASE;PD
PA166283442;rs917881;VARIANT;PA443899;DIARRHEA;DISEASE;PD
PA166179967;rs548646;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166155048;rs3213422;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166177209;rs78615940;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166155938;rs3746574;VARIANT;PA443340;ANEMIA;DISEASE;PD
PA166155938;rs3746574;VARIANT;PA445046;NASOPHARYNGEAL NEOPLASMS;DISEASE;PD
PA166155620;rs1056827;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166170342;rs111618861;VARIANT;PA443297;AGRANULOCYTOSIS;DISEASE;PD
PA166156011;rs8133052;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166156011;rs8133052;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166157235;rs371194629;VARIANT;PA443434;ARTHRITIS, RHEUMATOID;DISEASE;PD
PA166157235;rs371194629;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166156589;rs4554144;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166156286;rs324026;VARIANT;PA447196;ANXIETY DISORDERS;DISEASE;PD
PA166156586;rs4413407;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166156337;rs2016848;VARIANT;PA443803;COUGH;DISEASE;PD
PA166156337;rs2016848;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166154846;rs684513;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166154846;rs684513;VARIANT;PA446878;COCAINE DEPENDENCE;DISEASE;
PA166157643;rs13250975;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166185404;rs7184292;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166154929;rs10851907;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;
PA166154303;rs962369;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166154694;rs1059751;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166176937;rs12302749;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166156273;rs333;VARIANT;PA444987;MULTIPLE SCLEROSIS;DISEASE;
PA166153991;rs2070296;VARIANT;PA134850558;MACULAR DEGENERATION;DISEASE;PD
PA166157528;rs121434569;VARIANT;PA165111675;DRUG RESISTANCE;DISEASE;PD
PA166157528;rs121434569;VARIANT;PA443265;ADENOCARCINOMA;DISEASE;PD
PA166157528;rs121434569;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166157528;rs121434569;VARIANT;PA444818;LUNG NEOPLASMS;DISEASE;PD
PA166155433;rs7254579;VARIANT;PA444819;LUPUS ERYTHEMATOSUS;DISEASE;
PA166199722;rs17587029;VARIANT;PA443324;AMENORRHEA;DISEASE;PD
PA166319463;rs201268750;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166160869;rs72800847;VARIANT;PA166123431;HEART VALVE REPLACEMENT;DISEASE;PD
PA166157534;rs193922525;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166157533;rs121909041;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166153647;rs1801160;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166156776;rs1801394;VARIANT;PA166129521;SEDATION;DISEASE;PD
PA166156776;rs1801394;VARIANT;PA443433;JUVENILE RHEUMATOID ARTHRITIS;DISEASE;PD
PA166156776;rs1801394;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166156776;rs1801394;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166156776;rs1801394;VARIANT;PA444840;LYMPHOMA;DISEASE;PD
PA166156776;rs1801394;VARIANT;PA445601;OSTEOSARCOMA;DISEASE;PD
PA166156776;rs1801394;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166156776;rs1801394;VARIANT;PA447004;MIGRAINE WITH AURA;DISEASE;PD
PA166180109;rs671531;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166155248;rs11868547;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166156930;rs594709;VARIANT;PA443890;DIABETES MELLITUS, TYPE 2;DISEASE;PD
PA166154043;rs3824662;VARIANT;PA162263533;NEPHROTOXICITY;DISEASE;PD
PA166157783;rs6151031;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166157783;rs6151031;VARIANT;PA443937;DRUG TOXICITY;DISEASE;
PA166157783;rs6151031;VARIANT;PA445062;NEOPLASMS;DISEASE;
PA166232961;rs28379954;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;
PA166203410;rs8904;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166203410;rs8904;VARIANT;PA444109;EXANTHEMA;DISEASE;PD
PA166157317;rs2032583;VARIANT;PA447207;DEPRESSIVE DISORDER;DISEASE;PD
PA166157317;rs2032583;VARIANT;PA447278;DEPRESSION;DISEASE;PD
PA166157317;rs2032583;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166155671;rs2228171;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166154420;rs7118900;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166154420;rs7118900;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166154416;rs5744247;VARIANT;PA134850491;TRANSPLANTATION;DISEASE;
PA166159507;rs376073289;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166283544;rs9927200;VARIANT;PA443899;DIARRHEA;DISEASE;PD
PA166156420;rs7624766;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166177107;rs13093500;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166157110;rs6900017;VARIANT;PA445204;OVARIAN NEOPLASMS;DISEASE;PD
PA166157348;rs2267715;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166182420;rs78239784;VARIANT;PA162316739;MACULOPAPULAR EXANTHEMA;DISEASE;PD
PA166155032;rs2232228;VARIANT;PA445018;CARDIOMYOPATHIES;DISEASE;PD
PA166199582;rs116181528;VARIANT;PA446199;OVERDOSE;DISEASE;PD
PA166257882;rs76103438;VARIANT;PA166151827;ADVERSE EVENTS;DISEASE;PD
PA166154891;rs2412459;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166154290;rs658903;VARIANT;PA443886;DIABETES MELLITUS;DISEASE;PD
PA166154290;rs658903;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166156530;rs1902023;VARIANT;PA445208;PAIN;DISEASE;PD
PA166155568;rs193922772;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166160687;rs393994;VARIANT;PA445941;TUBERCULOSIS;DISEASE;PD
PA166157154;rs9380524;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166155112;rs12595985;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166156804;rs2562519;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166156805;rs2569190;VARIANT;PA443750;ULCERATIVE COLITIS;DISEASE;PD
PA166203424;rs577001;VARIANT;PA443899;DIARRHEA;DISEASE;PD
PA166164947;rs121908753;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166157164;rs9479757;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166157164;rs9479757;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;
PA166157803;rs10306114;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166157803;rs10306114;VARIANT;PA444282;OPEN-ANGLE GLAUCOMA;DISEASE;PD
PA166157803;rs10306114;VARIANT;PA445019;MYOCARDIAL INFARCTION;DISEASE;PD
PA166154309;rs1042858;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166176952;rs11559290;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166185912;rs28935195;VARIANT;PA443367;FABRY DISEASE;DISEASE;PD
PA166156658;rs12233719;VARIANT;PA444065;EPILEPSY;DISEASE;
PA166154836;rs4646;VARIANT;PA166048848;MENOPAUSE;DISEASE;PD
PA166154836;rs4646;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166160559;rs11209026;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166156909;rs130072;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166154690;rs953977;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166156674;rs17731538;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166154918;rs6494223;VARIANT;PA443319;ALZHEIMER DISEASE;DISEASE;PD
PA166178052;rs77409459;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166162391;rs149104283;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166154830;rs17091162;VARIANT;PA445218;PANCREATIC NEOPLASMS;DISEASE;PD
PA166154720;rs7325568;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166155812;rs12467557;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166156106;rs4253778;VARIANT;PA443797;CORONARY DISEASE;DISEASE;PD
PA166156106;rs4253778;VARIANT;PA443886;DIABETES MELLITUS;DISEASE;PD
PA166157716;rs885004;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166155736;rs4849127;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166198164;rs997917;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166198164;rs997917;VARIANT;PA446878;COCAINE DEPENDENCE;DISEASE;PD
PA166156745;rs924607;VARIANT;PA445301;PERIPHERAL NERVOUS SYSTEM DISEASES;DISEASE;PD
PA166176176;rs193922764;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166155253;rs12946454;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166157728;rs1536475;VARIANT;PA445046;NASOPHARYNGEAL NEOPLASMS;DISEASE;PD
PA166157732;rs1554973;VARIANT;PA446116;INFLAMMATORY BOWEL DISEASES;DISEASE;PD
PA166177189;rs10771999;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166155440;rs8113007;VARIANT;PA444445;HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166155440;rs8113007;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166177199;rs61908405;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166155223;rs4790694;VARIANT;PA446876;SUBSTANCE-RELATED DISORDERS;DISEASE;PD
PA166185937;rs397515870;VARIANT;PA443367;FABRY DISEASE;DISEASE;PD
PA166156399;rs4533622;VARIANT;PA444985;MULTIPLE MYELOMA;DISEASE;PD
PA166155541;rs118192178;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166179445;rs4979223;VARIANT;PA166123207;OVERALL SURVIVAL;DISEASE;PD
PA166179445;rs4979223;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166165228;rs766023281;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166184546;rs3787138;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166154533;rs2238032;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166155797;rs10932125;VARIANT;PA443937;DRUG TOXICITY;DISEASE;
PA166241841;rs1556422499;VARIANT;PA162263534;OTOTOXICITY;DISEASE;PD
PA166154249;rs1695;VARIANT;PA162263534;OTOTOXICITY;DISEASE;PD
PA166154249;rs1695;VARIANT;PA166119041;DRUG-INDUCED LIVER INJURY;DISEASE;PD
PA166154249;rs1695;VARIANT;PA166128121;CARDIOTOXICITY;DISEASE;PD
PA166154249;rs1695;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166154249;rs1695;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166154249;rs1695;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166154249;rs1695;VARIANT;PA444257;GASTROINTESTINAL NEOPLASMS;DISEASE;PD
PA166154249;rs1695;VARIANT;PA444614;INFECTIOUS DISEASE;DISEASE;PD
PA166154249;rs1695;VARIANT;PA444773;LEUKOPENIA;DISEASE;PD
PA166154249;rs1695;VARIANT;PA444898;MEDULLOBLASTOMA;DISEASE;PD
PA166154249;rs1695;VARIANT;PA445048;NAUSEA;DISEASE;PD
PA166154249;rs1695;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166154249;rs1695;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166154249;rs1695;VARIANT;PA445204;OVARIAN NEOPLASMS;DISEASE;PD
PA166154249;rs1695;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166154249;rs1695;VARIANT;PA445503;RECTAL NEOPLASMS;DISEASE;PD
PA166154249;rs1695;VARIANT;PA445601;OSTEOSARCOMA;DISEASE;PD
PA166154249;rs1695;VARIANT;PA445828;TESTICULAR NEOPLASMS;DISEASE;PD
PA166154249;rs1695;VARIANT;PA445941;TUBERCULOSIS;DISEASE;PD
PA166154249;rs1695;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166154249;rs1695;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166203413;rs2695121;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166203413;rs2695121;VARIANT;PA443899;DIARRHEA;DISEASE;PD
PA166156808;rs2631372;VARIANT;PA151958383;GASTROINTESTINAL STROMAL TUMORS;DISEASE;PD
PA166155692;rs2952768;VARIANT;PA445210;PAIN, POSTOPERATIVE;DISEASE;PD
PA166156478;rs4073;VARIANT;PA134850558;MACULAR DEGENERATION;DISEASE;PD
PA166156953;rs806368;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166156953;rs806368;VARIANT;PA446878;COCAINE DEPENDENCE;DISEASE;
PA166156023;rs4633;VARIANT;PA443928;DIZZINESS;DISEASE;PD
PA166156023;rs4633;VARIANT;PA445208;PAIN;DISEASE;
PA166156023;rs4633;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166156023;rs4633;VARIANT;PA447218;PHYSIOLOGICAL SEXUAL DISORDER;DISEASE;PD
PA166200021;rs7720513;VARIANT;PA128406954;WEIGHT GAIN;DISEASE;PD
PA166153720;rs2842030;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166175927;rs2070762;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166175927;rs2070762;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166183890;rs3766951;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166155760;rs6759892;VARIANT;PA444065;EPILEPSY;DISEASE;PD
PA166155760;rs6759892;VARIANT;PA446432;BETA-THALASSEMIA AND RELATED DISEASES;DISEASE;PD
PA166412262;rs5841;VARIANT;PA444760;LEUKEMIA, MYELOID, ACUTE;DISEASE;
PA166159627;rs2535629;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166153554;rs6025;VARIANT;PA445850;THROMBOTIC DISEASE;DISEASE;PD
PA166156733;rs442767;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166156733;rs442767;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166182236;rs224534;VARIANT;PA445208;PAIN;DISEASE;PD
PA166257821;rs115346678;VARIANT;PA166151827;ADVERSE EVENTS;DISEASE;PD
PA166155152;rs5918;VARIANT;PA165108401;ACUTE CORONARY SYNDROME;DISEASE;PD
PA166155152;rs5918;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166155152;rs5918;VARIANT;PA445019;MYOCARDIAL INFARCTION;DISEASE;PD
PA166157496;rs56324128;VARIANT;PA165108401;ACUTE CORONARY SYNDROME;DISEASE;
PA166154996;rs875858;VARIANT;PA445425;PROSTATIC NEOPLASMS;DISEASE;PD
PA166154319;rs1125394;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166154319;rs1125394;VARIANT;PA446878;COCAINE DEPENDENCE;DISEASE;
PA166177177;rs12094644;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166155198;rs2036657;VARIANT;PA446876;SUBSTANCE-RELATED DISORDERS;DISEASE;PD
PA166154842;rs615470;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;
PA166157567;rs1800909;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166159102;rs10934498;VARIANT;PA443756;COLONIC NEOPLASMS;DISEASE;
PA166178579;rs57081354;VARIANT;PA443890;DIABETES MELLITUS, TYPE 2;DISEASE;PD
PA166153796;rs7551789;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166155209;rs2429427;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166157518;rs77010898;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166154366;rs2298826;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166156657;rs11947402;VARIANT;PA447207;DEPRESSIVE DISORDER;DISEASE;
PA166210003;rs494904;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166185754;rs2271339;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166157286;rs1057868;VARIANT;PA134850491;TRANSPLANTATION;DISEASE;
PA166157286;rs1057868;VARIANT;PA151958383;GASTROINTESTINAL STROMAL TUMORS;DISEASE;PD
PA166157286;rs1057868;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;PD
PA166157286;rs1057868;VARIANT;PA166114942;FAMILIAL HYPERCHOLESTEROLEMIA;DISEASE;PD
PA166156981;rs1264457;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166394541;rs397508573;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166154658;rs61764370;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166206604;rs12305038;VARIANT;PA445048;NAUSEA;DISEASE;PD
PA166206604;rs12305038;VARIANT;PA446051;VOMITING;DISEASE;PD
PA166157923;EPHX1 poor metabolizer;VARIANT;PA447178;PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;DISEASE;
PA166184314;rs2164660;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166154482;rs671;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166154482;rs671;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;
PA166205742;rs3762556;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166185489;rs7178270;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166319207;rs372307932;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166156964;rs909706;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166156610;rs6822844;VARIANT;PA444822;SYSTEMIC LUPUS ERYTHEMATOSUS;DISEASE;PD
PA166154506;rs880054;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166156558;rs2433320;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166161153;rs651630;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166154874;rs2069514;VARIANT;PA443940;PATENT DUCTUS ARTERIOSUS;DISEASE;
PA166154874;rs2069514;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166154874;rs2069514;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166154984;rs119774;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166156722;rs265976;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166177970;rs1260326;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166235764;rs7597593;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166155645;rs1801262;VARIANT;PA443886;DIABETES MELLITUS;DISEASE;PD
PA166157948;NAT2 slow acetylator;VARIANT;PA164925725;TOXIC LIVER DISEASE;DISEASE;
PA166157948;NAT2 slow acetylator;VARIANT;PA443434;ARTHRITIS, RHEUMATOID;DISEASE;
PA166157948;NAT2 slow acetylator;VARIANT;PA445941;TUBERCULOSIS;DISEASE;
PA166161442;rs35112940;VARIANT;PA444760;LEUKEMIA, MYELOID, ACUTE;DISEASE;PD
PA166171046;rs3919583;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166157645;rs13266634;VARIANT;PA443890;DIABETES MELLITUS, TYPE 2;DISEASE;PD
PA166178403;rs148235907;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166178403;rs148235907;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166181040;rs701829;VARIANT;PA443936;DRUG HYPERSENSITIVITY;DISEASE;PD
PA166153648;rs1801265;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166154607;rs7973796;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166199006;rs8068318;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166153837;rs12022243;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166155965;rs10485828;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;
PA166156476;rs698;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166156476;rs698;VARIANT;PA445204;OVARIAN NEOPLASMS;DISEASE;PD
PA166185727;rs886043595;VARIANT;PA447130;MYOTONIC DISORDERS;DISEASE;PD
PA166185905;rs397515874;VARIANT;PA443367;FABRY DISEASE;DISEASE;PD
PA166154503;rs784888;VARIANT;PA443890;DIABETES MELLITUS, TYPE 2;DISEASE;PD
PA166268441;rs11640115;VARIANT;PA165108401;ACUTE CORONARY SYNDROME;DISEASE;PD
PA166268441;rs11640115;VARIANT;PA166129560;MAJOR ADVERSE CARDIAC EVENTS (MACE);DISEASE;PD
PA166155442;rs8192709;VARIANT;PA134850491;TRANSPLANTATION;DISEASE;PD
PA166155442;rs8192709;VARIANT;PA443833;CYSTITIS;DISEASE;PD
PA166180546;rs8124728;VARIANT;PA445301;PERIPHERAL NERVOUS SYSTEM DISEASES;DISEASE;PD
PA166180546;rs8124728;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166155564;rs193922747;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166154695;rs1061472;VARIANT;PA445204;OVARIAN NEOPLASMS;DISEASE;PD
PA166153653;rs1805054;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166157430;rs7793837;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166154813;rs7160796;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166155096;rs9934438;VARIANT;PA445848;THROMBOEMBOLISM;DISEASE;PD
PA166153600;rs928655;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166155356;rs735482;VARIANT;PA444985;MULTIPLE MYELOMA;DISEASE;PD
PA166171094;rs2228000;VARIANT;PA166124386;GASTROINTESTINAL TOXICITY;DISEASE;PD
PA166171094;rs2228000;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166171094;rs2228000;VARIANT;PA444395;HEMATOLOGIC DISORDER;DISEASE;PD
PA166171094;rs2228000;VARIANT;PA444773;LEUKOPENIA;DISEASE;PD
PA166154797;rs2498804;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166154384;rs2734833;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166155210;rs2857657;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166206221;rs3802281;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166197644;rs78886294;VARIANT;PA446876;SUBSTANCE-RELATED DISORDERS;DISEASE;
PA166155735;rs4848306;VARIANT;PA443750;ULCERATIVE COLITIS;DISEASE;PD
PA166155735;rs4848306;VARIANT;PA446116;INFLAMMATORY BOWEL DISEASES;DISEASE;PD
PA166155789;rs10490162;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166185405;rs7606603;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166153578;rs581111;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166285101;rs6686529;VARIANT;PA166129521;SEDATION;DISEASE;PD
PA166156697;rs80143932;VARIANT;PA444760;LEUKEMIA, MYELOID, ACUTE;DISEASE;PD
PA166155963;rs6138150;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166199061;rs1446468;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166211543;rs36120609;VARIANT;PA443340;ANEMIA;DISEASE;
PA166211543;rs36120609;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166211543;rs36120609;VARIANT;PA445058;NEOPLASM METASTASIS;DISEASE;
PA166211543;rs36120609;VARIANT;PA445204;OVARIAN NEOPLASMS;DISEASE;
PA166211543;rs36120609;VARIANT;PA445601;OSTEOSARCOMA;DISEASE;
PA166211543;rs36120609;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;
PA166211543;rs36120609;VARIANT;PA446975;NEUROTOXICITY SYNDROMES;DISEASE;
PA166154421;rs7124442;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166159131;rs1801157;VARIANT;PA446169;LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL;DISEASE;PD
PA166155329;rs17751934;VARIANT;PA445187;OSTEONECROSIS;DISEASE;PD
PA166154337;rs1799978;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166154337;rs1799978;VARIANT;PA444545;HYPERPROLACTINEMIA;DISEASE;PD
PA166154337;rs1799978;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166197661;rs34214870;VARIANT;PA446876;SUBSTANCE-RELATED DISORDERS;DISEASE;
PA166157694;rs770063251;VARIANT;PA443937;DRUG TOXICITY;DISEASE;
PA166157694;rs770063251;VARIANT;PA445062;NEOPLASMS;DISEASE;
PA166210044;rs6589386;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166319223;rs374527058;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166156528;rs1870377;VARIANT;PA166114377;HAND-FOOT SYNDROME;DISEASE;PD
PA166156528;rs1870377;VARIANT;PA444447;HEPATOCELLULAR CARCINOMA;DISEASE;PD
PA166156528;rs1870377;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166155680;rs2298771;VARIANT;PA444065;EPILEPSY;DISEASE;PD
PA166155733;rs4673993;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166160283;rs4643786;VARIANT;PA444760;LEUKEMIA, MYELOID, ACUTE;DISEASE;
PA166199721;rs147451859;VARIANT;PA443324;AMENORRHEA;DISEASE;PD
PA166157876;rs4825476;VARIANT;PA165374639;SUICIDE;DISEASE;PD
PA166157876;rs4825476;VARIANT;PA447278;DEPRESSION;DISEASE;PD
PA166154722;rs7984870;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166156873;rs11960832;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166183884;rs6473797;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166183884;rs6473797;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166157742;rs2120266;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166157742;rs2120266;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166156676;rs28365062;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;
PA166266704;rs1353327;VARIANT;PA162263533;NEPHROTOXICITY;DISEASE;PD
PA166154808;rs7142143;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166157870;rs2497538;VARIANT;PA128406954;WEIGHT GAIN;DISEASE;PD
PA166157516;rs75527207;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166154477;rs61886492;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166339141;rs137852517;VARIANT;PA446481;KALLMANN SYNDROME;DISEASE;
PA166154936;rs12903202;VARIANT;PA445187;OSTEONECROSIS;DISEASE;PD
PA166155511;rs58425034;VARIANT;PA447230;HIV INFECTIONS;DISEASE;
PA166156794;rs2279020;VARIANT;PA444065;EPILEPSY;DISEASE;PD
PA166176935;rs10413455;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166155981;rs428785;VARIANT;PA443797;CORONARY DISEASE;DISEASE;PD
PA166155981;rs428785;VARIANT;PA445019;MYOCARDIAL INFARCTION;DISEASE;PD
PA166155715;rs3812718;VARIANT;PA444065;EPILEPSY;DISEASE;PD
PA166154316;rs1079598;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166155327;rs16973410;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166154088;rs7912580;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166163444;rs8450;VARIANT;PA134850491;TRANSPLANTATION;DISEASE;PD
PA166263684;rs55944529;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166156018;rs74795342;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166157077;rs3734254;VARIANT;PA445425;PROSTATIC NEOPLASMS;DISEASE;PD
PA166197261;rs61826952;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166169975;rs2298881;VARIANT;PA445742;STOMACH NEOPLASMS;DISEASE;PD
PA166156966;rs992160;VARIANT;PA445218;PANCREATIC NEOPLASMS;DISEASE;PD
PA166157023;rs2227956;VARIANT;PA444065;EPILEPSY;DISEASE;PD
PA166156481;rs5522;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166154624;rs10878232;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166154097;rs9332096;VARIANT;PA162316739;MACULOPAPULAR EXANTHEMA;DISEASE;PD
PA166154097;rs9332096;VARIANT;PA445941;TUBERCULOSIS;DISEASE;PD
PA166154121;rs10997242;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166157942;CYP2C19 ultrarapid metabolizer;VARIANT;PA445009;MYCOSES;DISEASE;
PA166156974;rs1059288;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166155970;rs117532069;VARIANT;PA445187;OSTEONECROSIS;DISEASE;PD
PA166155970;rs117532069;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166156991;rs1799971;VARIANT;PA162263525;NEUROPATHIC PAIN;DISEASE;PD
PA166156991;rs1799971;VARIANT;PA165108809;NEONATAL ABSTINENCE SYNDROME;DISEASE;PD
PA166156991;rs1799971;VARIANT;PA166115462;DRY MOUTH;DISEASE;PD
PA166156991;rs1799971;VARIANT;PA166151827;ADVERSE EVENTS;DISEASE;PD
PA166156991;rs1799971;VARIANT;PA166185626;SOMNOLENCE;DISEASE;PD
PA166156991;rs1799971;VARIANT;PA166186039;SUICIDAL IDEATION;DISEASE;PD
PA166156991;rs1799971;VARIANT;PA166232141;AMPLIFICATION OF SEXUAL BEHAVIOR;DISEASE;PD
PA166156991;rs1799971;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166156991;rs1799971;VARIANT;PA443602;MARIJUANA ABUSE;DISEASE;PD
PA166156991;rs1799971;VARIANT;PA443782;CONSTIPATION;DISEASE;PD
PA166156991;rs1799971;VARIANT;PA443851;DELIRIUM;DISEASE;PD
PA166156991;rs1799971;VARIANT;PA443928;DIZZINESS;DISEASE;PD
PA166156991;rs1799971;VARIANT;PA444083;ERYTHEMA;DISEASE;PD
PA166156991;rs1799971;VARIANT;PA444365;CARDIAC ARREST;DISEASE;PD
PA166156991;rs1799971;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166156991;rs1799971;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166156991;rs1799971;VARIANT;PA445048;NAUSEA;DISEASE;PD
PA166156991;rs1799971;VARIANT;PA445208;PAIN;DISEASE;PD
PA166156991;rs1799971;VARIANT;PA445210;PAIN, POSTOPERATIVE;DISEASE;PD
PA166156991;rs1799971;VARIANT;PA445437;PRURITUS;DISEASE;PD
PA166156991;rs1799971;VARIANT;PA445522;RESPIRATORY INSUFFICIENCY;DISEASE;PD
PA166156991;rs1799971;VARIANT;PA445687;SLEEP APNEA SYNDROMES;DISEASE;PD
PA166156991;rs1799971;VARIANT;PA445689;SLEEP DISORDERS;DISEASE;PD
PA166156991;rs1799971;VARIANT;PA445768;SUBSTANCE WITHDRAWAL SYNDROME;DISEASE;
PA166156991;rs1799971;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166156991;rs1799971;VARIANT;PA446051;VOMITING;DISEASE;PD
PA166156991;rs1799971;VARIANT;PA446199;OVERDOSE;DISEASE;PD
PA166156991;rs1799971;VARIANT;PA446264;URINARY RETENTION;DISEASE;PD
PA166156991;rs1799971;VARIANT;PA446876;SUBSTANCE-RELATED DISORDERS;DISEASE;PD
PA166156991;rs1799971;VARIANT;PA446878;COCAINE DEPENDENCE;DISEASE;PD
PA166156991;rs1799971;VARIANT;PA446970;POSTOPERATIVE NAUSEA AND VOMITING;DISEASE;PD
PA166156991;rs1799971;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166252581;rs4149009;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;
PA166157167;rs10305420;VARIANT;PA445131;OBESITY;DISEASE;PD
PA166157167;rs10305420;VARIANT;PA445376;POLYCYSTIC OVARY SYNDROME;DISEASE;PD
PA166161851;rs11126740;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166196165;rs3781719;VARIANT;PA165108779;MIGRAINE DISORDER;DISEASE;PD
PA166185751;rs7041;VARIANT;PA446432;BETA-THALASSEMIA AND RELATED DISEASES;DISEASE;PD
PA166156705;rs686;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;
PA166223623;rs78132896;VARIANT;PA444417;HEMORRHAGE;DISEASE;PD
PA166210023;rs62250713;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166154730;rs9315310;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166156621;rs7662029;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166154955;rs57064725;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;
PA166176243;rs648893;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166176247;rs963549;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166155396;rs2302948;VARIANT;PA444760;LEUKEMIA, MYELOID, ACUTE;DISEASE;PD
PA166154752;rs16965962;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166155464;rs12461964;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166236541;rs745364489;VARIANT;PA443407;APNEA;DISEASE;PD
PA166156057;rs740603;VARIANT;PA165108809;NEONATAL ABSTINENCE SYNDROME;DISEASE;PD
PA166161186;rs77932196;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166157371;rs2960436;VARIANT;PA445742;STOMACH NEOPLASMS;DISEASE;PD
PA166157083;rs3800373;VARIANT;PA447278;DEPRESSION;DISEASE;PD
PA166156997;rs1800629;VARIANT;PA164925725;TOXIC LIVER DISEASE;DISEASE;PD
PA166156997;rs1800629;VARIANT;PA165108401;ACUTE CORONARY SYNDROME;DISEASE;
PA166156997;rs1800629;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;PD
PA166156997;rs1800629;VARIANT;PA166114377;HAND-FOOT SYNDROME;DISEASE;PD
PA166156997;rs1800629;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166156997;rs1800629;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166156997;rs1800629;VARIANT;PA443815;CROHN DISEASE;DISEASE;PD
PA166156997;rs1800629;VARIANT;PA444447;HEPATOCELLULAR CARCINOMA;DISEASE;PD
PA166156997;rs1800629;VARIANT;PA444546;HYPERSENSITIVITY;DISEASE;PD
PA166156997;rs1800629;VARIANT;PA444620;INFLAMMATION;DISEASE;PD
PA166156997;rs1800629;VARIANT;PA444949;MIGRAINE WITHOUT AURA;DISEASE;PD
PA166156997;rs1800629;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166156997;rs1800629;VARIANT;PA445724;SPONDYLITIS, ANKYLOSING;DISEASE;PD
PA166156997;rs1800629;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166156997;rs1800629;VARIANT;PA445941;TUBERCULOSIS;DISEASE;PD
PA166156997;rs1800629;VARIANT;PA446198;ARTHRITIS, PSORIATIC;DISEASE;PD
PA166171088;rs3219489;VARIANT;PA166123026;PROGRESSION-FREE SURVIVAL;DISEASE;PD
PA166171088;rs3219489;VARIANT;PA443626;CARCINOMA, SQUAMOUS CELL;DISEASE;PD
PA166210045;rs8008020;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166161944;rs10485058;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166153847;rs12082710;VARIANT;PA447278;DEPRESSION;DISEASE;PD
PA166183707;rs609148;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166160689;rs320003;VARIANT;PA445941;TUBERCULOSIS;DISEASE;PD
PA166155481;rs28933396;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166156751;rs1053129;VARIANT;PA445601;OSTEOSARCOMA;DISEASE;PD
PA166155535;rs118192167;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166161126;rs3087465;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166157431;rs7794356;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166154978;rs8832;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166153880;rs35687416;VARIANT;PA445218;PANCREATIC NEOPLASMS;DISEASE;PD
PA166184309;rs2636719;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166156925;rs544093;VARIANT;PA445204;OVARIAN NEOPLASMS;DISEASE;PD
PA166154509;rs1051375;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166154509;rs1051375;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166157531;rs121909005;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166156088;rs2236624;VARIANT;PA166151827;ADVERSE EVENTS;DISEASE;PD
PA166156088;rs2236624;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166156710;rs7387;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;
PA166153683;rs2239622;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166153683;rs2239622;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166155665;rs2070959;VARIANT;PA443756;COLONIC NEOPLASMS;DISEASE;PD
PA166155665;rs2070959;VARIANT;PA444065;EPILEPSY;DISEASE;PD
PA166155665;rs2070959;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166157853;rs502434;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166155940;rs3787429;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166155569;rs193922802;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166176961;rs17279558;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166177137;rs12603700;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166177739;rs1799972;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166177739;rs1799972;VARIANT;PA446876;SUBSTANCE-RELATED DISORDERS;DISEASE;PD
PA166220461;rs3788853;VARIANT;PA443371;ANGIOEDEMA;DISEASE;PD
PA166156582;rs4148157;VARIANT;PA443557;BRAIN NEOPLASMS;DISEASE;
PA166307621;rs533334893;VARIANT;PA166307601;DUBIN-JOHNSON SYNDROME;DISEASE;
PA166307621;rs533334893;VARIANT;PA443937;DRUG TOXICITY;DISEASE;
PA166307621;rs533334893;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;
PA166154110;rs10509681;VARIANT;PA443937;DRUG TOXICITY;DISEASE;
PA166180924;rs2303377;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166155853;rs17863778;VARIANT;PA444511;HYPERBILIRUBINEMIA;DISEASE;PD
PA166155853;rs17863778;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166153989;rs1937840;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166259903;rs756770;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166164953;rs121909020;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166210010;rs2582405;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166156949;rs761142;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166177180;rs12502866;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166154534;rs2239050;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166155966;rs17309872;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166156367;rs2742423;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166157294;rs1419555;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166154552;rs2660845;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166154823;rs11623866;VARIANT;PA445204;OVARIAN NEOPLASMS;DISEASE;PD
PA166209221;rs1800035;VARIANT;PA445210;PAIN, POSTOPERATIVE;DISEASE;PD
PA166155271;rs520210;VARIANT;PA447278;DEPRESSION;DISEASE;PD
PA166178414;rs145623321;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166178414;rs145623321;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166178405;rs299314;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166178405;rs299314;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166155854;rs17863783;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166154304;rs964184;VARIANT;PA446120;HYPERTRIGLYCERIDEMIA;DISEASE;PD
PA166154507;rs1006737;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166157594;rs3780126;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166157459;rs12720441;VARIANT;PA446294;TORSADES DE POINTES;DISEASE;PD
PA166319721;rs569661196;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166155371;rs1799793;VARIANT;PA166124223;PNEUMONITIS;DISEASE;PD
PA166155371;rs1799793;VARIANT;PA166151827;ADVERSE EVENTS;DISEASE;PD
PA166155371;rs1799793;VARIANT;PA443340;ANEMIA;DISEASE;PD
PA166155371;rs1799793;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166155371;rs1799793;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166155371;rs1799793;VARIANT;PA445828;TESTICULAR NEOPLASMS;DISEASE;PD
PA166177793;rs10457090;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166161853;rs2546890;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166337441;rs2229300;VARIANT;PA166123207;OVERALL SURVIVAL;DISEASE;
PA166337441;rs2229300;VARIANT;PA166127658;RECURRENCE FREE SURVIVAL;DISEASE;
PA166337441;rs2229300;VARIANT;PA444760;LEUKEMIA, MYELOID, ACUTE;DISEASE;
PA166157288;rs1128503;VARIANT;PA134850491;TRANSPLANTATION;DISEASE;PD
PA166157288;rs1128503;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;PD
PA166157288;rs1128503;VARIANT;PA166122058;MUCOSITIS;DISEASE;PD
PA166157288;rs1128503;VARIANT;PA166123007;HEMATOPOIETIC STEM CELL TRANSPLANTATION;DISEASE;PD
PA166157288;rs1128503;VARIANT;PA166169457;TONSILLECTOMY;DISEASE;PD
PA166157288;rs1128503;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166157288;rs1128503;VARIANT;PA443512;URINARY BLADDER NEOPLASMS;DISEASE;
PA166157288;rs1128503;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166157288;rs1128503;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166157288;rs1128503;VARIANT;PA443624;RENAL CELL CARCINOMA;DISEASE;PD
PA166157288;rs1128503;VARIANT;PA443750;ULCERATIVE COLITIS;DISEASE;PD
PA166157288;rs1128503;VARIANT;PA444065;EPILEPSY;DISEASE;PD
PA166157288;rs1128503;VARIANT;PA444284;GLIOMA;DISEASE;
PA166157288;rs1128503;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166157288;rs1128503;VARIANT;PA444516;HYPERCHOLESTEROLEMIA;DISEASE;PD
PA166157288;rs1128503;VARIANT;PA444591;HYPOVENTILATION;DISEASE;PD
PA166157288;rs1128503;VARIANT;PA444760;LEUKEMIA, MYELOID, ACUTE;DISEASE;PD
PA166157288;rs1128503;VARIANT;PA444840;LYMPHOMA;DISEASE;PD
PA166157288;rs1128503;VARIANT;PA445004;MYASTHENIA GRAVIS;DISEASE;PD
PA166157288;rs1128503;VARIANT;PA445042;NARCOLEPSY;DISEASE;PD
PA166157288;rs1128503;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166157288;rs1128503;VARIANT;PA445062;NEOPLASMS;DISEASE;
PA166157288;rs1128503;VARIANT;PA445089;NEPHROTIC SYNDROME;DISEASE;PD
PA166157288;rs1128503;VARIANT;PA445208;PAIN;DISEASE;PD
PA166157288;rs1128503;VARIANT;PA445210;PAIN, POSTOPERATIVE;DISEASE;PD
PA166157288;rs1128503;VARIANT;PA445301;PERIPHERAL NERVOUS SYSTEM DISEASES;DISEASE;PD
PA166157288;rs1128503;VARIANT;PA445601;OSTEOSARCOMA;DISEASE;PD
PA166157288;rs1128503;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166157288;rs1128503;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166157288;rs1128503;VARIANT;PA446171;CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE;DISEASE;PD
PA166157288;rs1128503;VARIANT;PA446975;NEUROTOXICITY SYNDROMES;DISEASE;PD
PA166157288;rs1128503;VARIANT;PA447198;AUTISM;DISEASE;PD
PA166157288;rs1128503;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;
PA166157288;rs1128503;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166155845;rs17587100;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166178427;rs112783657;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166178427;rs112783657;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166161290;rs1124491;VARIANT;PA447215;PSYCHOTIC DISORDER;DISEASE;PD
PA166155974;rs20572;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166160547;rs3213094;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166155475;rs28399454;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;
PA166319662;rs140989814;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166155176;rs1051640;VARIANT;PA162263534;OTOTOXICITY;DISEASE;PD
PA166155176;rs1051640;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166155176;rs1051640;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166179462;rs10759637;VARIANT;PA166123207;OVERALL SURVIVAL;DISEASE;PD
PA166179462;rs10759637;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166154334;rs1799732;VARIANT;PA166123368;SCHIZOAFFECTIVE DISORDER;DISEASE;
PA166154334;rs1799732;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166154334;rs1799732;VARIANT;PA445254;PARKINSON DISEASE;DISEASE;PD
PA166154334;rs1799732;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166154334;rs1799732;VARIANT;PA447215;PSYCHOTIC DISORDER;DISEASE;PD
PA166154334;rs1799732;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166157331;rs2227983;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166157331;rs2227983;VARIANT;PA444352;HEAD AND NECK NEOPLASMS;DISEASE;PD
PA166157331;rs2227983;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166157331;rs2227983;VARIANT;PA445218;PANCREATIC NEOPLASMS;DISEASE;PD
PA166157331;rs2227983;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166157529;rs121908755;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166155635;rs1402467;VARIANT;PA445425;PROSTATIC NEOPLASMS;DISEASE;PD
PA166157329;rs2227631;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166184317;rs785423;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166157053;rs2844665;VARIANT;PA166120929;SEVERE CUTANEOUS ADVERSE REACTIONS;DISEASE;PD
PA166157053;rs2844665;VARIANT;PA444059;EPIDERMAL NECROLYSIS, TOXIC;DISEASE;PD
PA166157053;rs2844665;VARIANT;PA445738;STEVENS-JOHNSON SYNDROME;DISEASE;PD
PA166154632;rs11045872;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;
PA166178049;rs121909019;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166153760;rs3918290;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166156820;rs3846662;VARIANT;PA443635;CARDIOVASCULAR DISEASE;DISEASE;
PA166156110;rs4823613;VARIANT;PA133888799;ORGAN TRANSPLANTATION;DISEASE;
PA166156979;rs1143684;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166156411;rs6785049;VARIANT;PA165817398;MYELOSUPPRESSION;DISEASE;PD
PA166156411;rs6785049;VARIANT;PA166124386;GASTROINTESTINAL TOXICITY;DISEASE;PD
PA166156411;rs6785049;VARIANT;PA443512;URINARY BLADDER NEOPLASMS;DISEASE;PD
PA166156411;rs6785049;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166156513;rs1449683;VARIANT;PA447207;DEPRESSIVE DISORDER;DISEASE;PD
PA166185728;rs1567817380;VARIANT;PA447130;MYOTONIC DISORDERS;DISEASE;PD
PA166178399;rs150688309;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166178399;rs150688309;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166154454;rs11231809;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166177103;rs4971678;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166156385;rs3814058;VARIANT;PA443340;ANEMIA;DISEASE;PD
PA166156385;rs3814058;VARIANT;PA445046;NASOPHARYNGEAL NEOPLASMS;DISEASE;PD
PA166156635;rs9996584;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166153654;rs1805087;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166153654;rs1805087;VARIANT;PA443553;BRAIN DISEASES;DISEASE;PD
PA166153654;rs1805087;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166153654;rs1805087;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166153654;rs1805087;VARIANT;PA445601;OSTEOSARCOMA;DISEASE;PD
PA166153654;rs1805087;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166153654;rs1805087;VARIANT;PA447288;ESSENTIAL HYPERTENSION;DISEASE;PD
PA166210006;rs13129401;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166157851;rs179008;VARIANT;PA443613;BASAL CELL CARCINOMA;DISEASE;PD
PA166157195;rs17885382;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166154714;rs3765534;VARIANT;PA446116;INFLAMMATORY BOWEL DISEASES;DISEASE;PD
PA166154737;rs9535828;VARIANT;PA444818;LUNG NEOPLASMS;DISEASE;PD
PA166157441;rs10264272;VARIANT;PA444859;MALARIA;DISEASE;
PA166153756;rs3818822;VARIANT;PA131285571;ASPIRIN-INDUCED ASTHMA;DISEASE;PD
PA166171042;rs7405404;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166157261;rs705379;VARIANT;PA444516;HYPERCHOLESTEROLEMIA;DISEASE;PD
PA166156936;rs683369;VARIANT;PA151958383;GASTROINTESTINAL STROMAL TUMORS;DISEASE;PD
PA166156936;rs683369;VARIANT;PA446171;CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE;DISEASE;PD
PA166154320;rs1138272;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166154843;rs637137;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166157264;rs724226;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;
PA166157264;rs724226;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166154676;rs6314;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166154676;rs6314;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166154524;rs2058878;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166154112;rs10737062;VARIANT;PA447288;ESSENTIAL HYPERTENSION;DISEASE;PD
PA166155785;rs10210302;VARIANT;PA443815;CROHN DISEASE;DISEASE;PD
PA166156502;rs1126647;VARIANT;PA443624;RENAL CELL CARCINOMA;DISEASE;PD
PA166157532;rs121909013;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166153915;rs80223967;VARIANT;PA445187;OSTEONECROSIS;DISEASE;PD
PA166153915;rs80223967;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166155225;rs4793665;VARIANT;PA445208;PAIN;DISEASE;
PA166319465;rs527580106;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166156984;rs1415744;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166177192;rs17724494;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166161197;rs17268282;VARIANT;PA444370;HEART FAILURE;DISEASE;PD
PA166155171;rs967676;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166154681;rs585719;VARIANT;PA447207;DEPRESSIVE DISORDER;DISEASE;PD
PA166154514;rs1487278;VARIANT;PA447278;DEPRESSION;DISEASE;PD
PA166153748;rs3753380;VARIANT;PA444282;OPEN-ANGLE GLAUCOMA;DISEASE;PD
PA166155574;rs193922818;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166153998;rs2177370;VARIANT;PA443319;ALZHEIMER DISEASE;DISEASE;PD
PA166155175;rs1050565;VARIANT;PA443314;ALOPECIA;DISEASE;PD
PA166155175;rs1050565;VARIANT;PA445208;PAIN;DISEASE;PD
PA166155175;rs1050565;VARIANT;PA445828;TESTICULAR NEOPLASMS;DISEASE;PD
PA166160738;rs4273729;VARIANT;PA446863;CHRONIC HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166153964;rs1113129;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166155393;rs2279343;VARIANT;PA134850491;TRANSPLANTATION;DISEASE;PD
PA166155393;rs2279343;VARIANT;PA165108809;NEONATAL ABSTINENCE SYNDROME;DISEASE;PD
PA166155393;rs2279343;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166155393;rs2279343;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166160922;rs2954625;VARIANT;PA443886;DIABETES MELLITUS;DISEASE;
PA166155341;rs7412;VARIANT;PA443797;CORONARY DISEASE;DISEASE;PD
PA166155341;rs7412;VARIANT;PA444528;HYPERLIPIDEMIAS;DISEASE;PD
PA166155341;rs7412;VARIANT;PA446120;HYPERTRIGLYCERIDEMIA;DISEASE;PD
PA166155341;rs7412;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166164874;rs12050587;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166164874;rs12050587;VARIANT;PA444773;LEUKOPENIA;DISEASE;PD
PA166164874;rs12050587;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166156524;rs1801058;VARIANT;PA166152848;HYPERTENSIVE NEPHROSCLEROSIS;DISEASE;PD
PA166157203;rs36056065;VARIANT;PA443890;DIABETES MELLITUS, TYPE 2;DISEASE;PD
PA166156753;rs1062535;VARIANT;PA445019;MYOCARDIAL INFARCTION;DISEASE;PD
PA166328661;rs1154831;VARIANT;PA447163;SPONDYLARTHROPATHIES;DISEASE;
PA166154449;rs11042725;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166153907;rs75114882;VARIANT;PA445046;NASOPHARYNGEAL NEOPLASMS;DISEASE;PD
PA166153907;rs75114882;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166157695;rs238;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166157074;rs3213207;VARIANT;PA447215;PSYCHOTIC DISORDER;DISEASE;PD
PA166155996;rs2070995;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;
PA166155996;rs2070995;VARIANT;PA445208;PAIN;DISEASE;PD
PA166157825;rs10981694;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166154136;rs11252394;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166157018;rs2125739;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;
PA166153539;rs699;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166153539;rs699;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166153539;rs699;VARIANT;PA446479;HYPERTROPHY, LEFT VENTRICULAR;DISEASE;PD
PA166165398;rs3888190;VARIANT;PA166123368;SCHIZOAFFECTIVE DISORDER;DISEASE;PD
PA166165398;rs3888190;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166165398;rs3888190;VARIANT;PA447207;DEPRESSIVE DISORDER;DISEASE;PD
PA166165398;rs3888190;VARIANT;PA447215;PSYCHOTIC DISORDER;DISEASE;PD
PA166254981;rs958804;VARIANT;PA445210;PAIN, POSTOPERATIVE;DISEASE;PD
PA166154060;rs4752220;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166183759;rs894160;VARIANT;PA128406954;WEIGHT GAIN;DISEASE;PD
PA166183759;rs894160;VARIANT;PA443890;DIABETES MELLITUS, TYPE 2;DISEASE;PD
PA166154461;rs12221497;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166177200;rs61908406;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166160628;rs117648444;VARIANT;PA446863;CHRONIC HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166156278;rs49411;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166155638;rs1594160;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166164945;rs397508759;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166184667;rs9384169;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166153867;rs17021408;VARIANT;PA445187;OSTEONECROSIS;DISEASE;PD
PA166153867;rs17021408;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166155453;rs10423928;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166164939;rs397508256;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166156716;rs153549;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166156928;rs558025;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166156928;rs558025;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166229161;rs28358571;VARIANT;PA162263534;OTOTOXICITY;DISEASE;PD
PA166153598;rs890293;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;PD
PA166299601;rs2097432;VARIANT;PA446116;INFLAMMATORY BOWEL DISEASES;DISEASE;PD
PA166178428;rs74743371;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166178428;rs74743371;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166257822;rs9620007;VARIANT;PA166151827;ADVERSE EVENTS;DISEASE;PD
PA166271161;rs2292596;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166169840;rs34550074;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166169840;rs34550074;VARIANT;PA444575;HYPONATREMIA;DISEASE;PD
PA166197646;rs74611272;VARIANT;PA446876;SUBSTANCE-RELATED DISORDERS;DISEASE;
PA166157865;rs2106809;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166154826;rs12050217;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166155540;rs118192177;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166344461;rs16906115;VARIANT;PA166151827;ADVERSE EVENTS;DISEASE;PD
PA166157707;rs495828;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166180928;rs117986340;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166186981;rs1047303;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166157633;rs11545077;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166157147;rs9351963;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166155769;rs7588295;VARIANT;PA445187;OSTEONECROSIS;DISEASE;PD
PA166233886;rs1611114;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166233886;rs1611114;VARIANT;PA444910;MEMORY IMPAIRMENT;DISEASE;PD
PA166179594;rs704212;VARIANT;PA443450;ASTHMA;DISEASE;
PA166155952;rs6051702;VARIANT;PA444445;HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166169901;rs10132552;VARIANT;PA165817398;MYELOSUPPRESSION;DISEASE;PD
PA166169901;rs10132552;VARIANT;PA166122058;MUCOSITIS;DISEASE;PD
PA166169901;rs10132552;VARIANT;PA443340;ANEMIA;DISEASE;PD
PA166169901;rs10132552;VARIANT;PA443875;DERMATITIS;DISEASE;PD
PA166169901;rs10132552;VARIANT;PA444773;LEUKOPENIA;DISEASE;PD
PA166169901;rs10132552;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166169901;rs10132552;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166155666;rs2075252;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166154107;rs10490924;VARIANT;PA134850558;MACULAR DEGENERATION;DISEASE;PD
PA166155914;rs1059150;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166177058;rs2229205;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166154261;rs6277;VARIANT;PA446876;SUBSTANCE-RELATED DISORDERS;DISEASE;PD
PA166154261;rs6277;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166170682;rs2838958;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166154498;rs557881;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166157514;rs75039782;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166177794;rs589046;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166155587;rs16944;VARIANT;PA166048740;HELICOBACTER INFECTIONS;DISEASE;PD
PA166155587;rs16944;VARIANT;PA445172;OSTEITIS DEFORMANS;DISEASE;PD
PA166155587;rs16944;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166155795;rs10929303;VARIANT;PA162355520;NEPHROLITHIASIS;DISEASE;PD
PA166155795;rs10929303;VARIANT;PA446443;LIVER FAILURE, ACUTE;DISEASE;PD
PA166155795;rs10929303;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166154819;rs10140457;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166263961;rs523349;VARIANT;PA445425;PROSTATIC NEOPLASMS;DISEASE;PD
PA166155478;rs28399499;VARIANT;PA444059;EPIDERMAL NECROLYSIS, TOXIC;DISEASE;PD
PA166155478;rs28399499;VARIANT;PA445738;STEVENS-JOHNSON SYNDROME;DISEASE;PD
PA166155478;rs28399499;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;
PA166177187;rs10771997;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166184666;rs3778150;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166155740;rs5030743;VARIANT;PA444760;LEUKEMIA, MYELOID, ACUTE;DISEASE;PD
PA166157162;rs9469003;VARIANT;PA166120929;SEVERE CUTANEOUS ADVERSE REACTIONS;DISEASE;PD
PA166157162;rs9469003;VARIANT;PA444059;EPIDERMAL NECROLYSIS, TOXIC;DISEASE;PD
PA166157162;rs9469003;VARIANT;PA445738;STEVENS-JOHNSON SYNDROME;DISEASE;PD
PA166153888;rs55886062;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166155269;rs489693;VARIANT;PA128406954;WEIGHT GAIN;DISEASE;PD
PA166155269;rs489693;VARIANT;PA166123368;SCHIZOAFFECTIVE DISORDER;DISEASE;PD
PA166155269;rs489693;VARIANT;PA446120;HYPERTRIGLYCERIDEMIA;DISEASE;PD
PA166155269;rs489693;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166158794;rs11568315;VARIANT;PA443622;CARCINOMA, NON-SMALL-CELL LUNG;DISEASE;PD
PA166155400;rs2738466;VARIANT;PA443797;CORONARY DISEASE;DISEASE;
PA166155400;rs2738466;VARIANT;PA446021;VASCULAR DISEASES;DISEASE;PD
PA166153664;rs2072658;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;
PA166161538;rs12720066;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166161538;rs12720066;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166177196;rs61908402;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166156488;rs437943;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166154643;rs12817819;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166154643;rs12817819;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166153877;rs34717272;VARIANT;PA444552;HYPERTENSION;DISEASE;
PA166155415;rs4802101;VARIANT;PA444819;LUPUS ERYTHEMATOSUS;DISEASE;PD
PA166155617;rs1047891;VARIANT;PA444065;EPILEPSY;DISEASE;
PA166155617;rs1047891;VARIANT;PA447146;HYPERAMMONEMIA;DISEASE;
PA166155287;rs2741171;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166185175;rs6088638;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166156323;rs1523130;VARIANT;PA443853;DEMENTIA;DISEASE;
PA166156323;rs1523130;VARIANT;PA446876;SUBSTANCE-RELATED DISORDERS;DISEASE;
PA166156323;rs1523130;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;
PA166156323;rs1523130;VARIANT;PA447278;DEPRESSION;DISEASE;
PA166157116;rs6922548;VARIANT;PA445425;PROSTATIC NEOPLASMS;DISEASE;PD
PA166289381;rs12885713;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166180969;rs1225367412;VARIANT;PA166163391;STATIN-RELATED MYOPATHY;DISEASE;
PA166180969;rs1225367412;VARIANT;PA444552;HYPERTENSION;DISEASE;
PA166180969;rs1225367412;VARIANT;PA444682;KIDNEY DISEASES;DISEASE;
PA166180969;rs1225367412;VARIANT;PA444801;LIVER DISEASES;DISEASE;
PA166180969;rs1225367412;VARIANT;PA445549;RHABDOMYOLYSIS;DISEASE;
PA166163246;rs7187684;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166155857;rs17868323;VARIANT;PA444511;HYPERBILIRUBINEMIA;DISEASE;PD
PA166155857;rs17868323;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166185904;rs398123217;VARIANT;PA443367;FABRY DISEASE;DISEASE;PD
PA166177104;rs2933304;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166159979;rs7170924;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166185417;rs2074957;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166155159;rs25531;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166155159;rs25531;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166154560;rs3184504;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166155988;rs1051298;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166155988;rs1051298;VARIANT;PA444937;MESOTHELIOMA;DISEASE;PD
PA166156935;rs672170;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166201525;rs2233980;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166201525;rs2233980;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166154785;rs1799722;VARIANT;PA443803;COUGH;DISEASE;PD
PA166154785;rs1799722;VARIANT;PA447288;ESSENTIAL HYPERTENSION;DISEASE;PD
PA166154159;rs12782374;VARIANT;PA444065;EPILEPSY;DISEASE;PD
PA166154803;rs4982133;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166154856;rs1051730;VARIANT;PA166048714;PREGNANCY;DISEASE;
PA166154856;rs1051730;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;
PA166154856;rs1051730;VARIANT;PA445208;PAIN;DISEASE;PD
PA166154856;rs1051730;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166153636;rs1760217;VARIANT;PA445218;PANCREATIC NEOPLASMS;DISEASE;PD
PA166157173;rs11155012;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166169895;rs1829346;VARIANT;PA445046;NASOPHARYNGEAL NEOPLASMS;DISEASE;PD
PA166153638;rs1800559;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166157966;CYP1A2 low activity;VARIANT;PA166048714;PREGNANCY;DISEASE;
PA166177197;rs61908403;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166197645;rs1890881;VARIANT;PA446876;SUBSTANCE-RELATED DISORDERS;DISEASE;
PA166155572;rs193922809;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166154738;rs9552679;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166157262;rs712829;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166157262;rs712829;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166157773;rs4358872;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166157773;rs4358872;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166155608;rs889895;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166156732;rs408626;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166157549;rs1041983;VARIANT;PA164925725;TOXIC LIVER DISEASE;DISEASE;PD
PA166157549;rs1041983;VARIANT;PA165108622;DRUG INTERACTION WITH DRUG;DISEASE;PD
PA166157549;rs1041983;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166157549;rs1041983;VARIANT;PA445941;TUBERCULOSIS;DISEASE;PD
PA166283741;rs4035887;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166157932;CYP2C9 poor metabolizer;VARIANT;PA444773;LEUKOPENIA;DISEASE;
PA166157932;CYP2C9 poor metabolizer;VARIANT;PA446023;VASCULITIS;DISEASE;
PA166157932;CYP2C9 poor metabolizer;VARIANT;PA446065;WEGENER GRANULOMATOSIS;DISEASE;
PA166156673;rs17701271;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166154293;rs662799;VARIANT;PA444528;HYPERLIPIDEMIAS;DISEASE;PD
PA166155741;rs5030952;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;PD
PA166154269;rs183484;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166153993;rs2070673;VARIANT;PA444760;LEUKEMIA, MYELOID, ACUTE;DISEASE;PD
PA166183768;rs104894021;VARIANT;PA166183774;SHORT QT SYNDROME 1;DISEASE;PD
PA166153814;rs10916852;VARIANT;PA445218;PANCREATIC NEOPLASMS;DISEASE;PD
PA166154001;rs2230345;VARIANT;PA444368;HEART DISEASES;DISEASE;PD
PA166154001;rs2230345;VARIANT;PA444370;HEART FAILURE;DISEASE;PD
PA166156874;rs12054895;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166156310;rs1065776;VARIANT;PA445019;MYOCARDIAL INFARCTION;DISEASE;PD
PA166160715;rs2302489;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166177201;rs61908407;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166154437;rs10835210;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166154437;rs10835210;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166156350;rs2251954;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166235801;rs2023239;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166156402;rs4688040;VARIANT;PA444065;EPILEPSY;DISEASE;
PA166155146;rs4341;VARIANT;PA443886;DIABETES MELLITUS;DISEASE;PD
PA166154046;rs4132670;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166153639;rs1800871;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;
PA166153639;rs1800871;VARIANT;PA447247;LIVER TRANSPLANTATION;DISEASE;PD
PA166155616;rs1042640;VARIANT;PA162355520;NEPHROLITHIASIS;DISEASE;PD
PA166155616;rs1042640;VARIANT;PA446443;LIVER FAILURE, ACUTE;DISEASE;PD
PA166155616;rs1042640;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166156000;rs2831440;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166154816;rs8016905;VARIANT;PA443803;COUGH;DISEASE;PD
PA166233301;rs2449598;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166156887;rs17495520;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166157457;rs12718541;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166155008;rs1110470;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166155290;rs2853539;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166185913;rs104894827;VARIANT;PA443367;FABRY DISEASE;DISEASE;PD
PA166157243;rs15524;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;
PA166157243;rs15524;VARIANT;PA444065;EPILEPSY;DISEASE;
PA166157243;rs15524;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166157243;rs15524;VARIANT;PA447247;LIVER TRANSPLANTATION;DISEASE;
PA166156140;rs13058338;VARIANT;PA444760;LEUKEMIA, MYELOID, ACUTE;DISEASE;PD
PA166156140;rs13058338;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166177117;rs9819548;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166165401;rs1000940;VARIANT;PA166123368;SCHIZOAFFECTIVE DISORDER;DISEASE;
PA166165401;rs1000940;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;
PA166165401;rs1000940;VARIANT;PA447207;DEPRESSIVE DISORDER;DISEASE;
PA166165401;rs1000940;VARIANT;PA447215;PSYCHOTIC DISORDER;DISEASE;
PA166156754;rs1105525;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166156970;rs1042136;VARIANT;PA131285571;ASPIRIN-INDUCED ASTHMA;DISEASE;PD
PA166156970;rs1042136;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166181277;rs13137622;VARIANT;PA445601;OSTEOSARCOMA;DISEASE;
PA166177121;rs10007051;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166154371;rs2499984;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166156985;rs1570360;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166156985;rs1570360;VARIANT;PA443624;RENAL CELL CARCINOMA;DISEASE;PD
PA166156985;rs1570360;VARIANT;PA445425;PROSTATIC NEOPLASMS;DISEASE;PD
PA166155781;rs10197559;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166160309;rs11543791;VARIANT;PA166048848;MENOPAUSE;DISEASE;PD
PA166160309;rs11543791;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166153910;rs76387818;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166155586;rs10012;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166154636;rs11064426;VARIANT;PA447288;ESSENTIAL HYPERTENSION;DISEASE;PD
PA166154733;rs9514091;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166155631;rs1344706;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166157368;rs2854744;VARIANT;PA445742;STOMACH NEOPLASMS;DISEASE;PD
PA166155148;rs4344;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166155245;rs11080344;VARIANT;PA164925725;TOXIC LIVER DISEASE;DISEASE;PD
PA166155245;rs11080344;VARIANT;PA445941;TUBERCULOSIS;DISEASE;PD
PA166154585;rs4149570;VARIANT;PA443815;CROHN DISEASE;DISEASE;PD
PA166154585;rs4149570;VARIANT;PA446116;INFLAMMATORY BOWEL DISEASES;DISEASE;PD
PA166156275;rs5182;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166156275;rs5182;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166199981;rs28404156;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166155035;rs2239347;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166155144;rs4292;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166156078;rs1534891;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166161849;rs9304742;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166160867;rs3826041;VARIANT;PA166123431;HEART VALVE REPLACEMENT;DISEASE;PD
PA166203341;rs11227247;VARIANT;PA164925725;TOXIC LIVER DISEASE;DISEASE;PD
PA166203341;rs11227247;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166154017;rs2515641;VARIANT;PA444760;LEUKEMIA, MYELOID, ACUTE;DISEASE;PD
PA166154017;rs2515641;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166210021;rs9679319;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166154339;rs1800497;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166154339;rs1800497;VARIANT;PA443842;DEATH;DISEASE;PD
PA166154339;rs1800497;VARIANT;PA444065;EPILEPSY;DISEASE;PD
PA166154339;rs1800497;VARIANT;PA444545;HYPERPROLACTINEMIA;DISEASE;PD
PA166154339;rs1800497;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166154339;rs1800497;VARIANT;PA445048;NAUSEA;DISEASE;PD
PA166154339;rs1800497;VARIANT;PA445131;OBESITY;DISEASE;PD
PA166154339;rs1800497;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166154339;rs1800497;VARIANT;PA446876;SUBSTANCE-RELATED DISORDERS;DISEASE;PD
PA166154339;rs1800497;VARIANT;PA446878;COCAINE DEPENDENCE;DISEASE;PD
PA166154339;rs1800497;VARIANT;PA447198;AUTISM;DISEASE;PD
PA166154339;rs1800497;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166319424;rs758649719;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166154551;rs2532560;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166156617;rs7438135;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;PD
PA166156617;rs7438135;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166176940;rs2886059;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166156900;rs4880;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166156900;rs4880;VARIANT;PA444065;EPILEPSY;DISEASE;PD
PA166156900;rs4880;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166153832;rs11587213;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166161846;rs2916205;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166155833;rs13429709;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;
PA166177179;rs4437856;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166155027;rs2066844;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;PD
PA166157045;rs2647087;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166157045;rs2647087;VARIANT;PA445220;PANCREATITIS;DISEASE;PD
PA166157045;rs2647087;VARIANT;PA446116;INFLAMMATORY BOWEL DISEASES;DISEASE;PD
PA166155437;rs8103142;VARIANT;PA444445;HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166178413;rs77769901;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166178413;rs77769901;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166154143;rs11819745;VARIANT;PA131285571;ASPIRIN-INDUCED ASTHMA;DISEASE;PD
PA166154143;rs11819745;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166153982;rs1901633;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166153701;rs2368564;VARIANT;PA443886;DIABETES MELLITUS;DISEASE;PD
PA166153701;rs2368564;VARIANT;PA443994;EDEMA;DISEASE;PD
PA166153701;rs2368564;VARIANT;PA444528;HYPERLIPIDEMIAS;DISEASE;PD
PA166162510;rs10995;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166156811;rs2973049;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166159981;rs1690924;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166205741;rs3762555;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166153852;rs12132152;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166177123;rs55881666;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166283641;rs1868089;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166154922;rs7179742;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166154559;rs2965667;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;
PA166283581;rs12366035;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166210008;rs13135092;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166153735;rs3091244;VARIANT;PA162370415;METABOLIC SYNDROME;DISEASE;PD
PA166200821;rs2392165;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166153774;rs4655226;VARIANT;PA445062;NEOPLASMS;DISEASE;
PA166153586;rs696692;VARIANT;PA447207;DEPRESSIVE DISORDER;DISEASE;PD
PA166157146;rs9349256;VARIANT;PA162263533;NEPHROTOXICITY;DISEASE;PD
PA166157146;rs9349256;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166157525;rs113993960;VARIANT;PA166151827;ADVERSE EVENTS;DISEASE;
PA166157525;rs113993960;VARIANT;PA166175756;CYSTIC FIBROSIS PULMONARY EXACERBATION;DISEASE;
PA166157525;rs113993960;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166157525;rs113993960;VARIANT;PA445217;EXOCRINE PANCREATIC INSUFFICIENCY;DISEASE;
PA166183704;rs1381376;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166155744;rs6432512;VARIANT;PA445425;PROSTATIC NEOPLASMS;DISEASE;PD
PA166155919;rs2071197;VARIANT;PA444065;EPILEPSY;DISEASE;PD
PA166238764;rs1760944;VARIANT;PA166123207;OVERALL SURVIVAL;DISEASE;PD
PA166238764;rs1760944;VARIANT;PA443626;CARCINOMA, SQUAMOUS CELL;DISEASE;PD
PA166155405;rs3211371;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166155405;rs3211371;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166154606;rs7958904;VARIANT;PA444818;LUNG NEOPLASMS;DISEASE;PD
PA166157835;rs12346562;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166154858;rs1062033;VARIANT;PA166048848;MENOPAUSE;DISEASE;
PA166154858;rs1062033;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;
PA166153942;rs12418;VARIANT;PA445425;PROSTATIC NEOPLASMS;DISEASE;PD
PA166154910;rs4646427;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166178078;rs36210737;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166154981;rs12960;VARIANT;PA445425;PROSTATIC NEOPLASMS;DISEASE;PD
PA166155286;rs2717162;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166156022;rs4630;VARIANT;PA444985;MULTIPLE MYELOMA;DISEASE;PD
PA166156878;rs12654264;VARIANT;PA443756;COLONIC NEOPLASMS;DISEASE;
PA166171050;rs1521470;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166154500;rs731236;VARIANT;PA445172;OSTEITIS DEFORMANS;DISEASE;PD
PA166154500;rs731236;VARIANT;PA446432;BETA-THALASSEMIA AND RELATED DISEASES;DISEASE;PD
PA166180184;rs6961071;VARIANT;PA445210;PAIN, POSTOPERATIVE;DISEASE;PD
PA166154873;rs2061051;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166155030;rs2228478;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166155526;rs112563513;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166165309;rs11506105;VARIANT;PA446863;CHRONIC HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166154611;rs10161126;VARIANT;PA443532;BONE DISEASES;DISEASE;PD
PA166183378;rs193922752;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;
PA166165231;rs746071566;VARIANT;PA165817398;MYELOSUPPRESSION;DISEASE;PD
PA166165231;rs746071566;VARIANT;PA443464;AUTOIMMUNE DISEASES;DISEASE;
PA166165231;rs746071566;VARIANT;PA444773;LEUKOPENIA;DISEASE;
PA166165231;rs746071566;VARIANT;PA445221;PANCYTOPENIA;DISEASE;PD
PA166165231;rs746071566;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166165231;rs746071566;VARIANT;PA446116;INFLAMMATORY BOWEL DISEASES;DISEASE;PD
PA166165231;rs746071566;VARIANT;PA446155;PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;DISEASE;PD
PA166156903;rs6296;VARIANT;PA447196;ANXIETY DISORDERS;DISEASE;PD
PA166156903;rs6296;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166156354;rs2292997;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166157785;rs6475448;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166199003;rs12579720;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166177118;rs9824595;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166157872;rs3761555;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166179458;rs10817464;VARIANT;PA443340;ANEMIA;DISEASE;PD
PA166179458;rs10817464;VARIANT;PA444773;LEUKOPENIA;DISEASE;PD
PA166179458;rs10817464;VARIANT;PA445048;NAUSEA;DISEASE;PD
PA166179458;rs10817464;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166179458;rs10817464;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166179458;rs10817464;VARIANT;PA446051;VOMITING;DISEASE;PD
PA166153665;rs2072660;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166155054;rs3784864;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166156819;rs3836790;VARIANT;PA443842;DEATH;DISEASE;
PA166156819;rs3836790;VARIANT;PA445254;PARKINSON DISEASE;DISEASE;PD
PA166156819;rs3836790;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;
PA166156819;rs3836790;VARIANT;PA446878;COCAINE-RELATED DISORDERS;DISEASE;
PA166157548;rs719235;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166157328;rs2189814;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;
PA166159490;rs4910008;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166210009;rs2533200;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166229181;rs28358572;VARIANT;PA162263534;OTOTOXICITY;DISEASE;PD
PA166157778;rs4877847;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166283521;rs17682789;VARIANT;PA443899;DIARRHEA;DISEASE;PD
PA166155319;rs11872992;VARIANT;PA128406954;WEIGHT GAIN;DISEASE;PD
PA166155319;rs11872992;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166155999;rs2826494;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166153919;rs115232898;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166155438;rs8105790;VARIANT;PA446863;CHRONIC HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166156945;rs747199;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166153815;rs10917670;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;
PA166199004;rs4387287;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166153596;rs846910;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;
PA166153758;rs3917412;VARIANT;PA443756;COLONIC NEOPLASMS;DISEASE;PD
PA166178396;rs9389568;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166178396;rs9389568;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166155847;rs17645700;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166156531;rs1947275;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166157546;rs352428;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166156737;rs639174;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166154306;rs1001179;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;
PA166155447;rs8192726;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;
PA166154901;rs3743078;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166157832;rs11788456;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;
PA166161252;rs1439050;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166155614;rs1042597;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;PD
PA166155614;rs1042597;VARIANT;PA166048848;MENOPAUSE;DISEASE;PD
PA166155614;rs1042597;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166177939;rs910080;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166157345;rs2242480;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;
PA166157345;rs2242480;VARIANT;PA166114455;ACUTE CELLULAR REJECTION;DISEASE;
PA166157345;rs2242480;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166157345;rs2242480;VARIANT;PA444065;EPILEPSY;DISEASE;
PA166157345;rs2242480;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166157345;rs2242480;VARIANT;PA444528;HYPERLIPIDEMIAS;DISEASE;PD
PA166157345;rs2242480;VARIANT;PA444591;HYPOVENTILATION;DISEASE;PD
PA166157345;rs2242480;VARIANT;PA445208;PAIN;DISEASE;PD
PA166157345;rs2242480;VARIANT;PA445210;PAIN, POSTOPERATIVE;DISEASE;PD
PA166157345;rs2242480;VARIANT;PA447247;LIVER TRANSPLANTATION;DISEASE;PD
PA166165378;rs10515074;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166165378;rs10515074;VARIANT;PA444522;HYPERGLYCEMIA;DISEASE;PD
PA166165378;rs10515074;VARIANT;PA444773;LEUKOPENIA;DISEASE;PD
PA166156943;rs742105;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166176942;rs4805162;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166155573;rs193922816;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166177102;rs6700741;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166182188;rs9787901;VARIANT;PA151958383;GASTROINTESTINAL STROMAL TUMORS;DISEASE;PD
PA166154010;rs2289310;VARIANT;PA445058;METASTATIC NEOPLASM;DISEASE;PD
PA166183887;rs694066;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166155774;rs9679162;VARIANT;PA444445;HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166155774;rs9679162;VARIANT;PA444447;HEPATOCELLULAR CARCINOMA;DISEASE;PD
PA166155774;rs9679162;VARIANT;PA444804;LIVER CANCER;DISEASE;PD
PA166156743;rs878567;VARIANT;PA446876;SUBSTANCE-RELATED DISORDERS;DISEASE;PD
PA166154140;rs11572080;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166154140;rs11572080;VARIANT;PA446975;NEUROTOXICITY SYNDROMES;DISEASE;PD
PA166156445;rs11716445;VARIANT;PA444516;HYPERCHOLESTEROLEMIA;DISEASE;PD
PA166156444;rs11710163;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166157927;CYP2D6 poor metabolizer;VARIANT;PA166123368;SCHIZOAFFECTIVE DISORDER;DISEASE;
PA166157927;CYP2D6 poor metabolizer;VARIANT;PA443319;ALZHEIMER DISEASE;DISEASE;
PA166157927;CYP2D6 poor metabolizer;VARIANT;PA445174;OSTEOARTHRITIS;DISEASE;
PA166157927;CYP2D6 poor metabolizer;VARIANT;PA445208;PAIN;DISEASE;
PA166157927;CYP2D6 poor metabolizer;VARIANT;PA446444;LOW BACK PAIN;DISEASE;
PA166157927;CYP2D6 poor metabolizer;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;
PA166157927;CYP2D6 poor metabolizer;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;
PA166157927;CYP2D6 poor metabolizer;VARIANT;PA447321;DEPRESSIVE DISORDER, MAJOR;DISEASE;
PA166195022;rs11749255;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166157442;rs10267099;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166184034;rs1709083;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166157250;rs255100;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166154059;rs4752219;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166412243;rs17103168;VARIANT;PA444760;LEUKEMIA, MYELOID, ACUTE;DISEASE;
PA166157627;rs9657182;VARIANT;PA446863;CHRONIC HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166178404;rs117951771;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166178404;rs117951771;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166155293;rs4149601;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166155565;rs193922753;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166153666;rs2072661;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166155685;rs2592551;VARIANT;PA443459;ATRIAL FIBRILLATION;DISEASE;PD
PA166156001;rs2832407;VARIANT;PA446879;ALCOHOL-RELATED DISORDERS;DISEASE;PD
PA166161835;CYP2C19 extensive metabolizer;VARIANT;PA166123203;INTRAGASTRIC PH;DISEASE;
PA166176962;rs3761372;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166184252;rs363226;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166161292;rs9567733;VARIANT;PA447215;PSYCHOTIC DISORDER;DISEASE;PD
PA166210041;rs75967634;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166163632;rs727479;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166157325;rs2070744;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166157325;rs2070744;VARIANT;PA444447;HEPATOCELLULAR CARCINOMA;DISEASE;PD
PA166157325;rs2070744;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166157325;rs2070744;VARIANT;PA444606;ERECTILE DYSFUNCTION;DISEASE;PD
PA166182126;rs3192723;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166154034;rs3793790;VARIANT;PA443319;ALZHEIMER DISEASE;DISEASE;PD
PA166165381;rs9906827;VARIANT;PA166123026;PROGRESSION-FREE SURVIVAL;DISEASE;PD
PA166165381;rs9906827;VARIANT;PA166124223;PNEUMONITIS;DISEASE;PD
PA166177125;rs61692318;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166154734;rs9516519;VARIANT;PA443580;BURKITT LYMPHOMA;DISEASE;PD
PA166170338;rs652888;VARIANT;PA443297;AGRANULOCYTOSIS;DISEASE;PD
PA166178407;rs115457081;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166178407;rs115457081;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166154903;rs3759811;VARIANT;PA166048848;MENOPAUSE;DISEASE;
PA166154903;rs3759811;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;
PA166154523;rs2010851;VARIANT;PA443756;COLONIC NEOPLASMS;DISEASE;
PA166155417;rs4803219;VARIANT;PA446863;CHRONIC HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166159181;rs267606617;VARIANT;PA162263534;OTOTOXICITY;DISEASE;PD
PA166155409;rs3745274;VARIANT;PA134850491;TRANSPLANTATION;DISEASE;PD
PA166155409;rs3745274;VARIANT;PA164925725;TOXIC LIVER DISEASE;DISEASE;PD
PA166155409;rs3745274;VARIANT;PA165108809;NEONATAL ABSTINENCE SYNDROME;DISEASE;PD
PA166155409;rs3745274;VARIANT;PA166120927;DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;DISEASE;PD
PA166155409;rs3745274;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166155409;rs3745274;VARIANT;PA443899;DIARRHEA;DISEASE;PD
PA166155409;rs3745274;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166155409;rs3745274;VARIANT;PA444434;HEPATIC VENO-OCCLUSIVE DISEASE;DISEASE;PD
PA166155409;rs3745274;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166155409;rs3745274;VARIANT;PA444614;INFECTIOUS DISEASE;DISEASE;PD
PA166155409;rs3745274;VARIANT;PA444823;LUPUS NEPHRITIS;DISEASE;PD
PA166155409;rs3745274;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166155409;rs3745274;VARIANT;PA445738;STEVENS-JOHNSON SYNDROME;DISEASE;PD
PA166155409;rs3745274;VARIANT;PA445941;TUBERCULOSIS;DISEASE;PD
PA166155409;rs3745274;VARIANT;PA446171;CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE;DISEASE;PD
PA166155409;rs3745274;VARIANT;PA446644;ADRENOCORTICAL CARCINOMA;DISEASE;
PA166155409;rs3745274;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166157626;rs7387065;VARIANT;PA447288;ESSENTIAL HYPERTENSION;DISEASE;PD
PA166203407;rs2233406;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166203407;rs2233406;VARIANT;PA443899;DIARRHEA;DISEASE;PD
PA166156572;rs3114020;VARIANT;PA444065;EPILEPSY;DISEASE;
PA166249641;rs774072493;VARIANT;PA443407;APNEA;DISEASE;PD
PA166157802;rs10121600;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;
PA166178025;rs1800100;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166169979;rs2075685;VARIANT;PA445742;STOMACH NEOPLASMS;DISEASE;PD
PA166153597;rs878949;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166155522;rs72552266;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166155187;rs1799752;VARIANT;PA166197121;COVID-19;DISEASE;
PA166155187;rs1799752;VARIANT;PA443425;ARTERIOSCLEROSIS;DISEASE;PD
PA166155187;rs1799752;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166155187;rs1799752;VARIANT;PA443797;CORONARY DISEASE;DISEASE;PD
PA166155187;rs1799752;VARIANT;PA443803;COUGH;DISEASE;
PA166155187;rs1799752;VARIANT;PA443842;DEATH;DISEASE;
PA166155187;rs1799752;VARIANT;PA443886;DIABETES MELLITUS;DISEASE;PD
PA166155187;rs1799752;VARIANT;PA443888;DIABETES MELLITUS, TYPE 1;DISEASE;PD
PA166155187;rs1799752;VARIANT;PA443890;DIABETES MELLITUS, TYPE 2;DISEASE;PD
PA166155187;rs1799752;VARIANT;PA444288;GLOMERULONEPHRITIS, IGA;DISEASE;PD
PA166155187;rs1799752;VARIANT;PA444370;HEART FAILURE;DISEASE;PD
PA166155187;rs1799752;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166155187;rs1799752;VARIANT;PA444682;KIDNEY DISORDER;DISEASE;PD
PA166155187;rs1799752;VARIANT;PA444684;KIDNEY FAILURE, CHRONIC;DISEASE;
PA166155187;rs1799752;VARIANT;PA444949;MIGRAINE WITHOUT AURA;DISEASE;
PA166155187;rs1799752;VARIANT;PA444987;MULTIPLE SCLEROSIS;DISEASE;
PA166155187;rs1799752;VARIANT;PA446479;HYPERTROPHY, LEFT VENTRICULAR;DISEASE;PD
PA166155187;rs1799752;VARIANT;PA447004;MIGRAINE WITH AURA;DISEASE;
PA166155187;rs1799752;VARIANT;PA447076;HEADACHE DISORDERS;DISEASE;
PA166155187;rs1799752;VARIANT;PA447178;PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;DISEASE;PD
PA166155187;rs1799752;VARIANT;PA447207;DEPRESSIVE DISORDER;DISEASE;PD
PA166155187;rs1799752;VARIANT;PA447288;ESSENTIAL HYPERTENSION;DISEASE;PD
PA166157543;rs4994;VARIANT;PA128406954;WEIGHT GAIN;DISEASE;PD
PA166157543;rs4994;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166157789;rs7851395;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166155524;rs111888148;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166156510;rs1355368;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166157913;CYP2C19 intermediate metabolizer;VARIANT;PA443937;DRUG TOXICITY;DISEASE;
PA166154256;rs5219;VARIANT;PA443886;DIABETES MELLITUS;DISEASE;PD
PA166154256;rs5219;VARIANT;PA443890;DIABETES MELLITUS, TYPE 2;DISEASE;PD
PA166157334;rs2229109;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;PD
PA166157334;rs2229109;VARIANT;PA166123026;PROGRESSION-FREE SURVIVAL;DISEASE;PD
PA166157334;rs2229109;VARIANT;PA444284;GLIOMA;DISEASE;PD
PA166157334;rs2229109;VARIANT;PA444845;NON-HODGKIN LYMPHOMA;DISEASE;PD
PA166157334;rs2229109;VARIANT;PA444985;MULTIPLE MYELOMA;DISEASE;PD
PA166157334;rs2229109;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166154284;rs588076;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166156580;rs3804099;VARIANT;PA446116;INFLAMMATORY BOWEL DISEASES;DISEASE;PD
PA166154898;rs2472304;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166154809;rs7142881;VARIANT;PA447300;ACQUIRED LONG QT SYNDROME (ALQTS);DISEASE;PD
PA166154741;rs9561778;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166154741;rs9561778;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166154741;rs9561778;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166156736;rs495794;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166154912;rs4775936;VARIANT;PA166048848;MENOPAUSE;DISEASE;
PA166154912;rs4775936;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;
PA166184250;rs2873804;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166156357;rs2461817;VARIANT;PA444065;EPILEPSY;DISEASE;
PA166183702;rs524731;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166183702;rs524731;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166183702;rs524731;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166183702;rs524731;VARIANT;PA446878;COCAINE DEPENDENCE;DISEASE;PD
PA166155647;rs1801701;VARIANT;PA446479;HYPERTROPHY, LEFT VENTRICULAR;DISEASE;PD
PA166157705;rs430397;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166156932;rs622342;VARIANT;PA443886;DIABETES MELLITUS;DISEASE;PD
PA166156932;rs622342;VARIANT;PA445254;PARKINSON DISEASE;DISEASE;PD
PA166157239;rs3842;VARIANT;PA443421;CARDIAC RHYTHM DISEASE;DISEASE;PD
PA166157239;rs3842;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;
PA166153696;rs2297595;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166157373;rs3213619;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166157782;rs5030728;VARIANT;PA446116;INFLAMMATORY BOWEL DISEASES;DISEASE;PD
PA166154937;rs16964189;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166156982;rs1265112;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166154525;rs2069502;VARIANT;PA445968;TURNER SYNDROME;DISEASE;
PA166154259;rs6265;VARIANT;PA166119022;METHAMPHETAMINE DEPENDENCE;DISEASE;PD
PA166154259;rs6265;VARIANT;PA446876;SUBSTANCE-RELATED DISORDERS;DISEASE;
PA166154259;rs6265;VARIANT;PA447207;DEPRESSIVE DISORDER;DISEASE;PD
PA166154259;rs6265;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166154259;rs6265;VARIANT;PA447321;DEPRESSIVE DISORDER, MAJOR;DISEASE;PD
PA166155712;rs3806596;VARIANT;PA444511;HYPERBILIRUBINEMIA;DISEASE;PD
PA166155712;rs3806596;VARIANT;PA446432;BETA-THALASSEMIA AND RELATED DISEASES;DISEASE;PD
PA166155712;rs3806596;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166185222;rs16917234;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;
PA166157460;rs12721627;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166157460;rs12721627;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166156626;rs7668282;VARIANT;PA443355;ANEMIA, SICKLE CELL;DISEASE;
PA166157263;rs712830;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166157174;rs11568817;VARIANT;PA447196;ANXIETY DISORDERS;DISEASE;PD
PA166155361;rs1052555;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166161831;TPMT intermediate activity;VARIANT;PA446155;PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;DISEASE;
PA166155364;rs1126757;VARIANT;PA447278;DEPRESSION;DISEASE;PD
PA166153956;rs915120;VARIANT;PA447207;DEPRESSIVE DISORDER;DISEASE;PD
PA166154332;rs1561876;VARIANT;PA444760;LEUKEMIA, MYELOID, ACUTE;DISEASE;PD
PA166156287;rs334558;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166156287;rs334558;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166179818;rs2070096;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166156740;rs730012;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166156740;rs730012;VARIANT;PA445999;URTICARIA;DISEASE;PD
PA166156542;rs2231135;VARIANT;PA445601;OSTEOSARCOMA;DISEASE;PD
PA166154645;rs12819505;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166169891;rs2027701;VARIANT;PA165817398;MYELOSUPPRESSION;DISEASE;PD
PA166169891;rs2027701;VARIANT;PA166122058;MUCOSITIS;DISEASE;PD
PA166169891;rs2027701;VARIANT;PA443340;ANEMIA;DISEASE;PD
PA166169891;rs2027701;VARIANT;PA443875;DERMATITIS;DISEASE;PD
PA166169891;rs2027701;VARIANT;PA444773;LEUKOPENIA;DISEASE;PD
PA166169891;rs2027701;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166169891;rs2027701;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166157388;rs4148808;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166177898;rs61824877;VARIANT;PA444522;HYPERGLYCEMIA;DISEASE;PD
PA166177898;rs61824877;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166157012;rs2071888;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166153940;rs772226819;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166154711;rs2301159;VARIANT;PA445425;PROSTATIC NEOPLASMS;DISEASE;PD
PA166157386;rs4148739;VARIANT;PA444065;EPILEPSY;DISEASE;
PA166157386;rs4148739;VARIANT;PA447278;DEPRESSION;DISEASE;PD
PA166157386;rs4148739;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166156318;rs1470579;VARIANT;PA443890;DIABETES MELLITUS, TYPE 2;DISEASE;PD
PA166178431;rs112242273;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166178431;rs112242273;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166156749;rs1042714;VARIANT;PA444370;HEART FAILURE;DISEASE;PD
PA166156749;rs1042714;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166156749;rs1042714;VARIANT;PA445802;TACHYCARDIA;DISEASE;PD
PA166156749;rs1042714;VARIANT;PA446479;HYPERTROPHY, LEFT VENTRICULAR;DISEASE;PD
PA166153799;rs10157410;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166154476;rs61734430;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166154476;rs61734430;VARIANT;PA444937;MESOTHELIOMA;DISEASE;PD
PA166157490;rs41303343;VARIANT;PA444859;MALARIA;DISEASE;
PA166154271;rs232043;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166177109;rs4334661;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166157346;rs2246709;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166157346;rs2246709;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166156601;rs6535454;VARIANT;PA444997;MUSCULAR DISEASES;DISEASE;PD
PA166159492;rs11052877;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166154383;rs2727786;VARIANT;PA446120;HYPERTRIGLYCERIDEMIA;DISEASE;PD
PA166157179;rs12210538;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166201501;rs5877;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166201501;rs5877;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166184310;rs7395555;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166176953;rs7858;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166210001;rs6421482;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166153571;rs396991;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;
PA166153571;rs396991;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166153571;rs396991;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166153571;rs396991;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166153571;rs396991;VARIANT;PA445109;NEUROMYELITIS OPTICA;DISEASE;PD
PA166153571;rs396991;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166253286;rs3212980;VARIANT;PA445204;OVARIAN NEOPLASMS;DISEASE;PD
PA166200041;rs62097526;VARIANT;PA128406954;WEIGHT GAIN;DISEASE;PD
PA166153658;rs1891059;VARIANT;PA445187;OSTEONECROSIS;DISEASE;PD
PA166153658;rs1891059;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166182127;rs2236256;VARIANT;PA446878;COCAINE DEPENDENCE;DISEASE;PD
PA166206605;rs11882256;VARIANT;PA445048;NAUSEA;DISEASE;PD
PA166206605;rs11882256;VARIANT;PA446051;VOMITING;DISEASE;PD
PA166154586;rs4238001;VARIANT;PA446120;HYPERTRIGLYCERIDEMIA;DISEASE;PD
PA166156141;rs13306278;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166156127;rs6002674;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166155636;rs1429376;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166155994;rs1805128;VARIANT;PA447300;ACQUIRED LONG QT SYNDROME (ALQTS);DISEASE;PD
PA166180322;rs193922748;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166155381;rs2108622;VARIANT;PA165108401;ACUTE CORONARY SYNDROME;DISEASE;
PA166155381;rs2108622;VARIANT;PA166123298;OVER-ANTICOAGULATION;DISEASE;
PA166155381;rs2108622;VARIANT;PA443459;ATRIAL FIBRILLATION;DISEASE;PD
PA166164959;rs11971167;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166177181;rs12657120;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166179568;rs9342288;VARIANT;PA443635;CARDIOVASCULAR DISEASE;DISEASE;PD
PA166179568;rs9342288;VARIANT;PA445549;RHABDOMYOLYSIS;DISEASE;PD
PA166155330;rs17782313;VARIANT;PA128406954;WEIGHT GAIN;DISEASE;PD
PA166153575;rs532545;VARIANT;PA444760;LEUKEMIA, MYELOID, ACUTE;DISEASE;PD
PA166153575;rs532545;VARIANT;PA444761;LEUKEMIA, MYELOID;DISEASE;PD
PA166153575;rs532545;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166171049;rs209474;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166179077;rs11574077;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;
PA166154593;rs4570625;VARIANT;PA447207;DEPRESSIVE DISORDER;DISEASE;PD
PA166299361;rs186089140;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166159497;rs7937567;VARIANT;PA443512;URINARY BLADDER NEOPLASMS;DISEASE;PD
PA166154574;rs4149015;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166157108;rs6454674;VARIANT;PA446878;COCAINE DEPENDENCE;DISEASE;
PA166154554;rs2683511;VARIANT;PA443886;DIABETES MELLITUS;DISEASE;PD
PA166163751;rs699517;VARIANT;PA443448;ASTHENIA;DISEASE;PD
PA166163751;rs699517;VARIANT;PA445048;NAUSEA;DISEASE;PD
PA166163751;rs699517;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166163751;rs699517;VARIANT;PA446051;VOMITING;DISEASE;PD
PA166156151;rs28371706;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;
PA166154092;rs7921977;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166157756;rs2769605;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166157396;rs4720833;VARIANT;PA164925725;TOXIC LIVER DISEASE;DISEASE;PD
PA166157396;rs4720833;VARIANT;PA166119041;DRUG-INDUCED LIVER INJURY;DISEASE;PD
PA166156446;rs11719165;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166156428;rs9288993;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166163394;rs2277984;VARIANT;PA162370415;METABOLIC SYNDROME;DISEASE;PD
PA166157265;rs757639;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166154880;rs2236722;VARIANT;PA445058;METASTATIC NEOPLASM;DISEASE;PD
PA166199042;rs9306160;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166154434;rs10770141;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166161570;rs17501331;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166161570;rs17501331;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166177971;rs11940694;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166155570;rs193922803;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166159319;rs3873352;VARIANT;PA445532;RETINAL DISEASES;DISEASE;PD
PA166203409;rs2233409;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166203409;rs2233409;VARIANT;PA443899;DIARRHEA;DISEASE;PD
PA166154939;rs16973225;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;
PA166163255;rs10741657;VARIANT;PA446863;CHRONIC HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166157467;rs16873129;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166153959;rs1057910;VARIANT;PA447288;ESSENTIAL HYPERTENSION;DISEASE;PD
PA166179289;rs834576;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166157071;rs3130931;VARIANT;PA166120929;SEVERE CUTANEOUS ADVERSE REACTIONS;DISEASE;PD
PA166157071;rs3130931;VARIANT;PA444059;EPIDERMAL NECROLYSIS, TOXIC;DISEASE;PD
PA166157071;rs3130931;VARIANT;PA445738;STEVENS-JOHNSON SYNDROME;DISEASE;PD
PA166156293;rs760316;VARIANT;PA444987;MULTIPLE SCLEROSIS;DISEASE;PD
PA166154840;rs578776;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;
PA166154840;rs578776;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166155363;rs1126510;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166156366;rs2742421;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166154084;rs7903146;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;PD
PA166154084;rs7903146;VARIANT;PA447247;LIVER TRANSPLANTATION;DISEASE;PD
PA166156846;rs7706429;VARIANT;PA447288;ESSENTIAL HYPERTENSION;DISEASE;PD
PA166154677;rs17655;VARIANT;PA445204;OVARIAN NEOPLASMS;DISEASE;PD
PA166157302;rs1799889;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166159104;rs8192935;VARIANT;PA443459;ATRIAL FIBRILLATION;DISEASE;
PA166256641;rs2736308;VARIANT;PA166256642;OSTEONECROSIS OF THE JAW;DISEASE;PD
PA166154899;rs2606345;VARIANT;PA444065;EPILEPSY;DISEASE;PD
PA166154899;rs2606345;VARIANT;PA446432;BETA-THALASSEMIA AND RELATED DISEASES;DISEASE;
PA166155589;rs231775;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;PD
PA166319622;rs558354142;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166163480;rs13144136;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166156499;rs1024323;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166156499;rs1024323;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166156499;rs1024323;VARIANT;PA444682;KIDNEY DISORDER;DISEASE;PD
PA166156499;rs1024323;VARIANT;PA445086;NEPHROSCLEROSIS;DISEASE;PD
PA166155627;rs1130609;VARIANT;PA444760;LEUKEMIA, MYELOID, ACUTE;DISEASE;PD
PA166156043;rs138337;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166155221;rs4459610;VARIANT;PA443803;COUGH;DISEASE;PD
PA166157244;rs37973;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166153913;rs78060119;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166153902;rs72549309;VARIANT;PA445476;PURINE-PYRIMIDINE METABOLISM, INBORN ERRORS;DISEASE;
PA166154581;rs4149081;VARIANT;PA443797;CORONARY DISEASE;DISEASE;PD
PA166154581;rs4149081;VARIANT;PA445601;OSTEOSARCOMA;DISEASE;
PA166154581;rs4149081;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166154495;rs310786;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166161868;rs4819554;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166154535;rs2239128;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166155193;rs1876828;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166154504;rs784892;VARIANT;PA443886;DIABETES MELLITUS;DISEASE;PD
PA166157760;rs3087879;VARIANT;PA447211;OBSESSIVE-COMPULSIVE DISORDER;DISEASE;PD
PA166157749;rs2289658;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166157749;rs2289658;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166197882;rs679899;VARIANT;PA166123431;HEART VALVE REPLACEMENT;DISEASE;PD
PA166197882;rs679899;VARIANT;PA444417;HEMORRHAGE;DISEASE;PD
PA166155879;rs55754655;VARIANT;PA446116;INFLAMMATORY BOWEL DISEASES;DISEASE;PD
PA166156973;rs1049353;VARIANT;PA153906318;AUTISM SPECTRUM DISORDER;DISEASE;PD
PA166156973;rs1049353;VARIANT;PA447215;PSYCHOTIC DISORDER;DISEASE;PD
PA166154563;rs3763980;VARIANT;PA443433;JUVENILE RHEUMATOID ARTHRITIS;DISEASE;PD
PA166155416;rs4803217;VARIANT;PA444445;HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166155416;rs4803217;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166155684;rs2372536;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166153645;rs1801158;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166157805;rs10465180;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166320941;rs755416212;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166185906;rs727505292;VARIANT;PA443367;FABRY DISEASE;DISEASE;PD
PA166155662;rs2011425;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;
PA166155662;rs2011425;VARIANT;PA444065;EPILEPSY;DISEASE;
PA166154054;rs4353229;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166156931;rs610604;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166156931;rs610604;VARIANT;PA446198;ARTHRITIS, PSORIATIC;DISEASE;PD
PA166156509;rs1353295;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166157150;rs9370867;VARIANT;PA444516;HYPERCHOLESTEROLEMIA;DISEASE;PD
PA166156850;rs9285669;VARIANT;PA447288;ESSENTIAL HYPERTENSION;DISEASE;PD
PA166156691;rs61767072;VARIANT;PA165108401;ACUTE CORONARY SYNDROME;DISEASE;
PA166156691;rs61767072;VARIANT;PA443632;CARDIOMYOPATHY, DILATED;DISEASE;PD
PA166156691;rs61767072;VARIANT;PA443842;DEATH;DISEASE;PD
PA166156691;rs61767072;VARIANT;PA444370;HEART FAILURE;DISEASE;PD
PA166156362;rs2699887;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166176936;rs2071421;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166177120;rs9879065;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166155766;rs7574865;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166176949;rs1048786;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166203361;rs2151222;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166203361;rs2151222;VARIANT;PA443899;DIARRHEA;DISEASE;PD
PA166155078;rs7194667;VARIANT;PA444773;LEUKOPENIA;DISEASE;PD
PA166155078;rs7194667;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166283282;rs4864950;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166154152;rs12415607;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166201503;rs1049709;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166201503;rs1049709;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166156889;rs17671591;VARIANT;PA444516;HYPERCHOLESTEROLEMIA;DISEASE;PD
PA166153642;rs1800896;VARIANT;PA134850491;TRANSPLANTATION;DISEASE;
PA166153642;rs1800896;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;
PA166153642;rs1800896;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166153642;rs1800896;VARIANT;PA447247;LIVER TRANSPLANTATION;DISEASE;PD
PA166164957;rs186045772;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166155066;rs4783961;VARIANT;PA444516;HYPERCHOLESTEROLEMIA;DISEASE;PD
PA166154388;rs2839698;VARIANT;PA444818;LUNG NEOPLASMS;DISEASE;PD
PA166156748;rs1042713;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166156748;rs1042713;VARIANT;PA443632;CARDIOMYOPATHY, DILATED;DISEASE;PD
PA166156748;rs1042713;VARIANT;PA444370;HEART FAILURE;DISEASE;PD
PA166156748;rs1042713;VARIANT;PA444797;LIVER CIRRHOSIS;DISEASE;PD
PA166156748;rs1042713;VARIANT;PA445802;TACHYCARDIA;DISEASE;PD
PA166156748;rs1042713;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166156748;rs1042713;VARIANT;PA447288;ESSENTIAL HYPERTENSION;DISEASE;PD
PA166337421;rs2228224;VARIANT;PA166127658;RECURRENCE FREE SURVIVAL;DISEASE;
PA166337421;rs2228224;VARIANT;PA444760;LEUKEMIA, MYELOID, ACUTE;DISEASE;
PA166156345;rs2228001;VARIANT;PA162263534;OTOTOXICITY;DISEASE;PD
PA166156345;rs2228001;VARIANT;PA443512;URINARY BLADDER NEOPLASMS;DISEASE;PD
PA166156345;rs2228001;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166156345;rs2228001;VARIANT;PA444614;INFECTIOUS DISEASE;DISEASE;PD
PA166156345;rs2228001;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166156345;rs2228001;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166156345;rs2228001;VARIANT;PA445601;OSTEOSARCOMA;DISEASE;PD
PA166156345;rs2228001;VARIANT;PA445828;TESTICULAR NEOPLASMS;DISEASE;PD
PA166155531;rs118192124;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166157145;rs9346455;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166283702;rs10958704;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166155623;rs1105879;VARIANT;PA443756;COLONIC NEOPLASMS;DISEASE;PD
PA166155623;rs1105879;VARIANT;PA444065;EPILEPSY;DISEASE;PD
PA166154987;rs212091;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166180901;rs2236947;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166202881;rs1034936;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166202881;rs1034936;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166394661;rs1800076;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166185466;rs3784921;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166155172;rs1042173;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166155172;rs1042173;VARIANT;PA445208;PAIN;DISEASE;PD
PA166259902;rs6973474;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166154625;rs10879346;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166177203;rs61908409;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166154675;rs6313;VARIANT;PA128406954;WEIGHT GAIN;DISEASE;PD
PA166154675;rs6313;VARIANT;PA166151827;ADVERSE EVENTS;DISEASE;PD
PA166154675;rs6313;VARIANT;PA443319;ALZHEIMER DISEASE;DISEASE;PD
PA166154675;rs6313;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166154675;rs6313;VARIANT;PA447196;ANXIETY DISORDERS;DISEASE;PD
PA166154675;rs6313;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166154675;rs6313;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166154675;rs6313;VARIANT;PA447218;PHYSIOLOGICAL SEXUAL DISORDER;DISEASE;PD
PA166154675;rs6313;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166154675;rs6313;VARIANT;PA447278;DEPRESSION;DISEASE;PD
PA166154675;rs6313;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166153874;rs17376848;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166154011;rs2299939;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166156347;rs2241766;VARIANT;PA443886;DIABETES MELLITUS;DISEASE;PD
PA166156760;rs1364043;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166159214;rs1799735;VARIANT;PA443340;ANEMIA;DISEASE;
PA166159214;rs1799735;VARIANT;PA445204;OVARIAN NEOPLASMS;DISEASE;PD
PA166159214;rs1799735;VARIANT;PA445301;PERIPHERAL NERVOUS SYSTEM DISEASES;DISEASE;
PA166159214;rs1799735;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;
PA166186213;rs1049305;VARIANT;PA443314;ALOPECIA;DISEASE;PD
PA166186213;rs1049305;VARIANT;PA443340;ANEMIA;DISEASE;PD
PA166186213;rs1049305;VARIANT;PA444773;LEUKOPENIA;DISEASE;PD
PA166186213;rs1049305;VARIANT;PA444937;MESOTHELIOMA;DISEASE;PD
PA166186213;rs1049305;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166184249;rs8075924;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166154448;rs11039149;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166154448;rs11039149;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166197641;rs34066662;VARIANT;PA446876;SUBSTANCE-RELATED DISORDERS;DISEASE;
PA166153848;rs12083537;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166177621;rs2758339;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166155407;rs3212986;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166155407;rs3212986;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166155407;rs3212986;VARIANT;PA444101;NEOPLASM OF ESOPHAGUS;DISEASE;PD
PA166155407;rs3212986;VARIANT;PA444614;INFECTIOUS DISEASE;DISEASE;PD
PA166155407;rs3212986;VARIANT;PA444773;LEUKOPENIA;DISEASE;PD
PA166155407;rs3212986;VARIANT;PA444937;MESOTHELIOMA;DISEASE;PD
PA166155407;rs3212986;VARIANT;PA445048;NAUSEA;DISEASE;PD
PA166155407;rs3212986;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166155407;rs3212986;VARIANT;PA445204;OVARIAN NEOPLASMS;DISEASE;PD
PA166155407;rs3212986;VARIANT;PA445601;OSTEOSARCOMA;DISEASE;PD
PA166155407;rs3212986;VARIANT;PA445742;STOMACH NEOPLASMS;DISEASE;PD
PA166155407;rs3212986;VARIANT;PA445828;TESTICULAR NEOPLASMS;DISEASE;PD
PA166155407;rs3212986;VARIANT;PA446051;VOMITING;DISEASE;PD
PA166201524;rs886423;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166201524;rs886423;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166157387;rs4148740;VARIANT;PA444065;EPILEPSY;DISEASE;
PA166157387;rs4148740;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166155810;rs11887534;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166155810;rs11887534;VARIANT;PA444516;HYPERCHOLESTEROLEMIA;DISEASE;PD
PA166185726;rs121908560;VARIANT;PA447130;MYOTONIC DISORDERS;DISEASE;PD
PA166154486;rs5443;VARIANT;PA128406954;WEIGHT GAIN;DISEASE;PD
PA166154486;rs5443;VARIANT;PA443742;CLUSTER HEADACHE;DISEASE;PD
PA166154486;rs5443;VARIANT;PA443886;DIABETES MELLITUS;DISEASE;PD
PA166154486;rs5443;VARIANT;PA444370;HEART FAILURE;DISEASE;PD
PA166154486;rs5443;VARIANT;PA444516;HYPERCHOLESTEROLEMIA;DISEASE;PD
PA166154486;rs5443;VARIANT;PA444606;ERECTILE DYSFUNCTION;DISEASE;PD
PA166154486;rs5443;VARIANT;PA444797;LIVER CIRRHOSIS;DISEASE;PD
PA166154486;rs5443;VARIANT;PA445019;MYOCARDIAL INFARCTION;DISEASE;PD
PA166154486;rs5443;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166154486;rs5443;VARIANT;PA445131;OBESITY;DISEASE;PD
PA166154486;rs5443;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166154486;rs5443;VARIANT;PA447288;ESSENTIAL HYPERTENSION;DISEASE;PD
PA166154486;rs5443;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166154481;rs669;VARIANT;PA447054;STROKE;DISEASE;PD
PA166233022;rs11265549;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166233022;rs11265549;VARIANT;PA445437;PRURITUS;DISEASE;PD
PA166235844;rs324029;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166153630;rs1417938;VARIANT;PA162370415;METABOLIC SYNDROME;DISEASE;PD
PA166157960;CYP2C19 poor metabolizer and intermediate metabolizer genotypes;VARIANT;PA166129560;MAJOR ADVERSE CARDIAC EVENTS (MACE);DISEASE;
PA166156990;rs1799964;VARIANT;PA445724;SPONDYLITIS, ANKYLOSING;DISEASE;PD
PA166156990;rs1799964;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166156750;rs1050152;VARIANT;PA151958383;GASTROINTESTINAL STROMAL TUMORS;DISEASE;PD
PA166156750;rs1050152;VARIANT;PA446171;CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE;DISEASE;PD
PA166180936;rs11280056;VARIANT;PA164925725;TOXIC LIVER DISEASE;DISEASE;PD
PA166180936;rs11280056;VARIANT;PA166122058;MUCOSITIS;DISEASE;PD
PA166180936;rs11280056;VARIANT;PA166123007;HEMATOPOIETIC STEM CELL TRANSPLANTATION;DISEASE;PD
PA166180936;rs11280056;VARIANT;PA166123026;PROGRESSION-FREE SURVIVAL;DISEASE;
PA166180936;rs11280056;VARIANT;PA166123207;OVERALL SURVIVAL;DISEASE;
PA166180936;rs11280056;VARIANT;PA166124386;GASTROINTESTINAL TOXICITY;DISEASE;PD
PA166180936;rs11280056;VARIANT;PA443434;ARTHRITIS, RHEUMATOID;DISEASE;PD
PA166180936;rs11280056;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;
PA166180936;rs11280056;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166180936;rs11280056;VARIANT;PA444937;MESOTHELIOMA;DISEASE;PD
PA166180936;rs11280056;VARIANT;PA445013;MYELODYSPLASTIC SYNDROMES;DISEASE;
PA166180936;rs11280056;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166180936;rs11280056;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166180936;rs11280056;VARIANT;PA445218;PANCREATIC NEOPLASMS;DISEASE;
PA166180936;rs11280056;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166180936;rs11280056;VARIANT;PA445742;STOMACH NEOPLASMS;DISEASE;
PA166180936;rs11280056;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;
PA166180936;rs11280056;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166180936;rs11280056;VARIANT;PA446155;PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;DISEASE;PD
PA166180936;rs11280056;VARIANT;PA446975;NEUROTOXICITY SYNDROMES;DISEASE;
PA166180936;rs11280056;VARIANT;PA447146;HYPERAMMONEMIA;DISEASE;
PA166181000;rs17343066;VARIANT;PA444760;LEUKEMIA, MYELOID, ACUTE;DISEASE;
PA166153840;rs12042763;VARIANT;PA445425;PROSTATIC NEOPLASMS;DISEASE;PD
PA166157794;rs7862221;VARIANT;PA131285571;ASPIRIN-INDUCED ASTHMA;DISEASE;PD
PA166157794;rs7862221;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166157564;rs1799930;VARIANT;PA165108622;DRUG INTERACTION WITH DRUG;DISEASE;PD
PA166157564;rs1799930;VARIANT;PA166151827;ADVERSE EVENTS;DISEASE;PD
PA166157564;rs1799930;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166157564;rs1799930;VARIANT;PA444546;HYPERSENSITIVITY;DISEASE;PD
PA166157871;rs3761554;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166153717;rs2808630;VARIANT;PA443797;CORONARY DISEASE;DISEASE;PD
PA166154544;rs2291075;VARIANT;PA444760;LEUKEMIA, MYELOID, ACUTE;DISEASE;PD
PA166154340;rs1800532;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166154340;rs1800532;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166155151;rs4586;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166156731;rs351855;VARIANT;PA166123507;DISCONTINUATION;DISEASE;PD
PA166156731;rs351855;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166170341;rs1071816;VARIANT;PA443297;AGRANULOCYTOSIS;DISEASE;PD
PA166157788;rs7046653;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166153657;rs1886629;VARIANT;PA445187;OSTEONECROSIS;DISEASE;PD
PA166169847;rs10052999;VARIANT;PA447247;LIVER TRANSPLANTATION;DISEASE;
PA166155973;rs12659;VARIANT;PA151958383;GASTROINTESTINAL STROMAL TUMORS;DISEASE;PD
PA166155973;rs12659;VARIANT;PA443685;UTERINE CERVICAL NEOPLASM;DISEASE;PD
PA166157719;rs1104514;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166283542;rs11651488;VARIANT;PA443899;DIARRHEA;DISEASE;PD
PA166156525;rs1801260;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166165332;rs143414470;VARIANT;PA166114377;HAND-FOOT SYNDROME;DISEASE;
PA166165332;rs143414470;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;
PA166165332;rs143414470;VARIANT;PA445062;NEOPLASMS;DISEASE;
PA166165332;rs143414470;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;
PA166171044;rs62200793;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166158926;rs57098334;VARIANT;PA447212;PANIC DISORDER;DISEASE;PD
PA166158926;rs57098334;VARIANT;PA447278;DEPRESSION;DISEASE;PD
PA166158926;rs57098334;VARIANT;PA447321;DEPRESSIVE DISORDER, MAJOR;DISEASE;PD
PA166178138;rs397508453;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166319461;rs570122671;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166157257;rs472660;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;
PA166155846;rs17626122;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166155846;rs17626122;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166178426;rs149212925;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166178426;rs149212925;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166155026;rs2019604;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166159900;rs696;VARIANT;PA445210;PAIN, POSTOPERATIVE;DISEASE;PD
PA166319642;rs538703919;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166154629;rs11045821;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;
PA166156507;rs1229984;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166175994;rs678849;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166175994;rs678849;VARIANT;PA446878;COCAINE DEPENDENCE;DISEASE;PD
PA166156761;rs1382368;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166156920;rs462779;VARIANT;PA445601;OSTEOSARCOMA;DISEASE;PD
PA166258781;rs77583603;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166156276;rs5186;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166156276;rs5186;VARIANT;PA443890;DIABETES MELLITUS, TYPE 2;DISEASE;PD
PA166156276;rs5186;VARIANT;PA444370;HEART FAILURE;DISEASE;PD
PA166156276;rs5186;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166156276;rs5186;VARIANT;PA444797;LIVER CIRRHOSIS;DISEASE;PD
PA166156276;rs5186;VARIANT;PA446479;HYPERTROPHY, LEFT VENTRICULAR;DISEASE;PD
PA166157752;rs2378676;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166157752;rs2378676;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166156872;rs11959113;VARIANT;PA445210;PAIN, POSTOPERATIVE;DISEASE;PD
PA166153988;rs1935349;VARIANT;PA157379134;MYALGIA;DISEASE;PD
PA166178058;rs397508139;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166260384;rs10111937;VARIANT;PA446878;COCAINE DEPENDENCE;DISEASE;PD
PA166154051;rs4148947;VARIANT;PA445425;PROSTATIC NEOPLASMS;DISEASE;PD
PA166156588;rs4444903;VARIANT;PA445503;RECTAL NEOPLASMS;DISEASE;PD
PA166156588;rs4444903;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166233521;rs6990851;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166153635;rs1741981;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166154814;rs8012552;VARIANT;PA443803;COUGH;DISEASE;PD
PA166154814;rs8012552;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166154129;rs11189381;VARIANT;PA445187;OSTEONECROSIS;DISEASE;PD
PA166181041;rs17211071;VARIANT;PA443936;DRUG HYPERSENSITIVITY;DISEASE;PD
PA166156289;rs568408;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;PD
PA166156059;rs933271;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166365261;rs35516286;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166153552;rs5275;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166155420;rs4803419;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;
PA166154494;rs296766;VARIANT;PA443890;DIABETES MELLITUS, TYPE 2;DISEASE;PD
PA166163762;rs4678145;VARIANT;PA443448;ASTHENIA;DISEASE;PD
PA166163762;rs4678145;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166157251;rs274618;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;
PA166394581;rs397508572;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166196763;rs45545233;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166196761;rs294610;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166157958;DPYD poor metabolizer;VARIANT;PA444257;GASTROINTESTINAL NEOPLASMS;DISEASE;
PA166157958;DPYD poor metabolizer;VARIANT;PA445503;RECTAL NEOPLASMS;DISEASE;
PA166157958;DPYD poor metabolizer;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;
PA166349381;rs12615320;VARIANT;PA444949;MIGRAINE WITHOUT AURA;DISEASE;PD
PA166349381;rs12615320;VARIANT;PA447004;MIGRAINE WITH AURA;DISEASE;PD
PA166196173;rs222749;VARIANT;PA165108779;MIGRAINE DISORDER;DISEASE;PD
PA166153968;rs1409314;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166185911;rs869312136;VARIANT;PA443367;FABRY DISEASE;DISEASE;PD
PA166156565;rs2725252;VARIANT;PA446171;CHRONIC MYELOGENOUS LEUKEMIA, BCR-ABL1 POSITIVE;DISEASE;PD
PA166179575;rs35123024;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166157312;rs1922242;VARIANT;PA444516;HYPERCHOLESTEROLEMIA;DISEASE;PD
PA166235762;rs735668;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166153608;rs1044457;VARIANT;PA444760;LEUKEMIA, MYELOID, ACUTE;DISEASE;
PA166153608;rs1044457;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166156526;rs1816702;VARIANT;PA443815;CROHN DISEASE;DISEASE;PD
PA166201528;rs11229;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166201528;rs11229;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166177145;rs12630569;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166153786;rs6702335;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166155174;rs1045280;VARIANT;PA166151827;ADVERSE EVENTS;DISEASE;PD
PA166155174;rs1045280;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166155174;rs1045280;VARIANT;PA446876;SUBSTANCE-RELATED DISORDERS;DISEASE;
PA166157738;rs1927907;VARIANT;PA133888799;ORGAN TRANSPLANTATION;DISEASE;
PA166157028;rs2268639;VARIANT;PA128406954;WEIGHT GAIN;DISEASE;PD
PA166157028;rs2268639;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166178408;rs117341846;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166178408;rs117341846;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166238521;rs2253201;VARIANT;PA443371;ANGIOEDEMA;DISEASE;PD
PA166156301;rs963468;VARIANT;PA447196;ANXIETY DISORDERS;DISEASE;PD
PA166159539;rs367619008;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166161422;rs9263726;VARIANT;PA166120927;DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS;DISEASE;PD
PA166161422;rs9263726;VARIANT;PA445738;STEVENS-JOHNSON SYNDROME;DISEASE;PD
PA166156988;rs1799724;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166156988;rs1799724;VARIANT;PA443815;CROHN DISEASE;DISEASE;PD
PA166156988;rs1799724;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166156988;rs1799724;VARIANT;PA445724;SPONDYLITIS, ANKYLOSING;DISEASE;PD
PA166157621;rs6983267;VARIANT;PA444818;LUNG NEOPLASMS;DISEASE;PD
PA166154438;rs10836235;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166156491;rs734644;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166153757;rs3845446;VARIANT;PA445210;PAIN, POSTOPERATIVE;DISEASE;PD
PA166178425;rs181501757;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166178425;rs181501757;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166203343;rs12142086;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166203343;rs12142086;VARIANT;PA444109;EXANTHEMA;DISEASE;PD
PA166154401;rs3758987;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166154401;rs3758987;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166179590;rs7604115;VARIANT;PA443450;ASTHMA;DISEASE;
PA166161540;rs6498588;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;
PA166182208;rs3825876;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166182208;rs3825876;VARIANT;PA445218;PANCREATIC NEOPLASMS;DISEASE;PD
PA166233321;rs1437153;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166155411;rs3786547;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166257881;rs115200108;VARIANT;PA166151827;ADVERSE EVENTS;DISEASE;PD
PA166319703;rs548783838;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166157268;rs846664;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166154050;rs4148945;VARIANT;PA445425;PROSTATIC NEOPLASMS;DISEASE;PD
PA166154164;rs17431184;VARIANT;PA445058;METASTATIC NEOPLASM;DISEASE;PD
PA166179287;rs6929249;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166175997;rs2234918;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166175997;rs2234918;VARIANT;PA447218;PHYSIOLOGICAL SEXUAL DISORDER;DISEASE;PD
PA166155536;rs118192170;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166154673;rs6311;VARIANT;PA166151827;ADVERSE EVENTS;DISEASE;PD
PA166154673;rs6311;VARIANT;PA166264221;DIMINISHED ABILITY TO CONCENTRATE;DISEASE;PD
PA166154673;rs6311;VARIANT;PA443899;DIARRHEA;DISEASE;PD
PA166154673;rs6311;VARIANT;PA443928;DIZZINESS;DISEASE;PD
PA166154673;rs6311;VARIANT;PA445048;NAUSEA;DISEASE;PD
PA166154673;rs6311;VARIANT;PA445917;TREMOR;DISEASE;PD
PA166154673;rs6311;VARIANT;PA446051;VOMITING;DISEASE;PD
PA166154673;rs6311;VARIANT;PA447196;ANXIETY DISORDERS;DISEASE;PD
PA166154673;rs6311;VARIANT;PA447198;AUTISM;DISEASE;PD
PA166154673;rs6311;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166154673;rs6311;VARIANT;PA447211;OBSESSIVE-COMPULSIVE DISORDER;DISEASE;PD
PA166154673;rs6311;VARIANT;PA447218;PHYSIOLOGICAL SEXUAL DISORDER;DISEASE;PD
PA166154673;rs6311;VARIANT;PA447268;TARDIVE DYSKINESIA;DISEASE;PD
PA166154673;rs6311;VARIANT;PA447278;DEPRESSION;DISEASE;PD
PA166154673;rs6311;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166177110;rs4858478;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166156062;rs1065852;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166156062;rs1065852;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166156062;rs1065852;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166155747;rs6706232;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166206603;rs9393888;VARIANT;PA445048;NAUSEA;DISEASE;PD
PA166206603;rs9393888;VARIANT;PA446051;VOMITING;DISEASE;PD
PA166177128;rs10124893;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166268444;rs75750968;VARIANT;PA165108401;ACUTE CORONARY SYNDROME;DISEASE;PD
PA166268444;rs75750968;VARIANT;PA166129560;MAJOR ADVERSE CARDIAC EVENTS (MACE);DISEASE;PD
PA166154855;rs1048943;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166206621;rs10405238;VARIANT;PA445048;NAUSEA;DISEASE;PD
PA166206621;rs10405238;VARIANT;PA446051;VOMITING;DISEASE;PD
PA166154881;rs2242046;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166159968;rs8192675;VARIANT;PA443886;DIABETES MELLITUS;DISEASE;PD
PA166153842;rs12046844;VARIANT;PA444773;LEUKOPENIA;DISEASE;PD
PA166153842;rs12046844;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166157003;rs1883322;VARIANT;PA445425;PROSTATIC NEOPLASMS;DISEASE;PD
PA166257841;rs34545984;VARIANT;PA166151827;ADVERSE EVENTS;DISEASE;PD
PA166153994;rs2070676;VARIANT;PA445204;OVARIAN NEOPLASMS;DISEASE;PD
PA166157119;rs6927172;VARIANT;PA443750;ULCERATIVE COLITIS;DISEASE;PD
PA166157119;rs6927172;VARIANT;PA446116;INFLAMMATORY BOWEL DISEASES;DISEASE;PD
PA166157806;rs10511905;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166156518;rs1615111;VARIANT;PA166123207;OVERALL SURVIVAL;DISEASE;
PA166156518;rs1615111;VARIANT;PA443265;ADENOCARCINOMA;DISEASE;
PA166153781;rs6427528;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166153781;rs6427528;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166153680;rs2234922;VARIANT;PA443223;CONGENITAL ABNORMALITIES;DISEASE;PD
PA166153680;rs2234922;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166153680;rs2234922;VARIANT;PA444065;EPILEPSY;DISEASE;PD
PA166153680;rs2234922;VARIANT;PA446836;DISORDER OF FACIAL SKELETON;DISEASE;PD
PA166171040;rs7959663;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166156708;rs6295;VARIANT;PA447207;DEPRESSIVE DISORDER;DISEASE;PD
PA166156708;rs6295;VARIANT;PA447212;PANIC DISORDER;DISEASE;PD
PA166156708;rs6295;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166156708;rs6295;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166157834;rs12003906;VARIANT;PA444528;HYPERLIPIDEMIAS;DISEASE;PD
PA166171045;rs7588746;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166161134;CYP2D6 normal metabolizer and ultrarapid metabolizer;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;
PA166155037;rs2244613;VARIANT;PA443459;ATRIAL FIBRILLATION;DISEASE;PD
PA166155037;rs2244613;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166184316;rs711355;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166155357;rs895819;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166185903;rs398123212;VARIANT;PA443367;FABRY DISEASE;DISEASE;PD
PA166186212;rs28362731;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166210046;rs9937709;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166178410;rs142244113;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166178410;rs142244113;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166161857;rs12191877;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166156848;rs7725278;VARIANT;PA446771;SEPSIS;DISEASE;
PA166153946;rs290487;VARIANT;PA443890;DIABETES MELLITUS, TYPE 2;DISEASE;PD
PA166153946;rs290487;VARIANT;PA447247;LIVER TRANSPLANTATION;DISEASE;PD
PA166253503;rs11545076;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166156567;rs2869950;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166185647;rs5441;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166181039;rs201929247;VARIANT;PA443936;DRUG HYPERSENSITIVITY;DISEASE;PD
PA166184311;rs10170310;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166153777;rs4846051;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166153777;rs4846051;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166199005;rs10995311;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166155968;rs79085477;VARIANT;PA445187;OSTEONECROSIS;DISEASE;PD
PA166155968;rs79085477;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166257864;rs113100019;VARIANT;PA166151827;ADVERSE EVENTS;DISEASE;PD
PA166156660;rs12505746;VARIANT;PA447288;ESSENTIAL HYPERTENSION;DISEASE;PD
PA166153789;rs7518660;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166268443;rs4736529;VARIANT;PA165108401;ACUTE CORONARY SYNDROME;DISEASE;PD
PA166268443;rs4736529;VARIANT;PA166129560;MAJOR ADVERSE CARDIAC EVENTS (MACE);DISEASE;PD
PA166155835;rs13432159;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166170340;rs199564443;VARIANT;PA443297;AGRANULOCYTOSIS;DISEASE;PD
PA166157638;rs11993031;VARIANT;PA447288;ESSENTIAL HYPERTENSION;DISEASE;PD
PA166156105;rs4253728;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;PD
PA166184251;rs363225;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166155584;rs8330;VARIANT;PA162355520;NEPHROLITHIASIS;DISEASE;PD
PA166155584;rs8330;VARIANT;PA446443;LIVER FAILURE, ACUTE;DISEASE;PD
PA166155584;rs8330;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166156837;rs4958381;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166155418;rs4803381;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166157563;rs1799929;VARIANT;PA165108622;DRUG INTERACTION WITH DRUG;DISEASE;PD
PA166157563;rs1799929;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166157563;rs1799929;VARIANT;PA445941;TUBERCULOSIS;DISEASE;PD
PA166154549;rs2430561;VARIANT;PA443815;CROHN DISEASE;DISEASE;PD
PA166154549;rs2430561;VARIANT;PA446116;INFLAMMATORY BOWEL DISEASES;DISEASE;PD
PA166155696;rs3087403;VARIANT;PA445601;OSTEOSARCOMA;DISEASE;PD
PA166154365;rs2284449;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166155480;rs28493229;VARIANT;PA444977;MUCOCUTANEOUS LYMPH NODE SYNDROME;DISEASE;
PA166156960;rs833069;VARIANT;PA134850558;MACULAR DEGENERATION;DISEASE;PD
PA166182212;rs12148896;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166182212;rs12148896;VARIANT;PA445218;PANCREATIC NEOPLASMS;DISEASE;PD
PA166155374;rs1800471;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166164944;rs77834169;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166157025;rs2233945;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166153602;rs943580;VARIANT;PA165108401;ACUTE CORONARY SYNDROME;DISEASE;PD
PA166180145;rs7583431;VARIANT;PA445210;PAIN, POSTOPERATIVE;DISEASE;PD
PA166156340;rs2056527;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166164940;rs368505753;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166178423;rs117101815;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166178423;rs117101815;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166185418;rs10432303;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166181205;rs35068180;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166181205;rs35068180;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166181205;rs35068180;VARIANT;PA447054;STROKE;DISEASE;
PA166180009;rs11606194;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166154344;rs1946518;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;
PA166154344;rs1946518;VARIANT;PA166114457;LUNG TRANSPLANTATION;DISEASE;
PA166154344;rs1946518;VARIANT;PA446863;CHRONIC HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166155016;rs1799801;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166158911;rs2853826;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166176351;rs2241843;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166176960;rs757978;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166179353;rs544027339;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166177131;rs6479008;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166185909;rs398123226;VARIANT;PA443367;FABRY DISEASE;DISEASE;PD
PA166157445;rs10280101;VARIANT;PA447278;DEPRESSION;DISEASE;PD
PA166154866;rs1703794;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166156971;rs1042151;VARIANT;PA131285571;ASPIRIN-INDUCED ASTHMA;DISEASE;PD
PA166156971;rs1042151;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166155382;rs2108623;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166156053;rs518350;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166170863;rs2248359;VARIANT;PA162263533;NEPHROTOXICITY;DISEASE;PD
PA166170863;rs2248359;VARIANT;PA446432;BETA-THALASSEMIA AND RELATED DISEASES;DISEASE;
PA166170863;rs2248359;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166157069;rs3130501;VARIANT;PA166120929;SEVERE CUTANEOUS ADVERSE REACTIONS;DISEASE;PD
PA166157069;rs3130501;VARIANT;PA444059;EPIDERMAL NECROLYSIS, TOXIC;DISEASE;PD
PA166157069;rs3130501;VARIANT;PA445738;STEVENS-JOHNSON SYNDROME;DISEASE;PD
PA166154575;rs4149032;VARIANT;PA445941;TUBERCULOSIS;DISEASE;
PA166252261;rs10799590;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166200161;rs2133896;VARIANT;PA166119022;METHAMPHETAMINE DEPENDENCE;DISEASE;PD
PA166200161;rs2133896;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166200161;rs2133896;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166156602;rs6551665;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166178412;rs118129530;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166178412;rs118129530;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166156644;rs11269124;VARIANT;PA444797;LIVER CIRRHOSIS;DISEASE;PD
PA166157816;rs10811661;VARIANT;PA443890;DIABETES MELLITUS, TYPE 2;DISEASE;PD
PA166154850;rs762551;VARIANT;PA151958383;GASTROINTESTINAL STROMAL TUMORS;DISEASE;PD
PA166154850;rs762551;VARIANT;PA166123307;INSOMNIA;DISEASE;PD
PA166154850;rs762551;VARIANT;PA443227;ABORTION, SPONTANEOUS;DISEASE;PD
PA166154850;rs762551;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166154850;rs762551;VARIANT;PA445019;MYOCARDIAL INFARCTION;DISEASE;PD
PA166154850;rs762551;VARIANT;PA445629;SEIZURES;DISEASE;PD
PA166154850;rs762551;VARIANT;PA446432;BETA-THALASSEMIA AND RELATED DISEASES;DISEASE;
PA166154850;rs762551;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166154850;rs762551;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166153771;rs4648287;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166157901;CYP2C19 poor metabolizers and intermediate metabolizers;VARIANT;PA445009;MYCOSES;DISEASE;
PA166159072;rs16935279;VARIANT;PA447215;PSYCHOTIC DISORDER;DISEASE;
PA166159072;rs16935279;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;
PA166178401;rs299293;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166178401;rs299293;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166155806;rs11677416;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166155199;rs2071427;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166155114;rs13306673;VARIANT;PA447288;ESSENTIAL HYPERTENSION;DISEASE;PD
PA166157015;rs2075572;VARIANT;PA166119022;METHAMPHETAMINE DEPENDENCE;DISEASE;PD
PA166157015;rs2075572;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166157015;rs2075572;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166156755;rs1126643;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166156755;rs1126643;VARIANT;PA443797;CORONARY DISEASE;DISEASE;PD
PA166156755;rs1126643;VARIANT;PA445019;MYOCARDIAL INFARCTION;DISEASE;PD
PA166156108;rs4646316;VARIANT;PA162263533;NEPHROTOXICITY;DISEASE;PD
PA166156108;rs4646316;VARIANT;PA162263534;OTOTOXICITY;DISEASE;PD
PA166156108;rs4646316;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166156108;rs4646316;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166179122;rs2228130;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166153818;rs10919563;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166156375;rs3732360;VARIANT;PA443340;ANEMIA;DISEASE;PD
PA166156375;rs3732360;VARIANT;PA445046;NASOPHARYNGEAL NEOPLASMS;DISEASE;PD
PA166155471;rs28399433;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166155471;rs28399433;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;
PA166155730;rs4553808;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;
PA166157298;rs1468412;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166163371;rs5744174;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166171039;rs61123830;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166177191;rs17724464;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166184136;rs11969064;VARIANT;PA165817398;MYELOSUPPRESSION;DISEASE;PD
PA166184136;rs11969064;VARIANT;PA446116;INFLAMMATORY BOWEL DISEASES;DISEASE;PD
PA166153643;rs1801131;VARIANT;PA166123368;SCHIZOAFFECTIVE DISORDER;DISEASE;PD
PA166153643;rs1801131;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166153643;rs1801131;VARIANT;PA443580;BURKITT LYMPHOMA;DISEASE;PD
PA166153643;rs1801131;VARIANT;PA444845;NON-HODGKIN LYMPHOMA;DISEASE;PD
PA166153643;rs1801131;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166153643;rs1801131;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166153643;rs1801131;VARIANT;PA446309;LYMPHOMA, T-CELL;DISEASE;PD
PA166153643;rs1801131;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166153643;rs1801131;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166154287;rs619586;VARIANT;PA444818;LUNG NEOPLASMS;DISEASE;PD
PA166157469;rs17143212;VARIANT;PA447215;PSYCHOTIC DISORDER;DISEASE;PD
PA166155349;rs238406;VARIANT;PA444773;LEUKOPENIA;DISEASE;PD
PA166155349;rs238406;VARIANT;PA445828;TESTICULAR NEOPLASMS;DISEASE;PD
PA166156687;rs56061981;VARIANT;PA446863;CHRONIC HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166181200;rs73208473;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;
PA166154788;rs2075797;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166178583;rs2162145;VARIANT;PA443890;DIABETES MELLITUS, TYPE 2;DISEASE;PD
PA166235681;rs11030096;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166156902;rs5985;VARIANT;PA446974;CHOROIDAL NEOVASCULARIZATION;DISEASE;PD
PA166178430;rs118088833;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166178430;rs118088833;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166163669;rs118192168;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166175800;rs8177374;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166160991;rs3759467;VARIANT;PA446023;VASCULITIS;DISEASE;PD
PA166178395;rs144991623;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166178395;rs144991623;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166157144;rs9345389;VARIANT;PA162263533;NEPHROTOXICITY;DISEASE;PD
PA166157144;rs9345389;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166157144;rs9345389;VARIANT;PA446714;RESIDUAL NEOPLASM;DISEASE;PD
PA166157240;rs6092;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166199002;rs6722745;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166155611;rs993648;VARIANT;PA447300;ACQUIRED LONG QT SYNDROME (ALQTS);DISEASE;PD
PA166157304;rs1800795;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166157304;rs1800795;VARIANT;PA443635;CARDIOVASCULAR DISEASE;DISEASE;PD
PA166157304;rs1800795;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166157304;rs1800795;VARIANT;PA446863;CHRONIC HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166155370;rs1799782;VARIANT;PA166123207;OVERALL SURVIVAL;DISEASE;PD
PA166155370;rs1799782;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166155370;rs1799782;VARIANT;PA443626;CARCINOMA, SQUAMOUS CELL;DISEASE;PD
PA166155370;rs1799782;VARIANT;PA444818;LUNG NEOPLASMS;DISEASE;PD
PA166179883;rs2236857;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166156517;rs1522113;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166319222;rs369103276;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166154861;rs1378942;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166154917;rs6493497;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166156121;rs5760410;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166157355;rs2293347;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166157355;rs2293347;VARIANT;PA445742;STOMACH NEOPLASMS;DISEASE;PD
PA166160473;rs1042718;VARIANT;PA444584;HYPOTENSIVE DISORDER;DISEASE;PD
PA166154490;rs11226;VARIANT;PA445204;OVARIAN NEOPLASMS;DISEASE;PD
PA166155208;rs2314339;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166157048;rs2781659;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166210014;rs1783835;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166159082;rs2514036;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166154450;rs11212617;VARIANT;PA443890;DIABETES MELLITUS, TYPE 2;DISEASE;PD
PA166180083;rs10028494;VARIANT;PA445210;PAIN, POSTOPERATIVE;DISEASE;PD
PA166210007;rs13125415;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166155368;rs1613662;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166156467;rs28933389;VARIANT;PA166122649;BUTYRYLCHOLINESTERASE DEFICIENCY;DISEASE;
PA166156467;rs28933389;VARIANT;PA443407;APNEA;DISEASE;
PA166176908;rs237025;VARIANT;PA447247;LIVER TRANSPLANTATION;DISEASE;
PA166161859;rs6908425;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166216422;rs62103056;VARIANT;PA444859;MALARIA;DISEASE;PD
PA166157204;rs41271330;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166154355;rs2237895;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;PD
PA166154355;rs2237895;VARIANT;PA443890;DIABETES MELLITUS, TYPE 2;DISEASE;PD
PA166157338;rs2235040;VARIANT;PA151958383;GASTROINTESTINAL STROMAL TUMORS;DISEASE;PD
PA166157338;rs2235040;VARIANT;PA447278;DEPRESSION;DISEASE;PD
PA166178400;rs58695150;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166178400;rs58695150;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166179466;rs2233914;VARIANT;PA166123207;OVERALL SURVIVAL;DISEASE;PD
PA166179466;rs2233914;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166154919;rs7170068;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;
PA166176780;rs274558;VARIANT;PA151958383;GASTROINTESTINAL STROMAL TUMORS;DISEASE;PD
PA166184298;rs17584499;VARIANT;PA443890;DIABETES MELLITUS, TYPE 2;DISEASE;PD
PA166238462;rs1051792;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166238462;rs1051792;VARIANT;PA447163;SPONDYLARTHROPATHIES;DISEASE;
PA166178547;rs254271;VARIANT;PA443890;DIABETES MELLITUS, TYPE 2;DISEASE;PD
PA166157367;rs2740574;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;PD
PA166157367;rs2740574;VARIANT;PA166114454;TRANSPLANT REJECTION;DISEASE;PD
PA166157367;rs2740574;VARIANT;PA443314;ALOPECIA;DISEASE;PD
PA166157367;rs2740574;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166157367;rs2740574;VARIANT;PA444065;EPILEPSY;DISEASE;
PA166157367;rs2740574;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166157367;rs2740574;VARIANT;PA444859;MALARIA;DISEASE;PD
PA166157367;rs2740574;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166157367;rs2740574;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166157367;rs2740574;VARIANT;PA445208;PAIN;DISEASE;PD
PA166157367;rs2740574;VARIANT;PA445828;TESTICULAR NEOPLASMS;DISEASE;PD
PA166157367;rs2740574;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;
PA166180323;rs193922762;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166157393;rs4646440;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166161141;rs12436663;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166155528;rs118192116;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166160678;rs319952;VARIANT;PA445941;TUBERCULOSIS;DISEASE;PD
PA166155113;rs12708954;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166254982;rs7858836;VARIANT;PA445210;PAIN, POSTOPERATIVE;DISEASE;PD
PA166157135;rs9274407;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166154515;rs1540339;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166154934;rs11854484;VARIANT;PA162263533;NEPHROTOXICITY;DISEASE;PD
PA166154934;rs11854484;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166154934;rs11854484;VARIANT;PA444445;HEPATITIS C VIRUS INFECTION;DISEASE;PD
PA166154934;rs11854484;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166156383;rs3814055;VARIANT;PA164925725;TOXIC LIVER DISEASE;DISEASE;PD
PA166156383;rs3814055;VARIANT;PA165817398;MYELOSUPPRESSION;DISEASE;PD
PA166156383;rs3814055;VARIANT;PA166124386;GASTROINTESTINAL TOXICITY;DISEASE;PD
PA166156383;rs3814055;VARIANT;PA166151827;ADVERSE EVENTS;DISEASE;PD
PA166156383;rs3814055;VARIANT;PA443512;URINARY BLADDER NEOPLASMS;DISEASE;PD
PA166156383;rs3814055;VARIANT;PA444065;EPILEPSY;DISEASE;
PA166154909;rs4646425;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166185919;rs190347120;VARIANT;PA443367;FABRY DISEASE;DISEASE;PD
PA166153699;rs2298805;VARIANT;PA445999;URTICARIA;DISEASE;PD
PA166156387;rs3842689;VARIANT;PA447230;HIV INFECTIONS;DISEASE;
PA166155091;rs9923231;VARIANT;PA166123298;OVER-ANTICOAGULATION;DISEASE;PD
PA166155091;rs9923231;VARIANT;PA166129531;TIME IN THERAPEUTIC RANGE;DISEASE;PD
PA166155091;rs9923231;VARIANT;PA166129532;TIME TO THERAPEUTIC INR;DISEASE;PD
PA166155091;rs9923231;VARIANT;PA166129534;TIME ABOVE THERAPEUTIC RANGE;DISEASE;PD
PA166155091;rs9923231;VARIANT;PA444368;HEART DISEASES;DISEASE;
PA166155091;rs9923231;VARIANT;PA444417;HEMORRHAGE;DISEASE;PD
PA166156537;rs2071559;VARIANT;PA443624;RENAL CELL CARCINOMA;DISEASE;PD
PA166156537;rs2071559;VARIANT;PA444447;HEPATOCELLULAR CARCINOMA;DISEASE;PD
PA166210013;rs576859;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166153791;rs7541245;VARIANT;PA443886;DIABETES MELLITUS;DISEASE;PD
PA166155725;rs4261716;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166154191;rs71486745;VARIANT;PA444065;EPILEPSY;DISEASE;
PA166154853;rs934635;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166155538;rs118192175;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166156656;rs11942466;VARIANT;PA445503;RECTAL NEOPLASMS;DISEASE;PD
PA166156656;rs11942466;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166176951;rs751655;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166257862;rs739296;VARIANT;PA166151827;ADVERSE EVENTS;DISEASE;PD
PA166164952;rs397508513;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166210004;rs1402398;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166154568;rs3834935;VARIANT;PA445046;NASOPHARYNGEAL NEOPLASMS;DISEASE;
PA166156440;rs10937158;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166185916;rs372966991;VARIANT;PA443367;FABRY DISEASE;DISEASE;PD
PA166155972;rs9024;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166155972;rs9024;VARIANT;PA445018;CARDIOMYOPATHIES;DISEASE;PD
PA166155972;rs9024;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166190881;rs11322783;VARIANT;PA166131628;RAPID VIROLOGICAL RESPONSE (RVR);DISEASE;
PA166190881;rs11322783;VARIANT;PA166131629;SUSTAINED VIROLOGICAL RESPONSE (SVR);DISEASE;PD
PA166190881;rs11322783;VARIANT;PA166170534;COMPLETE EARLY VIROLOGICAL RESPONSE;DISEASE;
PA166190881;rs11322783;VARIANT;PA444437;HEPATITIS B;DISEASE;
PA166190881;rs11322783;VARIANT;PA444445;HEPATITIS C;DISEASE;
PA166190881;rs11322783;VARIANT;PA446863;HEPATITIS C, CHRONIC;DISEASE;PD
PA166157117;rs6923761;VARIANT;PA443890;DIABETES MELLITUS, TYPE 2;DISEASE;PD
PA166157117;rs6923761;VARIANT;PA445131;OBESITY;DISEASE;PD
PA166157117;rs6923761;VARIANT;PA445376;POLYCYSTIC OVARY SYNDROME;DISEASE;PD
PA166155959;rs6108160;VARIANT;PA447278;DEPRESSION;DISEASE;PD
PA166153729;rs3003596;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;
PA166154536;rs2239179;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166156948;rs760761;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166155227;rs4795893;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166155036;rs2242446;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166156283;rs275651;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166157094;rs3957357;VARIANT;PA134850491;TRANSPLANTATION;DISEASE;
PA166157094;rs3957357;VARIANT;PA160680212;LYMPHOMA, LARGE B-CELL, DIFFUSE;DISEASE;PD
PA166157094;rs3957357;VARIANT;PA443340;ANEMIA;DISEASE;PD
PA166157094;rs3957357;VARIANT;PA445204;OVARIAN NEOPLASMS;DISEASE;PD
PA166157094;rs3957357;VARIANT;PA445594;SARCOMA;DISEASE;PD
PA166155913;rs1044397;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;
PA166182219;rs6517442;VARIANT;PA445208;PAIN;DISEASE;PD
PA166182219;rs6517442;VARIANT;PA446444;LOW BACK PAIN;DISEASE;PD
PA166268446;rs140410716;VARIANT;PA165108401;ACUTE CORONARY SYNDROME;DISEASE;PD
PA166268446;rs140410716;VARIANT;PA166129560;MAJOR ADVERSE CARDIAC EVENTS (MACE);DISEASE;PD
PA166184248;rs2770296;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166155724;rs4251961;VARIANT;PA443750;ULCERATIVE COLITIS;DISEASE;PD
PA166159103;rs3814995;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166154321;rs1150226;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166176958;rs11553441;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166199001;rs1275988;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166157763;rs3761847;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166156625;rs7668258;VARIANT;PA444065;EPILEPSY;DISEASE;PD
PA166156625;rs7668258;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166156770;rs1650697;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166156770;rs1650697;VARIANT;PA444937;MESOTHELIOMA;DISEASE;PD
PA166155941;rs3787430;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166178032;rs1800111;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166157118;rs6924995;VARIANT;PA444516;HYPERCHOLESTEROLEMIA;DISEASE;PD
PA166196881;rs2251214;VARIANT;PA446878;COCAINE DEPENDENCE;DISEASE;PD
PA166162705;rs74551128;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166177113;rs7625956;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166154027;rs3740065;VARIANT;PA164925725;TOXIC LIVER DISEASE;DISEASE;PD
PA166154027;rs3740065;VARIANT;PA166122058;MUCOSITIS;DISEASE;PD
PA166154027;rs3740065;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166154027;rs3740065;VARIANT;PA443580;BURKITT LYMPHOMA;DISEASE;PD
PA166154027;rs3740065;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166154027;rs3740065;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166154027;rs3740065;VARIANT;PA444840;LYMPHOMA;DISEASE;PD
PA166154027;rs3740065;VARIANT;PA445601;OSTEOSARCOMA;DISEASE;PD
PA166154027;rs3740065;VARIANT;PA445941;TUBERCULOSIS;DISEASE;PD
PA166154027;rs3740065;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166153793;rs7543016;VARIANT;PA445218;PANCREATIC NEOPLASMS;DISEASE;PD
PA166157289;rs1137617;VARIANT;PA447288;ESSENTIAL HYPERTENSION;DISEASE;PD
PA166185423;rs10419980;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166156655;rs11940316;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166156021;rs79663003;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166206601;rs168107;VARIANT;PA445048;NAUSEA;DISEASE;PD
PA166206601;rs168107;VARIANT;PA446051;VOMITING;DISEASE;PD
PA166319467;rs528152707;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166156940;rs714368;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166178409;rs4968187;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166178409;rs4968187;VARIANT;PA445113;NEUTROPENIA;DISEASE;PD
PA166183703;rs3823010;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166183703;rs3823010;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166183703;rs3823010;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166183703;rs3823010;VARIANT;PA446878;COCAINE DEPENDENCE;DISEASE;PD
PA166185410;rs4807493;VARIANT;PA443309;ALCOHOL ABUSE;DISEASE;PD
PA166154358;rs2276302;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166412244;rs2396243;VARIANT;PA444760;LEUKEMIA, MYELOID, ACUTE;DISEASE;
PA166157478;rs17655652;VARIANT;PA443886;DIABETES MELLITUS;DISEASE;PD
PA166157478;rs17655652;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166157478;rs17655652;VARIANT;PA446021;VASCULAR DISEASES;DISEASE;PD
PA166157400;rs4731426;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166156775;rs1801020;VARIANT;PA447054;STROKE;DISEASE;PD
PA166176946;rs12409352;VARIANT;PA447197;ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;DISEASE;PD
PA166154763;rs6113;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166154763;rs6113;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166177108;rs4261893;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166157818;rs10819043;VARIANT;PA444987;MULTIPLE SCLEROSIS;DISEASE;PD
PA166257865;rs185462714;VARIANT;PA166151827;ADVERSE EVENTS;DISEASE;PD
PA166156299;rs901865;VARIANT;PA166129521;SEDATION;DISEASE;PD
PA166156299;rs901865;VARIANT;PA445999;URTICARIA;DISEASE;PD
PA166155646;rs1801278;VARIANT;PA443890;DIABETES MELLITUS, TYPE 2;DISEASE;PD
PA166155802;rs11563250;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166156285;rs324023;VARIANT;PA447196;ANXIETY DISORDERS;DISEASE;PD
PA166155242;rs9915451;VARIANT;PA447288;ESSENTIAL HYPERTENSION;DISEASE;PD
PA166156983;rs1360780;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166156983;rs1360780;VARIANT;PA447278;DEPRESSION;DISEASE;PD
PA166177132;rs7035619;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166154070;rs4986893;VARIANT;PA162316739;MACULOPAPULAR EXANTHEMA;DISEASE;PD
PA166154070;rs4986893;VARIANT;PA445941;TUBERCULOSIS;DISEASE;PD
PA166157550;rs1048101;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166155372;rs1800469;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166177932;rs1997794;VARIANT;PA445043;OPIOID-RELATED DISORDERS;DISEASE;PD
PA166180080;rs4587017;VARIANT;PA445210;PAIN, POSTOPERATIVE;DISEASE;PD
PA166177188;rs10771998;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166184845;rs9891146;VARIANT;PA446876;SUBSTANCE-RELATED DISORDERS;DISEASE;
PA166157427;rs7779029;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166155224;rs4791040;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166158910;rs28358569;VARIANT;PA162263534;OTOTOXICITY;DISEASE;PD
PA166154719;rs7319981;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166154979;rs9597;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166157287;rs1074373;VARIANT;PA131285571;ASPIRIN-INDUCED ASTHMA;DISEASE;PD
PA166157287;rs1074373;VARIANT;PA443450;ASTHMA;DISEASE;PD
PA166157064;rs3094188;VARIANT;PA166120929;SEVERE CUTANEOUS ADVERSE REACTIONS;DISEASE;PD
PA166157064;rs3094188;VARIANT;PA444059;EPIDERMAL NECROLYSIS, TOXIC;DISEASE;PD
PA166157064;rs3094188;VARIANT;PA445738;STEVENS-JOHNSON SYNDROME;DISEASE;PD
PA166153612;rs1051740;VARIANT;PA443223;CONGENITAL ABNORMALITIES;DISEASE;PD
PA166153612;rs1051740;VARIANT;PA444065;EPILEPSY;DISEASE;PD
PA166153612;rs1051740;VARIANT;PA445204;OVARIAN NEOPLASMS;DISEASE;PD
PA166153612;rs1051740;VARIANT;PA446836;DISORDER OF FACIAL SKELETON;DISEASE;PD
PA166153604;rs951439;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166159984;rs12621220;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166203441;rs9694958;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166203441;rs9694958;VARIANT;PA444109;EXANTHEMA;DISEASE;PD
PA166184847;rs2381356;VARIANT;PA446876;SUBSTANCE-RELATED DISORDERS;DISEASE;
PA166156099;rs2298383;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166156099;rs2298383;VARIANT;PA446827;HEMATOLOGIC NEOPLASMS;DISEASE;PD
PA166177186;rs3128624;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166184208;rs2298897;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166157519;rs78655421;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166156766;rs1544938;VARIANT;PA447216;SCHIZOPHRENIA;DISEASE;PD
PA166155791;rs10497203;VARIANT;PA445425;PROSTATIC NEOPLASMS;DISEASE;PD
PA166156288;rs352139;VARIANT;PA443815;CROHN DISEASE;DISEASE;PD
PA166156288;rs352139;VARIANT;PA445451;PSORIASIS;DISEASE;PD
PA166156288;rs352139;VARIANT;PA446116;INFLAMMATORY BOWEL DISEASES;DISEASE;PD
PA166156663;rs13104811;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166156405;rs5853517;VARIANT;PA166123766;PLATELET AGGREGATION;DISEASE;
PA166154590;rs4363657;VARIANT;PA444997;MUSCULAR DISEASES;DISEASE;PD
PA166155928;rs2585428;VARIANT;PA444445;HEPATITIS C VIRUS INFECTION;DISEASE;
PA166155928;rs2585428;VARIANT;PA446432;BETA-THALASSEMIA AND RELATED DISEASES;DISEASE;
PA166177183;rs13204353;VARIANT;PA447321;MAJOR DEPRESSIVE DISORDER;DISEASE;PD
PA166179816;rs773123;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166157165;rs9483947;VARIANT;PA446432;BETA-THALASSEMIA AND RELATED DISEASES;DISEASE;PD
PA166154148;rs12255372;VARIANT;PA443890;DIABETES MELLITUS, TYPE 2;DISEASE;PD
PA166157804;rs10306135;VARIANT;PA165108401;ACUTE CORONARY SYNDROME;DISEASE;PD
PA166185908;rs104894828;VARIANT;PA443367;FABRY DISEASE;DISEASE;PD
PA166155576;rs193922878;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166155834;rs13431554;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166155834;rs13431554;VARIANT;PA443890;DIABETES MELLITUS, TYPE 2;DISEASE;PD
PA166185407;rs3743075;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166157938;CYP2C19 poor metabolizer;VARIANT;PA445009;MYCOSES;DISEASE;
PA166157938;CYP2C19 poor metabolizer;VARIANT;PA447321;DEPRESSIVE DISORDER, MAJOR;DISEASE;
PA166153986;rs1934969;VARIANT;PA444065;EPILEPSY;DISEASE;
PA166153817;rs10919035;VARIANT;PA444807;LONG QT SYNDROME;DISEASE;PD
PA166185406;rs16872401;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166155836;rs16853826;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
PA166157086;rs3815087;VARIANT;PA166120929;SEVERE CUTANEOUS ADVERSE REACTIONS;DISEASE;PD
PA166157086;rs3815087;VARIANT;PA444059;EPIDERMAL NECROLYSIS, TOXIC;DISEASE;PD
PA166157086;rs3815087;VARIANT;PA445738;STEVENS-JOHNSON SYNDROME;DISEASE;PD
PA166157565;rs1799931;VARIANT;PA165108622;DRUG INTERACTION WITH DRUG;DISEASE;PD
PA166157565;rs1799931;VARIANT;PA166151827;ADVERSE EVENTS;DISEASE;PD
PA166157565;rs1799931;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166157565;rs1799931;VARIANT;PA444546;HYPERSENSITIVITY;DISEASE;PD
PA166157565;rs1799931;VARIANT;PA445425;PROSTATIC NEOPLASMS;DISEASE;PD
PA166169899;rs36080650;VARIANT;PA445046;NASOPHARYNGEAL NEOPLASMS;DISEASE;PD
PA166232221;rs1386493;VARIANT;PA444460;HEROIN DEPENDENCE;DISEASE;PD
PA166185387;rs2036527;VARIANT;PA445876;TOBACCO USE DISORDER;DISEASE;PD
PA166154759;rs116855232;VARIANT;PA165817398;MYELOSUPPRESSION;DISEASE;PD
PA166154759;rs116855232;VARIANT;PA445221;PANCYTOPENIA;DISEASE;PD
PA166154759;rs116855232;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166154759;rs116855232;VARIANT;PA446116;INFLAMMATORY BOWEL DISEASES;DISEASE;PD
PA166156297;rs870995;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166201504;rs10885;VARIANT;PA443622;NON-SMALL CELL LUNG CARCINOMA;DISEASE;PD
PA166201504;rs10885;VARIANT;PA445846;THROMBOCYTOPENIA;DISEASE;PD
PA166155571;rs193922807;VARIANT;PA444863;MALIGNANT HYPERTHERMIA;DISEASE;PD
PA166154068;rs4933824;VARIANT;PA447300;ACQUIRED LONG QT SYNDROME (ALQTS);DISEASE;PD
PA166203411;rs2053071;VARIANT;PA164925725;TOXIC LIVER DISEASE;DISEASE;PD
PA166156020;rs78015114;VARIANT;PA447199;BIPOLAR DISORDER;DISEASE;PD
PA166154265;rs9937;VARIANT;PA445062;NEOPLASMS;DISEASE;PD
PA166155056;rs3785161;VARIANT;PA443797;CORONARY DISEASE;DISEASE;PD
PA166195023;rs324498;VARIANT;PA444552;HYPERTENSION;DISEASE;PD
PA166156418;rs6809699;VARIANT;PA443796;CORONARY ARTERY DISEASE;DISEASE;PD
PA166157501;rs62471956;VARIANT;PA165108401;ACUTE CORONARY SYNDROME;DISEASE;
PA166319705;rs575853463;VARIANT;PA443937;DRUG TOXICITY;DISEASE;PD
PA166154324;rs1176744;VARIANT;PA447208;MENTAL DISORDERS;DISEASE;PD
PA166153953;rs717620;VARIANT;PA165817016;KIDNEY TRANSPLANTATION;DISEASE;
PA166153953;rs717620;VARIANT;PA443560;BREAST NEOPLASMS;DISEASE;PD
PA166153953;rs717620;VARIANT;PA443756;COLONIC NEOPLASMS;DISEASE;PD
PA166153953;rs717620;VARIANT;PA444065;EPILEPSY;DISEASE;PD
PA166153953;rs717620;VARIANT;PA444109;EXANTHEMA;DISEASE;PD
PA166153953;rs717620;VARIANT;PA444516;HYPERCHOLESTEROLEMIA;DISEASE;PD
PA166153953;rs717620;VARIANT;PA444750;LEUKEMIA;DISEASE;PD
PA166153953;rs717620;VARIANT;PA444756;LYMPHOID LEUKEMIA;DISEASE;
PA166153953;rs717620;VARIANT;PA444840;LYMPHOMA;DISEASE;PD
PA166153953;rs717620;VARIANT;PA445601;OSTEOSARCOMA;DISEASE;PD
PA166153953;rs717620;VARIANT;PA446108;COLORECTAL NEOPLASMS;DISEASE;PD
PA166153953;rs717620;VARIANT;PA446155;ACUTE LYMPHOBLASTIC LEUKEMIA;DISEASE;PD
PA166153953;rs717620;VARIANT;PA446432;BETA-THALASSEMIA AND RELATED DISEASES;DISEASE;PD
PA166153953;rs717620;VARIANT;PA447230;HIV INFECTIOUS DISEASE;DISEASE;PD
PA166164949;rs397508442;VARIANT;PA443829;CYSTIC FIBROSIS;DISEASE;PD
PA166155301;rs6506569;VARIANT;PA443434;RHEUMATOID ARTHRITIS;DISEASE;PD
